data_2rel_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rel _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.403 HG13 ' HG3' ' A' ' 34' ' ' LYS . 20.7 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.123 0.487 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.99 108.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.734 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -89.69 -21.03 22.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 108.949 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.05 72.44 76.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.768 . . . . 0.0 109.238 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.46 -93.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.56 2.174 . . . . 0.0 110.467 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 56' ' ' PRO . . . -136.52 -151.44 6.05 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -125.96 137.77 53.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -1.143 . . . . 0.0 109.708 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.23 152.72 95.6 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.903 . . . . 0.0 109.154 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.09 16.09 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.604 2.203 . . . . 0.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER 62.62 123.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.913 -1.117 . . . . 0.0 108.526 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' ILE . 4.4 mp -143.65 126.45 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.339 -0.851 . . . . 0.0 109.644 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.532 ' HG ' ' CG2' ' A' ' 21' ' ' ILE . 47.8 tp 37.11 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.416 0.627 . . . . 0.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -150.15 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.879 . . . . 0.0 108.965 178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.572 ' O ' ' C ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -173.87 35.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.921 -1.112 . . . . 0.0 109.682 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.572 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 5.13 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.557 0.694 . . . . 0.0 111.709 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.86 61.49 0.88 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.8 mmt -96.07 -100.12 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.497 -0.752 . . . . 0.0 110.319 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -117.68 -134.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.762 -1.211 . . . . 0.0 110.006 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -111.79 90.51 13.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 109.761 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 34.6 Cg_endo -76.12 168.33 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.711 2.274 . . . . 0.0 110.271 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' C ' ' ND2' ' A' ' 30' ' ' ASN . 36.0 Cg_endo -77.87 174.93 11.82 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.559 2.172 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.532 ' CB ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -155.27 134.97 12.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -85.86 -10.2 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 30.3 p -161.02 163.78 31.4 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' HB3' ' CE ' ' A' ' 34' ' ' LYS . 93.7 mt -158.04 -60.54 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.122 -0.986 . . . . 0.0 108.52 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CE ' ' HB3' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -120.35 -39.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -84.46 58.43 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.584 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.524 ' CG2' ' SG ' ' A' ' 38' ' ' CYS . 27.1 m -42.64 125.3 3.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.54 44.88 1.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.33 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 36' ' ' THR . 1.8 m -102.24 116.16 63.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.99 102.68 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.169 1.913 . . . . 0.0 110.38 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.8 -130.34 4.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 41' ' ' ILE . 8.6 tp -117.95 58.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -1.168 . . . . 0.0 109.288 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -111.51 -178.02 3.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.432 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 36' ' ' THR . 1.2 tmtt? -164.08 125.88 2.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.359 -0.838 . . . . 0.0 108.759 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 21.9 t -56.22 112.79 1.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.088 -1.007 . . . . 0.0 110.236 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -124.78 -159.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 109.214 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 19' ' ' ILE . 5.1 mt-10 -116.37 113.51 23.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.81 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -94.47 62.35 1.72 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 49' ' ' CYS . 39.0 p 44.52 85.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.326 -1.102 . . . . 0.0 108.889 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER 87.4 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.675 -0.64 . . . . 0.0 109.648 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.53 153.15 11.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.534 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -111.27 162.23 15.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -1.047 . . . . 0.0 109.202 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -170.9 -170.4 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.419 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 52.1 m -77.06 115.68 17.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 110.86 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 60.7 m-85 -129.54 137.43 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.932 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 56' ' ' PRO . 4.8 p -63.1 131.77 94.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.022 . . . . 0.0 108.625 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 55' ' ' VAL . 37.3 Cg_endo -81.29 51.41 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.48 2.12 . . . . 0.0 110.672 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.593 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 7.7 p . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.322 0.582 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 -162.27 1.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -72.57 -28.22 62.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -116.53 109.46 43.78 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 108.887 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.12 -175.63 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.402 2.068 . . . . 0.0 111.22 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.06 -125.64 0.16 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -109.14 73.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -1.17 . . . . 0.0 109.657 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 50.0 m -60.04 153.61 54.84 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.18 -0.95 . . . . 0.0 109.073 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -81.84 -157.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.132 2.554 . . . . 0.0 111.219 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -81.45 150.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.5 HG13 ' HA2' ' A' ' 47' ' ' GLY . 20.0 mm -120.48 128.33 76.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 111.254 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.624 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.49 -24.85 14.29 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.624 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 10.8 tp 117.95 92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.531 0.732 . . . . 0.0 110.414 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 27.32 39.3 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.66 -0.65 . . . . 0.0 112.32 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.669 ' O ' ' N ' ' A' ' 25' ' ' MET . 4.0 p 38.06 21.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.186 -0.946 . . . . 0.0 112.46 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' O ' ' C ' ' A' ' 25' ' ' MET . . . 45.78 -87.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.895 1.225 . . . . 0.0 108.453 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.669 ' N ' ' O ' ' A' ' 23' ' ' CYS . 11.4 mmm -5.22 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.299 0.571 . . . . 0.0 111.759 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 2.6 pt? -51.29 166.39 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.764 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 58.74 80.47 0.28 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 109.673 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 132.42 10.5 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.611 2.208 . . . . 0.0 110.213 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 36.6 Cg_endo -81.03 -164.82 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.519 2.146 . . . . 0.0 110.324 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 29' ' ' PRO . 1.5 m120 -150.5 111.05 4.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.351 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.45 -10.83 20.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.988 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 16.1 p -158.21 155.83 29.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.04 -1.037 . . . . 0.0 108.435 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 87.3 mt -152.39 -41.35 0.1 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.033 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 174.44 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' OD2' HG23 ' A' ' 36' ' ' THR . 13.6 t70 -41.32 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.278 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER 172.45 -36.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.123 . . . . 0.0 110.057 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 17.2 t0 -42.33 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.86 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' THR . 1.3 m -170.63 65.77 0.47 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 109.691 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.7 Cg_endo -79.46 154.75 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.878 2.385 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -68.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.408 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -84.24 -118.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -1.228 . . . . 0.0 110.76 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.586 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 11.3 ttmt -142.37 -34.58 0.45 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.625 -1.297 . . . . 0.0 110.247 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -163.9 1.31 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 t -106.92 143.98 34.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -138.01 -166.81 2.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.506 -0.746 . . . . 0.0 109.001 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 51' ' ' MET . 1.7 mp0 -122.99 124.72 43.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 19' ' ' ILE . . . -149.56 -145.4 4.12 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.139 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -65.89 117.0 7.65 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.913 -0.757 . . . . 0.0 109.826 -178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER 78.92 91.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.602 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -141.38 20.92 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -117.64 149.33 40.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -1.04 . . . . 0.0 109.14 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.421 ' C ' ' SG ' ' A' ' 32' ' ' CYS . . . -145.1 162.39 37.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.505 ' HB3' HD13 ' A' ' 41' ' ' ILE . 3.8 m -66.6 113.34 4.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.222 -0.924 . . . . 0.0 110.47 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 19.2 m-30 -112.22 -172.21 2.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' CG2' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -109.57 81.97 2.05 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.424 -0.798 . . . . 0.0 108.948 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 33.7 Cg_endo -73.74 178.02 7.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.656 2.237 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.534 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG2' ' HG2' ' A' ' 34' ' ' LYS . 65.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.412 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -168.62 75.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.585 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 12' ' ' LYS . 4.1 t -108.77 -39.81 5.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 2.1 mtmt -49.16 -51.76 53.85 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 109.685 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.1 Cg_endo -78.65 -47.07 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.385 2.056 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.86 -164.23 2.6 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -137.45 79.27 1.74 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.238 . . . . 0.0 109.821 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.2 m -47.8 166.25 0.21 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.197 -0.94 . . . . 0.0 108.752 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 34.4 Cg_endo -76.97 7.01 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.286 1.99 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' PRO . 14.5 mm 61.03 131.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 48' ' ' SER . 2.3 mm -132.76 -138.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 2.4 pt? -161.7 -41.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.534 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 39.7 mm -153.71 -105.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.447 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' CYS . 4.3 mtp180 169.65 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.685 -1.259 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 14.0 p 43.12 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 111.377 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' CG ' ' A' ' 25' ' ' MET . . . -73.45 83.63 1.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.402 -1.436 . . . . 0.0 107.633 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -168.23 96.26 0.41 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.4 -0.813 . . . . 0.0 109.141 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 5.3 tt -45.6 135.91 6.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.823 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER 163.95 -52.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.887 . . . . 0.0 110.315 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 27' ' ' ASN . 35.8 Cg_endo -80.33 111.26 2.6 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.654 2.236 . . . . 0.0 110.33 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 27' ' ' ASN . 36.6 Cg_endo -77.72 -100.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.197 1.931 . . . . 0.0 110.436 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' CG ' ' C ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -162.41 117.42 1.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.843 -1.161 . . . . 0.0 109.303 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.79 -26.23 34.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' C ' HD22 ' A' ' 33' ' ' LEU . 25.0 p -151.8 -176.21 5.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.32 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD22 ' C ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 173.86 -34.1 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.163 -0.961 . . . . 0.0 109.339 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG2' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 179.61 122.36 0.06 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 110.348 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 42.61 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.435 -0.791 . . . . 0.0 109.612 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.33 -142.48 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.346 -0.846 . . . . 0.0 109.184 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.536 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 47.41 60.54 15.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.032 -1.043 . . . . 0.0 109.416 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.6 Cg_endo -79.0 -179.86 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.591 2.194 . . . . 0.0 110.659 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . 44.9 -161.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 3.3 tt -41.81 -40.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.989 . . . . 0.0 109.824 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 5.4 mtmt -53.29 134.31 39.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.875 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HB2' ' HG3' ' A' ' 56' ' ' PRO . 3.2 mttt -149.25 148.84 30.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.421 -0.799 . . . . 0.0 109.002 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.62 124.15 20.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.033 -1.042 . . . . 0.0 109.789 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -133.64 -170.0 2.41 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 19' ' ' ILE . 36.0 mt-10 -91.82 162.21 14.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' C ' ' CG2' ' A' ' 19' ' ' ILE . . . -144.09 169.1 26.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -84.75 13.33 5.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.183 -1.186 . . . . 0.0 109.984 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.8 t 177.05 71.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.81 102.15 2.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.508 ' HE2' ' CZ ' ' A' ' 22' ' ' ARG . 1.6 mtt -49.3 168.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' CD1' ' A' ' 54' ' ' PHE . . . -179.53 168.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.993 -1.067 . . . . 0.0 110.053 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 m -68.65 99.75 1.04 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.602 ' CD2' ' HG3' ' A' ' 17' ' ' PRO . 96.2 m-85 -91.95 -169.16 2.19 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.279 -0.888 . . . . 0.0 109.046 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.5 104.92 36.59 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 34.9 Cg_endo -76.34 -159.75 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.186 1.924 . . . . 0.0 110.571 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 56' ' ' PRO . 2.3 pp0? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.99 35.18 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.256 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -122.13 153.01 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 115.05 12.05 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -77.85 -156.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.243 1.962 . . . . 0.0 110.02 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . -41.74 -93.83 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.09 131.63 40.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.244 . . . . 0.0 109.703 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.0 m -96.14 151.81 38.45 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.81 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.122 2.548 . . . . 0.0 110.328 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 19' ' ' ILE . 33.9 mm -120.99 140.68 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.319 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -115.04 -165.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -70.15 -44.69 68.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.479 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 161.93 -64.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.543 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -175.37 77.77 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -32.75 113.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.915 0.864 . . . . 0.0 110.625 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.1 59.16 3.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.478 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -122.32 101.5 7.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 pt? 38.18 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.59 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -108.86 93.48 12.49 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.526 -0.734 . . . . 0.0 109.668 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.0 Cg_endo -72.92 144.3 38.22 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.301 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 -164.57 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.683 2.255 . . . . 0.0 110.705 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.455 ' N ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -143.96 112.79 6.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 22.8 ttt180 -55.46 -18.35 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' CB ' ' OG1' ' A' ' 36' ' ' THR . 20.9 p -151.12 177.96 9.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 109.001 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.49 HD13 ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -174.86 -40.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.008 -1.058 . . . . 0.0 110.073 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.49 ' CG ' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -141.61 -56.56 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.423 ' O ' ' HB ' ' A' ' 36' ' ' THR . 8.2 t70 -87.94 -97.32 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.0 109.227 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.6 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 16.4 m 61.22 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 109.785 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 36' ' ' THR . 7.8 t70 91.93 -21.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 37' ' ' ASP . 4.6 m 56.67 162.46 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.5 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 35.9 Cg_endo -78.98 -89.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.658 2.238 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -58.39 -158.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.4 tp -75.86 82.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -1.107 . . . . 0.0 109.347 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -130.39 174.55 9.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.03 134.14 11.36 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 33.4 t -56.22 101.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.533 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.575 ' CB ' ' CD2' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -96.87 -167.36 1.54 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -116.36 93.99 4.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.782 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -72.67 -162.27 6.38 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.526 ' N ' HG13 ' A' ' 19' ' ' ILE . 5.5 p -94.37 -54.93 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.106 -1.232 . . . . 0.0 109.483 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 28' ' ' PRO . 10.1 t -67.02 -65.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.45 147.11 18.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.5 mtt -47.95 167.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 108.999 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -172.65 -176.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.454 ' SG ' HG22 ' A' ' 36' ' ' THR . 3.5 m -91.58 98.63 11.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 109.315 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CD2' ' CB ' ' A' ' 45' ' ' CYS . 13.5 m-30 -100.86 144.02 30.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 109.519 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 55' ' ' VAL . 9.9 p -75.41 120.15 80.31 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 108.964 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.4 -172.81 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.302 2.001 . . . . 0.0 110.919 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' OXT' ' CG ' ' A' ' 57' ' ' GLN . 3.0 pt20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.621 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -98.88 -84.76 0.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 12' ' ' LYS . 23.7 m -119.91 -94.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.081 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -131.94 57.08 27.38 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.959 -1.088 . . . . 0.0 109.505 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -77.94 -171.97 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.632 2.221 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . 55.19 169.02 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -129.23 135.11 48.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -1.056 . . . . 0.0 109.291 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 60.1 m -66.94 160.19 71.38 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 18' ' ' ILE . 36.4 Cg_endo -79.56 43.73 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 123.107 2.538 . . . . 0.0 111.589 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 17' ' ' PRO . 2.5 tp 40.47 100.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.89 . . . . 0.0 110.747 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -130.32 175.53 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 108.281 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -139.21 -65.29 0.49 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.534 -1.354 . . . . 0.0 111.78 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -38.16 85.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.589 0.709 . . . . 0.0 111.187 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' LEU . 3.5 mtt180 -81.59 2.41 29.4 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 25' ' ' MET . 17.7 p 38.5 51.74 1.69 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.663 . . . . 0.0 110.661 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 89.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.067 -1.021 . . . . 0.0 109.028 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -127.23 -103.46 0.34 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.697 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 2.0 pt? -164.57 26.08 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.508 -1.37 . . . . 0.0 110.84 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 2.9 m-20 164.76 80.07 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.859 -1.15 . . . . 0.0 110.145 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.03 170.37 17.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.517 2.145 . . . . 0.0 110.265 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.31 175.27 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.696 2.264 . . . . 0.0 110.353 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -144.56 93.91 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 109.389 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.525 ' CG ' ' HB3' ' A' ' 52' ' ' ALA . 10.7 tpt180 -89.61 -10.86 44.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.766 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 52' ' ' ALA . 17.5 p -153.56 169.01 24.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.972 -1.08 . . . . 0.0 109.814 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER 179.63 42.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.468 -0.77 . . . . 0.0 108.942 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 20.2 mtpt 65.34 -110.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 36' ' ' THR . 2.5 m-20 44.35 41.93 4.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.616 -1.303 . . . . 0.0 109.752 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 43.45 70.95 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.62 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -139.24 -169.57 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 42' ' ' LYS . 13.6 m 62.63 84.36 0.19 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.07 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.613 2.209 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.49 -130.63 45.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.491 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 1.6 tt -122.38 66.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -120.67 -162.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.749 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER 178.61 122.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.084 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.403 ' N ' ' HD3' ' A' ' 43' ' ' LYS . 50.7 t -49.93 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 110.166 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.87 -166.23 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' A' ' 19' ' ' ILE . 2.7 tt0 -118.49 105.93 12.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 109.315 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.614 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -97.93 88.83 0.93 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.194 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 57.44 -98.99 0.09 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.606 -0.937 . . . . 0.0 109.799 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -100.09 118.41 36.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.902 -1.124 . . . . 0.0 110.055 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 143.46 3.2 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -87.68 168.33 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -1.016 . . . . 0.0 109.342 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 54' ' ' PHE . . . -168.88 158.69 9.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 108.845 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 61.7 m -63.86 94.48 0.1 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.879 -1.138 . . . . 0.0 109.194 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.614 ' CZ ' ' HA3' ' A' ' 47' ' ' GLY . 90.6 m-85 -94.24 178.92 5.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.15 130.3 25.27 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.29 157.84 29.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.329 2.02 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.397 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 13.7 m 66.65 -149.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.628 -1.295 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 12' ' ' LYS . 1.7 t -159.44 -49.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 ptmt -139.01 61.85 23.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 35.5 Cg_endo -77.78 -84.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.633 2.222 . . . . 0.0 110.473 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.38 -138.21 5.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 107.49 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.11 155.26 90.86 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.37 -167.96 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 110.596 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -121.88 141.08 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.089 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.547 ' CD1' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -132.57 166.97 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 109.263 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -44.86 -71.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.521 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 90.6 mt -154.76 -109.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' SER . 22.1 mmm-85 -154.33 27.04 0.46 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.824 -1.172 . . . . 0.0 108.467 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 13.8 p 39.51 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.259 1.028 . . . . 0.0 110.415 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.76 55.94 3.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.605 -1.31 . . . . 0.0 108.936 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.6 mmm -98.53 -98.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.433 -0.792 . . . . 0.0 110.389 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 -105.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.595 -1.315 . . . . 0.0 110.43 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.78 92.31 49.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.782 -1.199 . . . . 0.0 109.865 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.33 164.87 33.12 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.374 2.05 . . . . 0.0 110.173 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 35.6 Cg_endo -77.87 177.43 8.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.702 2.268 . . . . 0.0 110.788 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' OD1' ' HA2' ' A' ' 50' ' ' GLY . 60.8 m-80 -158.84 157.76 32.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.674 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -42.78 5.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -145.75 166.55 25.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -161.81 51.54 0.23 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 109.35 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.5 mmtt 79.87 51.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.343 1.068 . . . . 0.0 108.97 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.07 -97.62 0.06 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.576 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.8 t -156.31 138.39 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.383 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 173.77 -27.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.16 94.05 20.1 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 109.161 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 35.4 Cg_endo -77.6 -27.71 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.69 2.26 . . . . 0.0 110.756 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -61.68 -125.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 5.1 tt -129.72 42.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.169 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' PHE . 23.2 mttt -119.82 -174.69 2.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 109.83 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 42' ' ' LYS . 58.8 mmtt -149.2 167.33 26.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.51 92.08 5.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.43 -1.419 . . . . 0.0 111.041 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 96.6 m -92.29 -165.17 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' ' CD1' ' A' ' 19' ' ' ILE . 7.9 mt-10 -101.52 140.52 35.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.699 -1.251 . . . . 0.0 109.688 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 48' ' ' SER . . . -122.3 33.35 4.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.591 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 8.0 t 75.9 -24.16 0.23 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.214 -0.58 . . . . 0.0 110.714 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 23.5 t -162.18 91.71 0.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.671 -1.268 . . . . 0.0 109.214 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' HA2' ' OD1' ' A' ' 30' ' ' ASN . . . 100.23 139.23 10.68 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -81.94 150.6 27.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -1.161 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.49 170.35 22.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 108.929 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 14.4 m -80.28 109.65 14.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.053 -1.029 . . . . 0.0 110.674 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m-85 -105.25 142.16 35.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 8.4 p -79.26 131.97 64.24 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.983 -1.073 . . . . 0.0 109.487 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 36.2 Cg_endo -78.62 -175.65 2.85 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.36 2.04 . . . . 0.0 110.667 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.18 71.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 4.4 t -152.64 160.59 43.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.094 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.75 61.31 15.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.984 -1.072 . . . . 0.0 110.267 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.7 Cg_endo -81.82 -40.65 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.509 2.139 . . . . 0.0 110.73 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 57' ' ' GLN . . . -58.51 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.947 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 10.1 t -161.35 75.0 0.49 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.034 -1.274 . . . . 0.0 110.819 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 40.6 m -93.48 145.12 29.38 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 120.409 -1.432 . . . . 0.0 108.581 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.09 -163.38 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.56 2.174 . . . . 0.0 110.585 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.472 ' O ' HD12 ' A' ' 19' ' ' ILE . 7.2 tp -85.35 131.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 47' ' ' GLY . 27.3 mm -136.57 114.51 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 117.58 -1.648 . . . . 0.0 113.579 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -101.69 104.52 15.34 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.58 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -75.65 80.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.669 -1.269 . . . . 0.0 109.748 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.58 ' CD ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.13 6.16 3.6 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.742 -0.599 . . . . 0.0 110.95 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' C ' ' O ' ' A' ' 22' ' ' ARG . 19.0 p -18.39 132.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.984 0.421 . . . . 0.0 111.624 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.89 60.13 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.6 mmt -143.56 124.76 14.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 2.9 tp -75.91 134.12 40.34 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 m120 77.03 90.52 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 34.0 Cg_endo -75.86 120.6 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.656 2.237 . . . . 0.0 111.363 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' ASN . 36.1 Cg_endo -78.75 -175.84 2.96 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.321 2.014 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 29' ' ' PRO . 56.8 m-80 -159.05 129.25 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -25.61 21.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 1.6 p -174.0 -169.55 0.49 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -161.2 -41.78 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 109.705 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 -65.87 1.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.937 . . . . 0.0 108.972 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -160.29 82.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.2 m -106.85 -77.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -118.66 -111.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.846 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 39.99 86.82 0.12 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 0.0 109.401 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 35.3 Cg_endo -77.16 178.43 7.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.444 2.096 . . . . 0.0 110.534 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.07 -178.92 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.449 ' HB ' ' HG3' ' A' ' 56' ' ' PRO . 8.7 pt -48.89 -24.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.118 -1.225 . . . . 0.0 109.075 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -52.87 138.11 30.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.166 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -153.51 -169.54 3.33 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.15 132.48 34.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.843 -1.161 . . . . 0.0 111.757 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 1.5 m -134.64 -166.38 1.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 19' ' ' ILE . 61.6 mt-10 -87.87 167.47 13.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.577 -1.327 . . . . 0.0 109.283 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' HG23 ' A' ' 19' ' ' ILE . . . -161.53 165.76 35.7 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -43.28 -43.45 4.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.205 -1.174 . . . . 0.0 109.033 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' N ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -116.9 129.52 56.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.789 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' CYS . . . 39.83 -115.54 0.58 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 mtt -149.35 176.98 10.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -1.117 . . . . 0.0 109.701 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -168.84 -173.61 1.89 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 60.8 m -86.48 96.96 10.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.785 -1.197 . . . . 0.0 111.936 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 47.9 m-85 -100.14 -124.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 108.183 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' CG1' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -86.59 -168.24 0.18 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.591 ' CD ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 Cg_endo -72.22 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 120.725 0.95 . . . . 0.0 111.823 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' CA ' ' HA3' ' A' ' 14' ' ' GLY . 32.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.234 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 -155.5 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.163 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 11' ' ' THR . 17.1 m -111.67 64.88 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -82.42 -55.29 0.57 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -79.77 177.36 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.327 2.018 . . . . 0.0 110.554 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.67 145.56 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.7 t -100.54 113.12 25.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -1.169 . . . . 0.0 109.51 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.2 m -72.21 137.64 81.55 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.573 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.2 Cg_endo -79.67 169.01 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.485 2.123 . . . . 0.0 110.148 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 mp -94.14 132.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.976 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.59 HG13 ' N ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -96.73 172.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 108.837 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 1.8 pt? -56.83 -55.85 29.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.052 -1.03 . . . . 0.0 110.388 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.546 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 36.4 mm -160.35 -104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.867 -1.146 . . . . 0.0 109.138 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.514 ' N ' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -143.53 102.74 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.377 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -35.93 124.06 0.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.318 0.58 . . . . 0.0 110.584 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.62 58.67 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.459 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 0.8 OUTLIER -127.93 124.15 36.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.97 3.6 14.27 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.576 -0.703 . . . . 0.0 109.425 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -129.83 77.73 76.33 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.324 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.32 134.6 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.481 2.121 . . . . 0.0 110.484 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 36.3 Cg_endo -77.77 -171.36 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.33 2.02 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 82.4 m-20 -158.84 100.49 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 109.704 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -23.0 42.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 0.0 108.933 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 37' ' ' ASP . 1.6 p -164.57 163.99 21.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -158.27 27.69 0.25 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.988 -1.07 . . . . 0.0 109.05 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -177.16 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -161.24 45.88 0.18 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.492 -0.755 . . . . 0.0 109.121 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -134.52 64.84 1.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 109.706 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 171.26 -171.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.024 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.67 76.83 0.5 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.072 -1.017 . . . . 0.0 108.856 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.7 -25.03 12.92 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.539 2.16 . . . . 0.0 110.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.76 -154.42 3.98 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.5 tt -86.5 51.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.147 -1.208 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 1.4 mptp? -131.2 177.83 7.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.022 -1.049 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -160.35 176.08 12.09 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -78.45 128.83 34.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.096 -1.628 . . . . 0.0 110.805 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.89 -165.99 2.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' HD13 ' A' ' 19' ' ' ILE . 3.1 tt0 -86.37 157.24 19.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.758 -1.213 . . . . 0.0 109.338 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 48' ' ' SER . . . -152.55 20.22 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.263 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.59 ' N ' HG13 ' A' ' 19' ' ' ILE . 1.1 p 82.45 -22.78 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.443 -1.033 . . . . 0.0 109.255 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 t -140.7 101.97 4.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 108.979 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 51' ' ' MET . . . 64.81 -126.36 32.01 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.476 ' CG ' ' C ' ' A' ' 50' ' ' GLY . 6.3 mtt -155.49 153.25 29.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -1.095 . . . . 0.0 108.57 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.34 -171.75 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 109.438 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 34.6 m -79.0 130.44 35.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 110.211 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.573 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 69.6 m-85 -129.23 172.37 11.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.481 -0.762 . . . . 0.0 109.188 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 55' ' ' VAL . 8.4 p -96.06 108.97 44.45 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 37.2 Cg_endo -80.74 -156.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.364 2.042 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.363 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.547 HG11 ' CB ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 26.5 p 173.61 162.61 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.078 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 13' ' ' PRO . 1.5 m -128.99 -168.74 1.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.0 mmtp -89.03 -43.89 0.44 Allowed Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.169 -0.957 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.2 Cg_endo -78.96 -157.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.172 1.915 . . . . 0.0 110.874 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' CA ' ' HB2' ' A' ' 57' ' ' GLN . . . -40.86 101.87 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.87 -42.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.0 109.733 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.82 142.66 37.16 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 35.4 Cg_endo -78.93 -176.68 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.58 2.186 . . . . 0.0 110.929 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -80.18 137.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 109.126 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.502 ' CG2' ' C ' ' A' ' 47' ' ' GLY . 38.5 mm -136.76 101.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.0 110.124 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -45.14 -93.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.582 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 5.5 tp -121.84 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.582 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 15.3 mtm-85 -143.21 56.46 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.316 -1.49 . . . . 0.0 109.509 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.569 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.2 p 34.34 55.42 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.839 -0.538 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 23' ' ' CYS . . . -20.04 -59.35 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.996 -0.44 . . . . 0.0 111.071 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 4.5 mmt 39.1 -98.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 110.02 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -150.42 -69.66 0.19 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.043 -1.035 . . . . 0.0 109.912 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -142.03 86.28 10.48 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.014 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.97 142.01 19.39 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.605 2.204 . . . . 0.0 110.12 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.38 -168.2 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.658 2.238 . . . . 0.0 110.776 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -164.2 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.288 -0.883 . . . . 0.0 109.358 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -142.95 -33.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -169.07 174.45 6.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -147.98 -38.56 0.18 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.875 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' CB ' HG11 ' A' ' 9' ' ' VAL . 11.9 pttm -170.21 -40.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.727 -1.233 . . . . 0.0 110.455 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.05 21.81 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.202 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.536 ' HB ' ' CB ' ' A' ' 32' ' ' CYS . 3.6 m -111.79 164.68 12.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 109.364 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -108.39 139.92 42.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.677 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 29.8 m -115.86 84.81 13.56 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 36.0 Cg_endo -79.54 67.62 8.54 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.474 2.116 . . . . 0.0 110.083 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.89 -40.25 0.07 OUTLIER Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.409 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.59 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 10.1 tt -148.85 90.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.777 -1.425 . . . . 0.0 110.912 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.59 ' CB ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER 45.86 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 112.291 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -160.68 -168.53 2.14 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.932 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.02 152.52 30.88 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.124 0.964 . . . . 0.0 111.129 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 1.5 m -160.62 -169.47 2.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 16.0 mt-10 -82.98 156.45 23.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.912 -1.118 . . . . 0.0 108.968 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 19' ' ' ILE . . . -139.77 151.89 22.29 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.945 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 14.1 m -64.55 -9.71 21.01 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -1.064 . . . . 0.0 109.568 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -161.55 86.79 0.67 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' MET . . . 88.75 112.86 1.22 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 45' ' ' CYS . 1.8 ttt -47.94 173.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 108.799 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' CE1' ' A' ' 54' ' ' PHE . . . 165.41 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.5 ' HB3' HG21 ' A' ' 41' ' ' ILE . 17.3 m -85.68 122.83 30.34 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.829 -1.17 . . . . 0.0 110.004 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 11.6 m-85 -116.15 179.55 3.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' HB ' ' CG1' ' A' ' 41' ' ' ILE . 9.0 p -113.55 86.14 9.95 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 42' ' ' LYS . 37.2 Cg_endo -78.9 -154.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.041 2.494 . . . . 0.0 110.775 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.547 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 73.1 mt-30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' CB ' ' A' ' 34' ' ' LYS . 31.5 m . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.29 0.567 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.513 ' HB3' ' CE ' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -67.12 113.05 4.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 11' ' ' THR . 18.7 m -88.74 60.84 5.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 5.5 mttt -95.78 -49.19 0.25 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 111.686 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 37.1 Cg_endo -78.71 -104.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.002 1.801 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' PRO . . . 32.7 -142.21 0.05 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 39.6 t -143.11 68.47 1.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.008 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 84.4 m -64.41 155.12 81.79 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.054 -1.029 . . . . 0.0 108.874 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 36.4 Cg_endo -78.21 -176.53 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.458 2.105 . . . . 0.0 110.38 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -107.97 113.06 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.225 -0.922 . . . . 0.0 109.058 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.597 ' CD1' ' HA2' ' A' ' 47' ' ' GLY . 3.4 mm -90.45 -166.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.182 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 21' ' ' ILE . 3.5 pp -117.5 -53.79 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.55 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.601 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -162.99 178.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 mtp180 -94.98 94.61 8.09 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.824 -1.172 . . . . 0.0 108.803 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -12.19 -53.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 79.02 -45.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.744 -1.223 . . . . 0.0 110.584 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.452 ' C ' ' O ' ' A' ' 24' ' ' ALA . 4.0 mmm -32.62 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.456 -0.777 . . . . 0.0 111.652 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -85.67 -178.32 6.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.057 -1.027 . . . . 0.0 110.662 -178.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -113.79 85.95 10.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.668 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' CG ' ' O ' ' A' ' 49' ' ' CYS . 35.8 Cg_endo -76.15 138.07 19.94 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.667 2.244 . . . . 0.0 110.291 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -79.44 -102.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 110.355 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -161.61 154.82 21.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.773 -1.205 . . . . 0.0 109.563 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -104.16 -32.52 9.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 108.933 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -166.1 156.32 12.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.586 ' CD1' ' C ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -149.12 11.2 0.81 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.041 -177.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' CB ' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -177.82 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.943 -1.098 . . . . 0.0 109.686 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.8 82.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.434 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 93.9 m -159.24 123.79 4.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 57.89 -156.14 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.582 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 54.82 64.52 5.87 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 109.189 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 35.6 Cg_endo -78.63 128.21 8.5 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.771 2.314 . . . . 0.0 110.952 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.31 -155.13 20.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.47 -12.4 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.506 -0.996 . . . . 0.0 109.82 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.2 mtmp? -79.46 143.15 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.219 -0.926 . . . . 0.0 110.225 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 27.1 mttp -154.19 -179.36 7.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -80.81 130.45 35.07 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.685 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -134.45 -166.45 1.81 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 51' ' ' MET . 17.2 mt-10 -98.23 138.54 35.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.597 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -121.71 -139.45 5.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.552 ' CA ' HG23 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -113.95 -73.43 0.66 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.339 -1.095 . . . . 0.0 109.355 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' PRO . 7.2 t -78.56 -42.63 28.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.967 -1.083 . . . . 0.0 110.188 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 51' ' ' MET . . . -145.3 114.92 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' GLY . 29.3 mtm -48.91 175.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . 171.98 -163.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.6 -1.312 . . . . 0.0 110.581 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 56.3 m -78.17 90.12 4.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.947 -1.096 . . . . 0.0 112.635 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.569 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 86.4 m-85 -96.09 -123.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.661 ' HB ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -82.75 -157.38 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.661 ' HD2' ' HB ' ' A' ' 55' ' ' VAL . 25.6 Cg_endo -65.52 -97.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.65 0 CA-C-N 121.119 1.435 . . . . 0.0 111.096 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.5 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 33.7 mt-30 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 120.302 -1.499 . . . . 0.0 110.037 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 34' ' ' LYS . 9.3 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.183 0.516 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.66 132.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 109.769 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 t -124.93 -37.33 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -81.48 -43.74 1.12 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.0 111.035 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 33.9 Cg_endo -77.08 -76.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.765 1.643 . . . . 0.0 110.933 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.34 149.14 38.41 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -113.68 111.82 22.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -1.212 . . . . 0.0 109.943 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 58.8 m -75.44 143.96 76.99 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.192 -0.943 . . . . 0.0 109.076 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.54 -175.5 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.554 2.169 . . . . 0.0 110.988 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' C ' HD12 ' A' ' 19' ' ' ILE . 29.8 mm -118.54 154.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.525 ' CG2' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -117.88 166.08 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.023 . . . . 0.0 110.12 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -46.31 -74.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.534 HG13 ' C ' ' A' ' 20' ' ' LEU . 65.7 mt -159.3 -77.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 108.968 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 23' ' ' CYS . 3.4 ttt85 -161.42 88.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' ALA . 1.5 p -30.65 -42.16 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.678 -0.639 . . . . 0.0 111.257 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' LEU . . . 72.38 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 24' ' ' ALA . 1.8 mmt 35.28 -92.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.821 -0.55 . . . . 0.0 110.779 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' ALA . 3.5 tp -132.61 -147.24 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.666 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -108.65 92.89 10.96 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.113 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 49' ' ' CYS . 32.9 Cg_endo -72.82 146.77 43.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.487 2.125 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.32 -159.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.65 2.233 . . . . 0.0 110.922 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.93 139.26 39.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.485 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 17.4 mmm180 -87.15 -38.94 15.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 110.026 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 1.2 p -155.76 172.01 19.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.022 -1.049 . . . . 0.0 109.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -161.5 36.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.42 -0.8 . . . . 0.0 109.123 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 95.08 -1.53 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.166 0.507 . . . . 0.0 109.79 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.36 -103.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.9 -1.125 . . . . 0.0 109.534 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.442 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -160.36 96.95 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.839 -1.163 . . . . 0.0 109.687 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 2.2 m-20 -172.87 -170.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -0.861 . . . . 0.0 108.86 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 1.3 m 62.64 173.03 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.991 -1.068 . . . . 0.0 109.121 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 31.1 Cg_endo -73.21 -171.07 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.137 1.892 . . . . 0.0 110.952 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . -87.13 -41.21 6.7 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.457 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 55' ' ' VAL . 13.4 pt -41.72 121.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.09 -1.241 . . . . 0.0 109.684 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.609 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 47.17 -130.76 1.43 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.391 -0.818 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 3.2 mmtt -162.55 -95.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.47 -1.394 . . . . 0.0 109.46 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -133.67 135.39 44.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 110.543 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 91.5 m -138.19 -173.06 3.42 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' O ' HD13 ' A' ' 19' ' ' ILE . 4.9 tt0 -84.9 153.9 22.58 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.999 -1.063 . . . . 0.0 109.155 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -133.53 14.41 4.76 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.525 ' OG ' ' CG2' ' A' ' 19' ' ' ILE . 80.3 p 51.28 14.2 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.879 . . . . 0.0 110.287 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' PRO . 23.9 t -161.9 29.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.625 -1.297 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 51' ' ' MET . . . 120.29 108.43 2.19 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 50' ' ' GLY . 19.7 mtm -43.21 145.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -1.102 . . . . 0.0 109.699 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . -157.34 -165.35 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.066 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.72 123.3 34.21 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.584 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 30.6 m-85 -116.93 156.36 27.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.609 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -94.23 161.88 28.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.552 ' N ' ' HG3' ' A' ' 42' ' ' LYS . 34.0 Cg_endo -76.68 -165.31 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.633 2.222 . . . . 0.0 111.056 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.5 -179.608 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -87.27 -176.14 5.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.98 145.16 29.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' LYS . 35.7 Cg_endo -78.55 69.59 7.65 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.566 2.177 . . . . 0.0 110.545 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t 51.88 -88.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.86 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' PRO . 4.3 mmtm -106.73 170.07 8.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.517 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.49 -71.54 0.16 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.93 -153.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.63 2.22 . . . . 0.0 109.752 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 HG13 ' HG3' ' A' ' 34' ' ' LYS . 20.7 m -83.46 42.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.956 -1.09 . . . . 0.0 109.906 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.99 108.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.734 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -89.69 -21.03 22.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 108.949 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.05 72.44 76.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.768 . . . . 0.0 109.238 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.46 -93.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.56 2.174 . . . . 0.0 110.467 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 56' ' ' PRO . . . -136.52 -151.44 6.05 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -125.96 137.77 53.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -1.143 . . . . 0.0 109.708 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.23 152.72 95.6 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.903 . . . . 0.0 109.154 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.09 16.09 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.604 2.203 . . . . 0.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER 62.62 123.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.913 -1.117 . . . . 0.0 108.526 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' ILE . 4.4 mp -143.65 126.45 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.339 -0.851 . . . . 0.0 109.644 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.532 ' HG ' ' CG2' ' A' ' 21' ' ' ILE . 47.8 tp 37.11 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.416 0.627 . . . . 0.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -150.15 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.879 . . . . 0.0 108.965 178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.572 ' O ' ' C ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -173.87 35.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.921 -1.112 . . . . 0.0 109.682 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.572 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 5.13 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.557 0.694 . . . . 0.0 111.709 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.86 61.49 0.88 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.8 mmt -96.07 -100.12 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.497 -0.752 . . . . 0.0 110.319 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -117.68 -134.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.762 -1.211 . . . . 0.0 110.006 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -111.79 90.51 13.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 109.761 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 34.6 Cg_endo -76.12 168.33 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.711 2.274 . . . . 0.0 110.271 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' C ' ' ND2' ' A' ' 30' ' ' ASN . 36.0 Cg_endo -77.87 174.93 11.82 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.559 2.172 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.532 ' CB ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -155.27 134.97 12.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -85.86 -10.2 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 30.3 p -161.02 163.78 31.4 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' HB3' ' CE ' ' A' ' 34' ' ' LYS . 93.7 mt -158.04 -60.54 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.122 -0.986 . . . . 0.0 108.52 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CE ' ' HB3' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -120.35 -39.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -84.46 58.43 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.584 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.524 ' CG2' ' SG ' ' A' ' 38' ' ' CYS . 27.1 m -42.64 125.3 3.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.54 44.88 1.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.33 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 36' ' ' THR . 1.8 m -102.24 116.16 63.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.99 102.68 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.169 1.913 . . . . 0.0 110.38 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.8 -130.34 4.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 41' ' ' ILE . 8.6 tp -117.95 58.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -1.168 . . . . 0.0 109.288 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -111.51 -178.02 3.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.432 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 36' ' ' THR . 1.2 tmtt? -164.08 125.88 2.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.359 -0.838 . . . . 0.0 108.759 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 21.9 t -56.22 112.79 1.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.088 -1.007 . . . . 0.0 110.236 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -124.78 -159.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 109.214 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 19' ' ' ILE . 5.1 mt-10 -116.37 113.51 23.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.81 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -94.47 62.35 1.72 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 49' ' ' CYS . 39.0 p 44.52 85.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.326 -1.102 . . . . 0.0 108.889 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER 87.4 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.675 -0.64 . . . . 0.0 109.648 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.53 153.15 11.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.534 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -111.27 162.23 15.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -1.047 . . . . 0.0 109.202 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -170.9 -170.4 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.419 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 52.1 m -77.06 115.68 17.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 110.86 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 60.7 m-85 -129.54 137.43 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.932 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 56' ' ' PRO . 4.8 p -63.1 131.77 94.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.022 . . . . 0.0 108.625 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 55' ' ' VAL . 37.3 Cg_endo -81.29 51.41 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.48 2.12 . . . . 0.0 110.672 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.593 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.25 71.34 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -137.31 65.55 49.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.631 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' VAL . 35.8 Cg_endo -78.32 4.9 5.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.539 2.16 . . . . 0.0 110.394 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' PRO . 13.9 p -43.89 168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 7' ' ' GLY . 6.4 ptpp? -106.51 -148.13 0.41 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.547 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' LYS . . . 136.54 91.99 0.32 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 33.7 Cg_endo -76.16 159.29 37.26 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.455 2.103 . . . . 0.0 110.826 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 8' ' ' PRO . 7.7 p 40.55 59.35 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.322 0.582 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -153.24 -162.27 1.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -72.57 -28.22 62.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 7' ' ' GLY . 17.6 mttt -116.53 109.46 43.78 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 108.887 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.12 -175.63 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.402 2.068 . . . . 0.0 111.22 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.06 -125.64 0.16 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -109.14 73.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -1.17 . . . . 0.0 109.657 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 50.0 m -60.04 153.61 54.84 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.18 -0.95 . . . . 0.0 109.073 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -81.84 -157.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.132 2.554 . . . . 0.0 111.219 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -81.45 150.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.5 HG13 ' HA2' ' A' ' 47' ' ' GLY . 20.0 mm -120.48 128.33 76.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 111.254 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.624 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.49 -24.85 14.29 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.624 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 10.8 tp 117.95 92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.531 0.732 . . . . 0.0 110.414 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 27.32 39.3 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.66 -0.65 . . . . 0.0 112.32 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.669 ' O ' ' N ' ' A' ' 25' ' ' MET . 4.0 p 38.06 21.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.186 -0.946 . . . . 0.0 112.46 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' O ' ' C ' ' A' ' 25' ' ' MET . . . 45.78 -87.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.895 1.225 . . . . 0.0 108.453 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.669 ' N ' ' O ' ' A' ' 23' ' ' CYS . 11.4 mmm -5.22 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.299 0.571 . . . . 0.0 111.759 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 2.6 pt? -51.29 166.39 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.764 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 58.74 80.47 0.28 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 109.673 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 132.42 10.5 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.611 2.208 . . . . 0.0 110.213 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 36.6 Cg_endo -81.03 -164.82 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.519 2.146 . . . . 0.0 110.324 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 29' ' ' PRO . 1.5 m120 -150.5 111.05 4.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.351 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.45 -10.83 20.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.988 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 16.1 p -158.21 155.83 29.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.04 -1.037 . . . . 0.0 108.435 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 87.3 mt -152.39 -41.35 0.1 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.033 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 174.44 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' OD2' HG23 ' A' ' 36' ' ' THR . 13.6 t70 -41.32 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.278 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER 172.45 -36.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.123 . . . . 0.0 110.057 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 17.2 t0 -42.33 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.86 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' THR . 1.3 m -170.63 65.77 0.47 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 109.691 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.7 Cg_endo -79.46 154.75 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.878 2.385 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -68.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.408 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -84.24 -118.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -1.228 . . . . 0.0 110.76 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.586 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 11.3 ttmt -142.37 -34.58 0.45 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.625 -1.297 . . . . 0.0 110.247 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -163.9 1.31 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 t -106.92 143.98 34.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -138.01 -166.81 2.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.506 -0.746 . . . . 0.0 109.001 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 51' ' ' MET . 1.7 mp0 -122.99 124.72 43.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 19' ' ' ILE . . . -149.56 -145.4 4.12 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.139 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -65.89 117.0 7.65 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.913 -0.757 . . . . 0.0 109.826 -178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER 78.92 91.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.602 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -141.38 20.92 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -117.64 149.33 40.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -1.04 . . . . 0.0 109.14 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.421 ' C ' ' SG ' ' A' ' 32' ' ' CYS . . . -145.1 162.39 37.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.505 ' HB3' HD13 ' A' ' 41' ' ' ILE . 3.8 m -66.6 113.34 4.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.222 -0.924 . . . . 0.0 110.47 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 19.2 m-30 -112.22 -172.21 2.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' CG2' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -109.57 81.97 2.05 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.424 -0.798 . . . . 0.0 108.948 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 33.7 Cg_endo -73.74 178.02 7.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.656 2.237 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.534 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.04 -68.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.253 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.11 99.73 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.66 -159.29 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.461 2.107 . . . . 0.0 110.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 75.5 t -68.43 -82.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER 170.19 179.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.633 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.2 -78.31 0.07 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 37.7 Cg_endo -80.93 58.26 6.93 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.983 2.455 . . . . 0.0 110.496 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 65.8 t 65.67 -94.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.618 -0.676 . . . . 0.0 109.434 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.412 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -168.62 75.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.585 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 12' ' ' LYS . 4.1 t -108.77 -39.81 5.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 2.1 mtmt -49.16 -51.76 53.85 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 109.685 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.1 Cg_endo -78.65 -47.07 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.385 2.056 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.86 -164.23 2.6 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -137.45 79.27 1.74 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.238 . . . . 0.0 109.821 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.2 m -47.8 166.25 0.21 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.197 -0.94 . . . . 0.0 108.752 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 34.4 Cg_endo -76.97 7.01 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.286 1.99 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' PRO . 14.5 mm 61.03 131.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 48' ' ' SER . 2.3 mm -132.76 -138.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 2.4 pt? -161.7 -41.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.534 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 39.7 mm -153.71 -105.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.447 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' CYS . 4.3 mtp180 169.65 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.685 -1.259 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 14.0 p 43.12 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 111.377 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' CG ' ' A' ' 25' ' ' MET . . . -73.45 83.63 1.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.402 -1.436 . . . . 0.0 107.633 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -168.23 96.26 0.41 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.4 -0.813 . . . . 0.0 109.141 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 5.3 tt -45.6 135.91 6.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.823 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER 163.95 -52.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.887 . . . . 0.0 110.315 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 27' ' ' ASN . 35.8 Cg_endo -80.33 111.26 2.6 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.654 2.236 . . . . 0.0 110.33 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 27' ' ' ASN . 36.6 Cg_endo -77.72 -100.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.197 1.931 . . . . 0.0 110.436 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' CG ' ' C ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -162.41 117.42 1.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.843 -1.161 . . . . 0.0 109.303 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.79 -26.23 34.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' C ' HD22 ' A' ' 33' ' ' LEU . 25.0 p -151.8 -176.21 5.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.32 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD22 ' C ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 173.86 -34.1 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.163 -0.961 . . . . 0.0 109.339 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG2' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 179.61 122.36 0.06 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 110.348 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 42.61 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.435 -0.791 . . . . 0.0 109.612 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.33 -142.48 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.346 -0.846 . . . . 0.0 109.184 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.536 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 47.41 60.54 15.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.032 -1.043 . . . . 0.0 109.416 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.6 Cg_endo -79.0 -179.86 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.591 2.194 . . . . 0.0 110.659 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . 44.9 -161.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 3.3 tt -41.81 -40.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.989 . . . . 0.0 109.824 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 5.4 mtmt -53.29 134.31 39.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.875 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HB2' ' HG3' ' A' ' 56' ' ' PRO . 3.2 mttt -149.25 148.84 30.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.421 -0.799 . . . . 0.0 109.002 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.62 124.15 20.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.033 -1.042 . . . . 0.0 109.789 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -133.64 -170.0 2.41 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 19' ' ' ILE . 36.0 mt-10 -91.82 162.21 14.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' C ' ' CG2' ' A' ' 19' ' ' ILE . . . -144.09 169.1 26.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -84.75 13.33 5.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.183 -1.186 . . . . 0.0 109.984 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.8 t 177.05 71.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.81 102.15 2.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.508 ' HE2' ' CZ ' ' A' ' 22' ' ' ARG . 1.6 mtt -49.3 168.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' CD1' ' A' ' 54' ' ' PHE . . . -179.53 168.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.993 -1.067 . . . . 0.0 110.053 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 m -68.65 99.75 1.04 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.602 ' CD2' ' HG3' ' A' ' 17' ' ' PRO . 96.2 m-85 -91.95 -169.16 2.19 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.279 -0.888 . . . . 0.0 109.046 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.5 104.92 36.59 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 34.9 Cg_endo -76.34 -159.75 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.186 1.924 . . . . 0.0 110.571 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 56' ' ' PRO . 2.3 pp0? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.255 0.55 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -26.8 64.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.699 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.19 103.03 10.66 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 -165.77 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.394 2.062 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 6' ' ' LYS . 8.5 p -101.95 -42.8 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' N ' HG12 ' A' ' 5' ' ' VAL . 16.9 mttt 56.52 81.74 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.207 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.84 100.95 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.58 37.68 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.647 2.231 . . . . 0.0 111.03 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.75 83.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.008 -1.058 . . . . 0.0 109.393 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.99 35.18 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.256 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -122.13 153.01 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 115.05 12.05 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -77.85 -156.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.243 1.962 . . . . 0.0 110.02 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . -41.74 -93.83 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.09 131.63 40.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.244 . . . . 0.0 109.703 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.0 m -96.14 151.81 38.45 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.81 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.122 2.548 . . . . 0.0 110.328 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 19' ' ' ILE . 33.9 mm -120.99 140.68 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.319 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -115.04 -165.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -70.15 -44.69 68.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.479 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 161.93 -64.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.543 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -175.37 77.77 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -32.75 113.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.915 0.864 . . . . 0.0 110.625 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.1 59.16 3.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.478 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -122.32 101.5 7.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 pt? 38.18 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.59 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -108.86 93.48 12.49 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.526 -0.734 . . . . 0.0 109.668 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.0 Cg_endo -72.92 144.3 38.22 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.301 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 -164.57 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.683 2.255 . . . . 0.0 110.705 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.455 ' N ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -143.96 112.79 6.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 22.8 ttt180 -55.46 -18.35 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' CB ' ' OG1' ' A' ' 36' ' ' THR . 20.9 p -151.12 177.96 9.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 109.001 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.49 HD13 ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -174.86 -40.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.008 -1.058 . . . . 0.0 110.073 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.49 ' CG ' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -141.61 -56.56 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.423 ' O ' ' HB ' ' A' ' 36' ' ' THR . 8.2 t70 -87.94 -97.32 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.0 109.227 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.6 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 16.4 m 61.22 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 109.785 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 36' ' ' THR . 7.8 t70 91.93 -21.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 37' ' ' ASP . 4.6 m 56.67 162.46 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.5 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 35.9 Cg_endo -78.98 -89.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.658 2.238 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -58.39 -158.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.4 tp -75.86 82.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -1.107 . . . . 0.0 109.347 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -130.39 174.55 9.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.03 134.14 11.36 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 33.4 t -56.22 101.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.533 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.575 ' CB ' ' CD2' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -96.87 -167.36 1.54 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -116.36 93.99 4.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.782 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -72.67 -162.27 6.38 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.526 ' N ' HG13 ' A' ' 19' ' ' ILE . 5.5 p -94.37 -54.93 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.106 -1.232 . . . . 0.0 109.483 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 28' ' ' PRO . 10.1 t -67.02 -65.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.45 147.11 18.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.5 mtt -47.95 167.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 108.999 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -172.65 -176.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.454 ' SG ' HG22 ' A' ' 36' ' ' THR . 3.5 m -91.58 98.63 11.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 109.315 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CD2' ' CB ' ' A' ' 45' ' ' CYS . 13.5 m-30 -100.86 144.02 30.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 109.519 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 55' ' ' VAL . 9.9 p -75.41 120.15 80.31 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 108.964 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.4 -172.81 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.302 2.001 . . . . 0.0 110.919 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' OXT' ' CG ' ' A' ' 57' ' ' GLN . 3.0 pt20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.621 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -157.0 172.04 19.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 108.988 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -174.27 75.1 0.35 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.13 -0.981 . . . . 0.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 35.3 Cg_endo -77.87 -91.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.566 2.178 . . . . 0.0 110.199 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER 164.68 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 108.839 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.03 58.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.02 141.32 16.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.87 -84.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.591 2.194 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.6 58.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -98.88 -84.76 0.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 12' ' ' LYS . 23.7 m -119.91 -94.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.081 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -131.94 57.08 27.38 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.959 -1.088 . . . . 0.0 109.505 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -77.94 -171.97 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.632 2.221 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . 55.19 169.02 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -129.23 135.11 48.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -1.056 . . . . 0.0 109.291 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 60.1 m -66.94 160.19 71.38 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 18' ' ' ILE . 36.4 Cg_endo -79.56 43.73 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 123.107 2.538 . . . . 0.0 111.589 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 17' ' ' PRO . 2.5 tp 40.47 100.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.89 . . . . 0.0 110.747 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -130.32 175.53 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 108.281 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -139.21 -65.29 0.49 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.534 -1.354 . . . . 0.0 111.78 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -38.16 85.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.589 0.709 . . . . 0.0 111.187 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' LEU . 3.5 mtt180 -81.59 2.41 29.4 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 25' ' ' MET . 17.7 p 38.5 51.74 1.69 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.663 . . . . 0.0 110.661 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 89.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.067 -1.021 . . . . 0.0 109.028 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -127.23 -103.46 0.34 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.697 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 2.0 pt? -164.57 26.08 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.508 -1.37 . . . . 0.0 110.84 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 2.9 m-20 164.76 80.07 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.859 -1.15 . . . . 0.0 110.145 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.03 170.37 17.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.517 2.145 . . . . 0.0 110.265 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.31 175.27 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.696 2.264 . . . . 0.0 110.353 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -144.56 93.91 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 109.389 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' CG ' ' HB3' ' A' ' 52' ' ' ALA . 10.7 tpt180 -89.61 -10.86 44.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.766 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 52' ' ' ALA . 17.5 p -153.56 169.01 24.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.972 -1.08 . . . . 0.0 109.814 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER 179.63 42.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.468 -0.77 . . . . 0.0 108.942 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 20.2 mtpt 65.34 -110.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 36' ' ' THR . 2.5 m-20 44.35 41.93 4.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.616 -1.303 . . . . 0.0 109.752 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 43.45 70.95 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.62 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -139.24 -169.57 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 42' ' ' LYS . 13.6 m 62.63 84.36 0.19 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.07 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.613 2.209 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.49 -130.63 45.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 1.6 tt -122.38 66.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -120.67 -162.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.749 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER 178.61 122.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.084 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.403 ' N ' ' HD3' ' A' ' 43' ' ' LYS . 50.7 t -49.93 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 110.166 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.87 -166.23 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' A' ' 19' ' ' ILE . 2.7 tt0 -118.49 105.93 12.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 109.315 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.614 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -97.93 88.83 0.93 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.194 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 57.44 -98.99 0.09 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.606 -0.937 . . . . 0.0 109.799 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -100.09 118.41 36.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.902 -1.124 . . . . 0.0 110.055 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 143.46 3.2 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -87.68 168.33 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -1.016 . . . . 0.0 109.342 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 54' ' ' PHE . . . -168.88 158.69 9.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 108.845 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 61.7 m -63.86 94.48 0.1 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.879 -1.138 . . . . 0.0 109.194 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.614 ' CZ ' ' HA3' ' A' ' 47' ' ' GLY . 90.6 m-85 -94.24 178.92 5.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.15 130.3 25.27 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.29 157.84 29.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.329 2.02 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.397 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 2.2 tt0 73.75 111.07 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -148.16 74.9 10.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.07 42.12 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.799 2.333 . . . . 0.0 111.055 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.06 97.77 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.035 . . . . 0.0 109.462 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -66.18 0.59 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.88 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.88 -77.84 0.26 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 10' ' ' SER . 36.2 Cg_endo -78.05 -170.98 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.522 2.148 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER 42.35 -88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.753 -0.592 . . . . 0.0 109.877 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 13.7 m 66.65 -149.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.628 -1.295 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 12' ' ' LYS . 1.7 t -159.44 -49.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 ptmt -139.01 61.85 23.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 35.5 Cg_endo -77.78 -84.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.633 2.222 . . . . 0.0 110.473 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.38 -138.21 5.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 107.49 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.11 155.26 90.86 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.37 -167.96 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 110.596 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -121.88 141.08 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.089 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.547 ' CD1' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -132.57 166.97 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 109.263 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -44.86 -71.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.521 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 90.6 mt -154.76 -109.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' SER . 22.1 mmm-85 -154.33 27.04 0.46 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.824 -1.172 . . . . 0.0 108.467 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 13.8 p 39.51 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.259 1.028 . . . . 0.0 110.415 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.76 55.94 3.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.605 -1.31 . . . . 0.0 108.936 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.6 mmm -98.53 -98.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.433 -0.792 . . . . 0.0 110.389 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 -105.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.595 -1.315 . . . . 0.0 110.43 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.78 92.31 49.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.782 -1.199 . . . . 0.0 109.865 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.33 164.87 33.12 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.374 2.05 . . . . 0.0 110.173 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 35.6 Cg_endo -77.87 177.43 8.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.702 2.268 . . . . 0.0 110.788 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' OD1' ' HA2' ' A' ' 50' ' ' GLY . 60.8 m-80 -158.84 157.76 32.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.674 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -42.78 5.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -145.75 166.55 25.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -161.81 51.54 0.23 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 109.35 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.5 mmtt 79.87 51.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.343 1.068 . . . . 0.0 108.97 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.07 -97.62 0.06 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.576 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.8 t -156.31 138.39 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.383 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 173.77 -27.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.16 94.05 20.1 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 109.161 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 35.4 Cg_endo -77.6 -27.71 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.69 2.26 . . . . 0.0 110.756 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -61.68 -125.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 5.1 tt -129.72 42.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.169 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' PHE . 23.2 mttt -119.82 -174.69 2.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 109.83 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 42' ' ' LYS . 58.8 mmtt -149.2 167.33 26.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.51 92.08 5.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.43 -1.419 . . . . 0.0 111.041 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 96.6 m -92.29 -165.17 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' ' CD1' ' A' ' 19' ' ' ILE . 7.9 mt-10 -101.52 140.52 35.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.699 -1.251 . . . . 0.0 109.688 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 48' ' ' SER . . . -122.3 33.35 4.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.591 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 8.0 t 75.9 -24.16 0.23 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.214 -0.58 . . . . 0.0 110.714 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 23.5 t -162.18 91.71 0.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.671 -1.268 . . . . 0.0 109.214 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' HA2' ' OD1' ' A' ' 30' ' ' ASN . . . 100.23 139.23 10.68 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -81.94 150.6 27.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -1.161 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.49 170.35 22.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 108.929 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 14.4 m -80.28 109.65 14.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.053 -1.029 . . . . 0.0 110.674 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m-85 -105.25 142.16 35.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 8.4 p -79.26 131.97 64.24 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.983 -1.073 . . . . 0.0 109.487 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 36.2 Cg_endo -78.62 -175.65 2.85 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.36 2.04 . . . . 0.0 110.667 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 12.4 pt20 -120.3 -0.03 10.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.541 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.97 98.58 35.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.12 -0.988 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 2' ' ' GLN . 34.8 Cg_endo -76.94 162.74 31.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.395 2.063 . . . . 0.0 110.466 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.39 -174.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.106 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 150.42 24.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.005 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . 161.71 -56.65 0.3 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 7' ' ' GLY . 36.2 Cg_endo -78.04 -167.06 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.628 2.219 . . . . 0.0 110.255 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 30.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.18 71.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 4.4 t -152.64 160.59 43.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.094 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.75 61.31 15.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.984 -1.072 . . . . 0.0 110.267 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.7 Cg_endo -81.82 -40.65 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.509 2.139 . . . . 0.0 110.73 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 57' ' ' GLN . . . -58.51 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.947 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 10.1 t -161.35 75.0 0.49 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.034 -1.274 . . . . 0.0 110.819 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 40.6 m -93.48 145.12 29.38 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 120.409 -1.432 . . . . 0.0 108.581 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.09 -163.38 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.56 2.174 . . . . 0.0 110.585 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.472 ' O ' HD12 ' A' ' 19' ' ' ILE . 7.2 tp -85.35 131.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 47' ' ' GLY . 27.3 mm -136.57 114.51 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 117.58 -1.648 . . . . 0.0 113.579 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -101.69 104.52 15.34 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.58 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -75.65 80.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.669 -1.269 . . . . 0.0 109.748 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.58 ' CD ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.13 6.16 3.6 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.742 -0.599 . . . . 0.0 110.95 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' C ' ' O ' ' A' ' 22' ' ' ARG . 19.0 p -18.39 132.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.984 0.421 . . . . 0.0 111.624 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.89 60.13 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.6 mmt -143.56 124.76 14.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 2.9 tp -75.91 134.12 40.34 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 m120 77.03 90.52 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 34.0 Cg_endo -75.86 120.6 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.656 2.237 . . . . 0.0 111.363 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' ASN . 36.1 Cg_endo -78.75 -175.84 2.96 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.321 2.014 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 29' ' ' PRO . 56.8 m-80 -159.05 129.25 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -25.61 21.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 1.6 p -174.0 -169.55 0.49 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -161.2 -41.78 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 109.705 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 -65.87 1.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.937 . . . . 0.0 108.972 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -160.29 82.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.2 m -106.85 -77.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -118.66 -111.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.846 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 39.99 86.82 0.12 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 0.0 109.401 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 35.3 Cg_endo -77.16 178.43 7.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.444 2.096 . . . . 0.0 110.534 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.07 -178.92 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.449 ' HB ' ' HG3' ' A' ' 56' ' ' PRO . 8.7 pt -48.89 -24.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.118 -1.225 . . . . 0.0 109.075 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -52.87 138.11 30.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.166 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -153.51 -169.54 3.33 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.15 132.48 34.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.843 -1.161 . . . . 0.0 111.757 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 1.5 m -134.64 -166.38 1.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 19' ' ' ILE . 61.6 mt-10 -87.87 167.47 13.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.577 -1.327 . . . . 0.0 109.283 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' HG23 ' A' ' 19' ' ' ILE . . . -161.53 165.76 35.7 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -43.28 -43.45 4.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.205 -1.174 . . . . 0.0 109.033 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' N ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -116.9 129.52 56.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.789 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' CYS . . . 39.83 -115.54 0.58 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 mtt -149.35 176.98 10.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -1.117 . . . . 0.0 109.701 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -168.84 -173.61 1.89 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 60.8 m -86.48 96.96 10.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.785 -1.197 . . . . 0.0 111.936 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 47.9 m-85 -100.14 -124.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 108.183 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' CG1' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -86.59 -168.24 0.18 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.591 ' CD ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 Cg_endo -72.22 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 120.725 0.95 . . . . 0.0 111.823 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' CA ' ' HA3' ' A' ' 14' ' ' GLY . 32.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.234 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.29 144.87 9.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -152.87 84.14 4.61 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.374 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.35 0.86 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.748 2.299 . . . . 0.0 110.473 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 5' ' ' VAL . 9.8 p -57.26 137.75 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -91.7 30.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -153.75 63.59 0.36 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 7' ' ' GLY . 36.2 Cg_endo -78.21 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.779 2.319 . . . . 0.0 110.553 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -172.82 -36.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 -155.5 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.163 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 11' ' ' THR . 17.1 m -111.67 64.88 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -82.42 -55.29 0.57 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -79.77 177.36 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.327 2.018 . . . . 0.0 110.554 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.67 145.56 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.7 t -100.54 113.12 25.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -1.169 . . . . 0.0 109.51 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.2 m -72.21 137.64 81.55 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.573 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.2 Cg_endo -79.67 169.01 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.485 2.123 . . . . 0.0 110.148 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 mp -94.14 132.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.976 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.59 HG13 ' N ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -96.73 172.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 108.837 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 1.8 pt? -56.83 -55.85 29.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.052 -1.03 . . . . 0.0 110.388 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.546 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 36.4 mm -160.35 -104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.867 -1.146 . . . . 0.0 109.138 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.514 ' N ' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -143.53 102.74 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.377 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -35.93 124.06 0.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.318 0.58 . . . . 0.0 110.584 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.62 58.67 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.459 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 0.8 OUTLIER -127.93 124.15 36.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.97 3.6 14.27 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.576 -0.703 . . . . 0.0 109.425 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -129.83 77.73 76.33 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.324 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.32 134.6 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.481 2.121 . . . . 0.0 110.484 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 36.3 Cg_endo -77.77 -171.36 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.33 2.02 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 82.4 m-20 -158.84 100.49 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 109.704 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -23.0 42.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 0.0 108.933 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 37' ' ' ASP . 1.6 p -164.57 163.99 21.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -158.27 27.69 0.25 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.988 -1.07 . . . . 0.0 109.05 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -177.16 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -161.24 45.88 0.18 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.492 -0.755 . . . . 0.0 109.121 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -134.52 64.84 1.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 109.706 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 171.26 -171.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.024 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.67 76.83 0.5 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.072 -1.017 . . . . 0.0 108.856 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.7 -25.03 12.92 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.539 2.16 . . . . 0.0 110.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.76 -154.42 3.98 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.5 tt -86.5 51.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.147 -1.208 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 1.4 mptp? -131.2 177.83 7.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.022 -1.049 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -160.35 176.08 12.09 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -78.45 128.83 34.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.096 -1.628 . . . . 0.0 110.805 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.89 -165.99 2.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' HD13 ' A' ' 19' ' ' ILE . 3.1 tt0 -86.37 157.24 19.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.758 -1.213 . . . . 0.0 109.338 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 48' ' ' SER . . . -152.55 20.22 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.263 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.59 ' N ' HG13 ' A' ' 19' ' ' ILE . 1.1 p 82.45 -22.78 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.443 -1.033 . . . . 0.0 109.255 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 t -140.7 101.97 4.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 108.979 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 51' ' ' MET . . . 64.81 -126.36 32.01 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.476 ' CG ' ' C ' ' A' ' 50' ' ' GLY . 6.3 mtt -155.49 153.25 29.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -1.095 . . . . 0.0 108.57 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.34 -171.75 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 109.438 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 34.6 m -79.0 130.44 35.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 110.211 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.573 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 69.6 m-85 -129.23 172.37 11.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.481 -0.762 . . . . 0.0 109.188 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 55' ' ' VAL . 8.4 p -96.06 108.97 44.45 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 37.2 Cg_endo -80.74 -156.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.364 2.042 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.363 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.04 98.24 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.399 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.49 79.88 2.37 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.46 84.29 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.652 2.235 . . . . 0.0 110.428 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 5' ' ' VAL . 14.5 p -144.24 43.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.533 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' CD ' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -127.48 -18.59 4.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.116 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 154.94 18.29 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.97 33.96 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.765 2.31 . . . . 0.0 111.199 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.547 HG11 ' CB ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -111.19 -33.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.005 -1.059 . . . . 0.0 109.242 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 26.5 p 173.61 162.61 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.078 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 13' ' ' PRO . 1.5 m -128.99 -168.74 1.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.0 mmtp -89.03 -43.89 0.44 Allowed Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.169 -0.957 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.2 Cg_endo -78.96 -157.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.172 1.915 . . . . 0.0 110.874 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' CA ' ' HB2' ' A' ' 57' ' ' GLN . . . -40.86 101.87 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.87 -42.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.0 109.733 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.82 142.66 37.16 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 35.4 Cg_endo -78.93 -176.68 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.58 2.186 . . . . 0.0 110.929 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -80.18 137.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 109.126 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.502 ' CG2' ' C ' ' A' ' 47' ' ' GLY . 38.5 mm -136.76 101.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.0 110.124 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -45.14 -93.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.582 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 5.5 tp -121.84 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.582 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 15.3 mtm-85 -143.21 56.46 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.316 -1.49 . . . . 0.0 109.509 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.569 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.2 p 34.34 55.42 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.839 -0.538 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 23' ' ' CYS . . . -20.04 -59.35 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.996 -0.44 . . . . 0.0 111.071 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 4.5 mmt 39.1 -98.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 110.02 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -150.42 -69.66 0.19 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.043 -1.035 . . . . 0.0 109.912 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -142.03 86.28 10.48 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.014 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.97 142.01 19.39 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.605 2.204 . . . . 0.0 110.12 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.38 -168.2 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.658 2.238 . . . . 0.0 110.776 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -164.2 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.288 -0.883 . . . . 0.0 109.358 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -142.95 -33.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -169.07 174.45 6.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -147.98 -38.56 0.18 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.875 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' CB ' HG11 ' A' ' 9' ' ' VAL . 11.9 pttm -170.21 -40.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.727 -1.233 . . . . 0.0 110.455 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.05 21.81 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.202 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.536 ' HB ' ' CB ' ' A' ' 32' ' ' CYS . 3.6 m -111.79 164.68 12.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 109.364 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -108.39 139.92 42.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.677 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 29.8 m -115.86 84.81 13.56 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 36.0 Cg_endo -79.54 67.62 8.54 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.474 2.116 . . . . 0.0 110.083 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.89 -40.25 0.07 OUTLIER Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.409 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.59 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 10.1 tt -148.85 90.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.777 -1.425 . . . . 0.0 110.912 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.59 ' CB ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER 45.86 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 112.291 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -160.68 -168.53 2.14 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.932 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.02 152.52 30.88 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.124 0.964 . . . . 0.0 111.129 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 1.5 m -160.62 -169.47 2.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 16.0 mt-10 -82.98 156.45 23.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.912 -1.118 . . . . 0.0 108.968 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 19' ' ' ILE . . . -139.77 151.89 22.29 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.945 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 14.1 m -64.55 -9.71 21.01 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -1.064 . . . . 0.0 109.568 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -161.55 86.79 0.67 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' MET . . . 88.75 112.86 1.22 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 45' ' ' CYS . 1.8 ttt -47.94 173.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 108.799 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' CE1' ' A' ' 54' ' ' PHE . . . 165.41 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.5 ' HB3' HG21 ' A' ' 41' ' ' ILE . 17.3 m -85.68 122.83 30.34 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.829 -1.17 . . . . 0.0 110.004 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 11.6 m-85 -116.15 179.55 3.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' HB ' ' CG1' ' A' ' 41' ' ' ILE . 9.0 p -113.55 86.14 9.95 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 42' ' ' LYS . 37.2 Cg_endo -78.9 -154.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.041 2.494 . . . . 0.0 110.775 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.547 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 73.1 mt-30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 2.7 mt-30 60.04 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.717 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.21 143.57 12.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.54 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 35.7 Cg_endo -78.17 -61.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.556 2.171 . . . . 0.0 110.045 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 4' ' ' PRO . 13.7 p 40.3 39.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -92.23 112.99 25.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.332 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.77 70.47 0.52 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.79 -158.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.588 2.192 . . . . 0.0 110.348 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' CB ' ' A' ' 34' ' ' LYS . 31.5 m -49.0 -22.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.163 -0.961 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.513 ' HB3' ' CE ' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -67.12 113.05 4.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 11' ' ' THR . 18.7 m -88.74 60.84 5.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 5.5 mttt -95.78 -49.19 0.25 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 111.686 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 37.1 Cg_endo -78.71 -104.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.002 1.801 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' PRO . . . 32.7 -142.21 0.05 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 39.6 t -143.11 68.47 1.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.008 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 84.4 m -64.41 155.12 81.79 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.054 -1.029 . . . . 0.0 108.874 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 36.4 Cg_endo -78.21 -176.53 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.458 2.105 . . . . 0.0 110.38 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -107.97 113.06 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.225 -0.922 . . . . 0.0 109.058 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.597 ' CD1' ' HA2' ' A' ' 47' ' ' GLY . 3.4 mm -90.45 -166.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.182 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 21' ' ' ILE . 3.5 pp -117.5 -53.79 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.55 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.601 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -162.99 178.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 mtp180 -94.98 94.61 8.09 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.824 -1.172 . . . . 0.0 108.803 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -12.19 -53.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 79.02 -45.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.744 -1.223 . . . . 0.0 110.584 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.452 ' C ' ' O ' ' A' ' 24' ' ' ALA . 4.0 mmm -32.62 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.456 -0.777 . . . . 0.0 111.652 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -85.67 -178.32 6.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.057 -1.027 . . . . 0.0 110.662 -178.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -113.79 85.95 10.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.668 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' CG ' ' O ' ' A' ' 49' ' ' CYS . 35.8 Cg_endo -76.15 138.07 19.94 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.667 2.244 . . . . 0.0 110.291 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -79.44 -102.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 110.355 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -161.61 154.82 21.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.773 -1.205 . . . . 0.0 109.563 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -104.16 -32.52 9.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 108.933 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -166.1 156.32 12.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.586 ' CD1' ' C ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -149.12 11.2 0.81 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.041 -177.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' CB ' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -177.82 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.943 -1.098 . . . . 0.0 109.686 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.8 82.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.434 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 93.9 m -159.24 123.79 4.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 57.89 -156.14 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.582 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 54.82 64.52 5.87 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 109.189 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 35.6 Cg_endo -78.63 128.21 8.5 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.771 2.314 . . . . 0.0 110.952 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.31 -155.13 20.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.47 -12.4 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.506 -0.996 . . . . 0.0 109.82 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.2 mtmp? -79.46 143.15 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.219 -0.926 . . . . 0.0 110.225 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 27.1 mttp -154.19 -179.36 7.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -80.81 130.45 35.07 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.685 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -134.45 -166.45 1.81 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 51' ' ' MET . 17.2 mt-10 -98.23 138.54 35.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.597 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -121.71 -139.45 5.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.552 ' CA ' HG23 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -113.95 -73.43 0.66 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.339 -1.095 . . . . 0.0 109.355 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' PRO . 7.2 t -78.56 -42.63 28.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.967 -1.083 . . . . 0.0 110.188 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 51' ' ' MET . . . -145.3 114.92 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' GLY . 29.3 mtm -48.91 175.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . 171.98 -163.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.6 -1.312 . . . . 0.0 110.581 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 56.3 m -78.17 90.12 4.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.947 -1.096 . . . . 0.0 112.635 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 86.4 m-85 -96.09 -123.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.661 ' HB ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -82.75 -157.38 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.661 ' HD2' ' HB ' ' A' ' 55' ' ' VAL . 25.6 Cg_endo -65.52 -97.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.65 0 CA-C-N 121.119 1.435 . . . . 0.0 111.096 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.5 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 33.7 mt-30 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 120.302 -1.499 . . . . 0.0 110.037 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 45.37 68.49 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.375 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.23 147.44 39.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.59 126.87 7.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.627 2.218 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 5' ' ' VAL . 9.9 p -89.87 57.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -77.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.1 -1.0 . . . . 0.0 109.252 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.91 -178.28 43.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 9' ' ' VAL . 35.0 Cg_endo -76.92 -154.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.79 2.327 . . . . 0.0 110.296 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 34' ' ' LYS . 9.3 m -40.58 -35.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.66 132.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 109.769 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 t -124.93 -37.33 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -81.48 -43.74 1.12 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.0 111.035 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 33.9 Cg_endo -77.08 -76.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.765 1.643 . . . . 0.0 110.933 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.34 149.14 38.41 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -113.68 111.82 22.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -1.212 . . . . 0.0 109.943 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 58.8 m -75.44 143.96 76.99 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.192 -0.943 . . . . 0.0 109.076 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.54 -175.5 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.554 2.169 . . . . 0.0 110.988 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' C ' HD12 ' A' ' 19' ' ' ILE . 29.8 mm -118.54 154.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.525 ' CG2' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -117.88 166.08 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.023 . . . . 0.0 110.12 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -46.31 -74.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.534 HG13 ' C ' ' A' ' 20' ' ' LEU . 65.7 mt -159.3 -77.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 108.968 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 23' ' ' CYS . 3.4 ttt85 -161.42 88.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' ALA . 1.5 p -30.65 -42.16 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.678 -0.639 . . . . 0.0 111.257 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' LEU . . . 72.38 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 24' ' ' ALA . 1.8 mmt 35.28 -92.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.821 -0.55 . . . . 0.0 110.779 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' ALA . 3.5 tp -132.61 -147.24 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.666 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -108.65 92.89 10.96 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.113 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 49' ' ' CYS . 32.9 Cg_endo -72.82 146.77 43.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.487 2.125 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.32 -159.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.65 2.233 . . . . 0.0 110.922 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.93 139.26 39.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.485 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 17.4 mmm180 -87.15 -38.94 15.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 110.026 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 1.2 p -155.76 172.01 19.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.022 -1.049 . . . . 0.0 109.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -161.5 36.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.42 -0.8 . . . . 0.0 109.123 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 95.08 -1.53 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.166 0.507 . . . . 0.0 109.79 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.36 -103.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.9 -1.125 . . . . 0.0 109.534 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.442 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -160.36 96.95 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.839 -1.163 . . . . 0.0 109.687 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 2.2 m-20 -172.87 -170.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -0.861 . . . . 0.0 108.86 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 1.3 m 62.64 173.03 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.991 -1.068 . . . . 0.0 109.121 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 31.1 Cg_endo -73.21 -171.07 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.137 1.892 . . . . 0.0 110.952 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . -87.13 -41.21 6.7 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.457 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 55' ' ' VAL . 13.4 pt -41.72 121.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.09 -1.241 . . . . 0.0 109.684 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.609 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 47.17 -130.76 1.43 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.391 -0.818 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 3.2 mmtt -162.55 -95.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.47 -1.394 . . . . 0.0 109.46 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -133.67 135.39 44.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 110.543 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 91.5 m -138.19 -173.06 3.42 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' O ' HD13 ' A' ' 19' ' ' ILE . 4.9 tt0 -84.9 153.9 22.58 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.999 -1.063 . . . . 0.0 109.155 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -133.53 14.41 4.76 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.525 ' OG ' ' CG2' ' A' ' 19' ' ' ILE . 80.3 p 51.28 14.2 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.879 . . . . 0.0 110.287 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' PRO . 23.9 t -161.9 29.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.625 -1.297 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 51' ' ' MET . . . 120.29 108.43 2.19 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 50' ' ' GLY . 19.7 mtm -43.21 145.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -1.102 . . . . 0.0 109.699 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . -157.34 -165.35 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.066 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.72 123.3 34.21 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.584 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 30.6 m-85 -116.93 156.36 27.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.609 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -94.23 161.88 28.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.552 ' N ' ' HG3' ' A' ' 42' ' ' LYS . 34.0 Cg_endo -76.68 -165.31 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.633 2.222 . . . . 0.0 111.056 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.5 -179.608 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.123 0.487 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.99 108.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.734 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -89.69 -21.03 22.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 108.949 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.05 72.44 76.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.768 . . . . 0.0 109.238 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.46 -93.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.56 2.174 . . . . 0.0 110.467 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 56' ' ' PRO . . . -136.52 -151.44 6.05 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -125.96 137.77 53.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -1.143 . . . . 0.0 109.708 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.23 152.72 95.6 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.903 . . . . 0.0 109.154 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.09 16.09 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.604 2.203 . . . . 0.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.62 123.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.913 -1.117 . . . . 0.0 108.526 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.965 HD13 ' O ' ' A' ' 46' ' ' GLU . 4.4 mp -143.65 126.45 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.339 -0.851 . . . . 0.0 109.644 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.047 ' HG ' HG22 ' A' ' 21' ' ' ILE . 47.8 tp 37.11 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.416 0.627 . . . . 0.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.047 HG22 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.15 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.879 . . . . 0.0 108.965 178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.725 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.87 35.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.921 -1.112 . . . . 0.0 109.682 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.572 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 5.13 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.557 0.694 . . . . 0.0 111.709 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.86 61.49 0.88 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.636 ' HB3' HD23 ' A' ' 26' ' ' LEU . 3.8 mmt -96.07 -100.12 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.497 -0.752 . . . . 0.0 110.319 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 25' ' ' MET . 1.0 OUTLIER -117.68 -134.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.762 -1.211 . . . . 0.0 110.006 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -111.79 90.51 13.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 109.761 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 34.6 Cg_endo -76.12 168.33 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.711 2.274 . . . . 0.0 110.271 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' C ' ' ND2' ' A' ' 30' ' ' ASN . 36.0 Cg_endo -77.87 174.93 11.82 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.559 2.172 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.485 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -155.27 134.97 12.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -85.86 -10.2 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.594 ' O ' HD23 ' A' ' 33' ' ' LEU . 30.3 p -161.02 163.78 31.4 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 32' ' ' CYS . 93.7 mt -158.04 -60.54 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.122 -0.986 . . . . 0.0 108.52 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' CE ' ' HB3' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -120.35 -39.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -84.46 58.43 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.584 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.524 ' CG2' ' SG ' ' A' ' 38' ' ' CYS . 27.1 m -42.64 125.3 3.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.54 44.88 1.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.33 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 36' ' ' THR . 1.8 m -102.24 116.16 63.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.99 102.68 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.169 1.913 . . . . 0.0 110.38 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.8 -130.34 4.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 41' ' ' ILE . 8.6 tp -117.95 58.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -1.168 . . . . 0.0 109.288 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -111.51 -178.02 3.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.432 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 1.2 tmtt? -164.08 125.88 2.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.359 -0.838 . . . . 0.0 108.759 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 21.9 t -56.22 112.79 1.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.088 -1.007 . . . . 0.0 110.236 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.612 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -124.78 -159.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 109.214 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.965 ' O ' HD13 ' A' ' 19' ' ' ILE . 5.1 mt-10 -116.37 113.51 23.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.81 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' HA2' HD13 ' A' ' 19' ' ' ILE . . . -94.47 62.35 1.72 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 49' ' ' CYS . 39.0 p 44.52 85.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.326 -1.102 . . . . 0.0 108.889 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER 87.4 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.675 -0.64 . . . . 0.0 109.648 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.53 153.15 11.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.549 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -111.27 162.23 15.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -1.047 . . . . 0.0 109.202 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -170.9 -170.4 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 52.1 m -77.06 115.68 17.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 110.86 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 60.7 m-85 -129.54 137.43 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.932 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.1 131.77 94.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.022 . . . . 0.0 108.625 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.3 Cg_endo -81.29 51.41 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.48 2.12 . . . . 0.0 110.672 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.593 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.654 ' O ' HG22 ' A' ' 9' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.322 0.582 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 -162.27 1.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -72.57 -28.22 62.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -116.53 109.46 43.78 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 108.887 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.12 -175.63 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.402 2.068 . . . . 0.0 111.22 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.06 -125.64 0.16 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -109.14 73.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -1.17 . . . . 0.0 109.657 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 50.0 m -60.04 153.61 54.84 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.18 -0.95 . . . . 0.0 109.073 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -81.84 -157.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.132 2.554 . . . . 0.0 111.219 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.753 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -81.45 150.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 21' ' ' ILE . 20.0 mm -120.48 128.33 76.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 111.254 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.691 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.49 -24.85 14.29 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.811 ' H ' HG22 ' A' ' 19' ' ' ILE . 10.8 tp 117.95 92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.531 0.732 . . . . 0.0 110.414 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 27.32 39.3 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.66 -0.65 . . . . 0.0 112.32 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.669 ' O ' ' N ' ' A' ' 25' ' ' MET . 4.0 p 38.06 21.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.186 -0.946 . . . . 0.0 112.46 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' O ' ' C ' ' A' ' 25' ' ' MET . . . 45.78 -87.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.895 1.225 . . . . 0.0 108.453 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.669 ' N ' ' O ' ' A' ' 23' ' ' CYS . 11.4 mmm -5.22 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.299 0.571 . . . . 0.0 111.759 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 26' ' ' LEU . 2.6 pt? -51.29 166.39 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.764 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 58.74 80.47 0.28 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 109.673 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 36.3 Cg_endo -79.03 132.42 10.5 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.611 2.208 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 36.6 Cg_endo -81.03 -164.82 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.519 2.146 . . . . 0.0 110.324 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 29' ' ' PRO . 1.5 m120 -150.5 111.05 4.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.351 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.45 -10.83 20.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.988 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 16.1 p -158.21 155.83 29.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.04 -1.037 . . . . 0.0 108.435 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 51' ' ' MET . 87.3 mt -152.39 -41.35 0.1 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.033 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 174.44 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 36' ' ' THR . 13.6 t70 -41.32 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.278 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 172.45 -36.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.123 . . . . 0.0 110.057 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 17.2 t0 -42.33 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.86 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' THR . 1.3 m -170.63 65.77 0.47 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 109.691 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.7 Cg_endo -79.46 154.75 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.878 2.385 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -68.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.408 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -84.24 -118.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -1.228 . . . . 0.0 110.76 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 41' ' ' ILE . 11.3 ttmt -142.37 -34.58 0.45 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.625 -1.297 . . . . 0.0 110.247 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -163.9 1.31 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 12.2 t -106.92 143.98 34.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.658 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -138.01 -166.81 2.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.506 -0.746 . . . . 0.0 109.001 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG3' ' HB3' ' A' ' 51' ' ' MET . 1.7 mp0 -122.99 124.72 43.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 19' ' ' ILE . . . -149.56 -145.4 4.12 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.139 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.759 ' N ' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -65.89 117.0 7.65 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.913 -0.757 . . . . 0.0 109.826 -178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER 78.92 91.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.602 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -141.38 20.92 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.574 ' HG3' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.64 149.33 40.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -1.04 . . . . 0.0 109.14 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -145.1 162.39 37.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.682 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 m -66.6 113.34 4.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.222 -0.924 . . . . 0.0 110.47 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.658 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 19.2 m-30 -112.22 -172.21 2.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -109.57 81.97 2.05 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.424 -0.798 . . . . 0.0 108.948 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 33.7 Cg_endo -73.74 178.02 7.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.656 2.237 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.534 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 10' ' ' SER . 65.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -168.62 75.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.585 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 12' ' ' LYS . 4.1 t -108.77 -39.81 5.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 2.1 mtmt -49.16 -51.76 53.85 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 109.685 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 36.1 Cg_endo -78.65 -47.07 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.385 2.056 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.86 -164.23 2.6 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -137.45 79.27 1.74 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.238 . . . . 0.0 109.821 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.2 m -47.8 166.25 0.21 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.197 -0.94 . . . . 0.0 108.752 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.639 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 34.4 Cg_endo -76.97 7.01 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.286 1.99 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.811 ' O ' HD13 ' A' ' 19' ' ' ILE . 14.5 mm 61.03 131.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.001 HG21 ' C ' ' A' ' 47' ' ' GLY . 2.3 mm -132.76 -138.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 2.4 pt? -161.7 -41.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 22' ' ' ARG . 39.7 mm -153.71 -105.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.447 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 21' ' ' ILE . 4.3 mtp180 169.65 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.685 -1.259 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 14.0 p 43.12 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 111.377 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' CG ' ' A' ' 25' ' ' MET . . . -73.45 83.63 1.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.402 -1.436 . . . . 0.0 107.633 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -168.23 96.26 0.41 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.4 -0.813 . . . . 0.0 109.141 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 5.3 tt -45.6 135.91 6.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.823 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 1.0 OUTLIER 163.95 -52.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.887 . . . . 0.0 110.315 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 27' ' ' ASN . 35.8 Cg_endo -80.33 111.26 2.6 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.654 2.236 . . . . 0.0 110.33 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 27' ' ' ASN . 36.6 Cg_endo -77.72 -100.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.197 1.931 . . . . 0.0 110.436 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' CG ' ' C ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -162.41 117.42 1.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.843 -1.161 . . . . 0.0 109.303 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.79 -26.23 34.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.756 ' O ' HD23 ' A' ' 33' ' ' LEU . 25.0 p -151.8 -176.21 5.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.32 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 173.86 -34.1 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.163 -0.961 . . . . 0.0 109.339 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 179.61 122.36 0.06 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 110.348 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 42.61 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.435 -0.791 . . . . 0.0 109.612 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.33 -142.48 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.346 -0.846 . . . . 0.0 109.184 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 47.41 60.54 15.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.032 -1.043 . . . . 0.0 109.416 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.6 Cg_endo -79.0 -179.86 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.591 2.194 . . . . 0.0 110.659 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . 44.9 -161.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.466 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 3.3 tt -41.81 -40.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.989 . . . . 0.0 109.824 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 5.4 mtmt -53.29 134.31 39.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.875 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 56' ' ' PRO . 3.2 mttt -149.25 148.84 30.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.421 -0.799 . . . . 0.0 109.002 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.62 124.15 20.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.033 -1.042 . . . . 0.0 109.789 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -133.64 -170.0 2.41 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -91.82 162.21 14.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 1.001 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -144.09 169.1 26.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.75 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -84.75 13.33 5.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.183 -1.186 . . . . 0.0 109.984 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.8 t 177.05 71.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.81 102.15 2.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 22' ' ' ARG . 1.6 mtt -49.3 168.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' CD1' ' A' ' 54' ' ' PHE . . . -179.53 168.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.993 -1.067 . . . . 0.0 110.053 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 m -68.65 99.75 1.04 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.639 ' CD2' ' HG3' ' A' ' 17' ' ' PRO . 96.2 m-85 -91.95 -169.16 2.19 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.279 -0.888 . . . . 0.0 109.046 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.5 104.92 36.59 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 34.9 Cg_endo -76.34 -159.75 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.186 1.924 . . . . 0.0 110.571 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 56' ' ' PRO . 2.3 pp0? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.99 35.18 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.256 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -122.13 153.01 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 115.05 12.05 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -77.85 -156.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.243 1.962 . . . . 0.0 110.02 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . -41.74 -93.83 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.09 131.63 40.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.244 . . . . 0.0 109.703 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.0 m -96.14 151.81 38.45 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -78.81 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.122 2.548 . . . . 0.0 110.328 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.514 ' C ' HD13 ' A' ' 19' ' ' ILE . 33.9 mm -120.99 140.68 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.319 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -115.04 -165.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -70.15 -44.69 68.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.479 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 161.93 -64.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.744 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -175.37 77.77 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -32.75 113.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.915 0.864 . . . . 0.0 110.625 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.1 59.16 3.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.835 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -122.32 101.5 7.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 25' ' ' MET . 1.3 pt? 38.18 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.59 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 27' ' ' ASN . 7.7 p-10 -108.86 93.48 12.49 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.526 -0.734 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.0 Cg_endo -72.92 144.3 38.22 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.301 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.0 Cg_endo -77.98 -164.57 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.683 2.255 . . . . 0.0 110.705 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.96 112.79 6.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 22.8 ttt180 -55.46 -18.35 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.737 ' C ' HD23 ' A' ' 33' ' ' LEU . 20.9 p -151.12 177.96 9.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 109.001 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.867 HD12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -174.86 -40.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.008 -1.058 . . . . 0.0 110.073 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.867 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -141.61 -56.56 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 36' ' ' THR . 8.2 t70 -87.94 -97.32 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.0 109.227 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 38' ' ' CYS . 16.4 m 61.22 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 109.785 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 36' ' ' THR . 7.8 t70 91.93 -21.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.693 ' H ' HG22 ' A' ' 36' ' ' THR . 4.6 m 56.67 162.46 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.5 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 35.9 Cg_endo -78.98 -89.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.658 2.238 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -58.39 -158.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 41' ' ' ILE . 3.4 tp -75.86 82.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -1.107 . . . . 0.0 109.347 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -130.39 174.55 9.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.03 134.14 11.36 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 33.4 t -56.22 101.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.533 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.575 ' CB ' ' CD2' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -96.87 -167.36 1.54 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -116.36 93.99 4.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.782 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -72.67 -162.27 6.38 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.562 ' H ' HG21 ' A' ' 19' ' ' ILE . 5.5 p -94.37 -54.93 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.106 -1.232 . . . . 0.0 109.483 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 28' ' ' PRO . 10.1 t -67.02 -65.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.45 147.11 18.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.5 mtt -47.95 167.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 108.999 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.932 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -172.65 -176.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 36' ' ' THR . 3.5 m -91.58 98.63 11.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 109.315 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.932 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 13.5 m-30 -100.86 144.02 30.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 109.519 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.9 p -75.41 120.15 80.31 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 108.964 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.4 -172.81 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.302 2.001 . . . . 0.0 110.919 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' OXT' ' CG ' ' A' ' 57' ' ' GLN . 3.0 pt20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.621 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -98.88 -84.76 0.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.722 HG22 ' CD ' ' A' ' 12' ' ' LYS . 23.7 m -119.91 -94.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.081 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.722 ' CD ' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -131.94 57.08 27.38 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.959 -1.088 . . . . 0.0 109.505 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -77.94 -171.97 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.632 2.221 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . 55.19 169.02 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -129.23 135.11 48.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -1.056 . . . . 0.0 109.291 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 60.1 m -66.94 160.19 71.38 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HD2' HD11 ' A' ' 19' ' ' ILE . 36.4 Cg_endo -79.56 43.73 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 123.107 2.538 . . . . 0.0 111.589 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 17' ' ' PRO . 2.5 tp 40.47 100.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.89 . . . . 0.0 110.747 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -130.32 175.53 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 108.281 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -139.21 -65.29 0.49 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.534 -1.354 . . . . 0.0 111.78 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.046 ' N ' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -38.16 85.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.589 0.709 . . . . 0.0 111.187 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' LEU . 3.5 mtt180 -81.59 2.41 29.4 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 25' ' ' MET . 17.7 p 38.5 51.74 1.69 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.663 . . . . 0.0 110.661 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 89.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.067 -1.021 . . . . 0.0 109.028 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.715 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -127.23 -103.46 0.34 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.697 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.797 ' N ' HD23 ' A' ' 26' ' ' LEU . 2.0 pt? -164.57 26.08 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.508 -1.37 . . . . 0.0 110.84 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 2.9 m-20 164.76 80.07 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.859 -1.15 . . . . 0.0 110.145 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.03 170.37 17.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.517 2.145 . . . . 0.0 110.265 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.31 175.27 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.696 2.264 . . . . 0.0 110.353 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -144.56 93.91 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 109.389 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' MET . 10.7 tpt180 -89.61 -10.86 44.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.766 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 52' ' ' ALA . 17.5 p -153.56 169.01 24.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.972 -1.08 . . . . 0.0 109.814 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER 179.63 42.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.468 -0.77 . . . . 0.0 108.942 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' HG12 ' A' ' 9' ' ' VAL . 20.2 mtpt 65.34 -110.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 36' ' ' THR . 2.5 m-20 44.35 41.93 4.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.616 -1.303 . . . . 0.0 109.752 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 43.45 70.95 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.62 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -139.24 -169.57 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 42' ' ' LYS . 13.6 m 62.63 84.36 0.19 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.07 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.613 2.209 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.49 -130.63 45.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.491 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 1.6 tt -122.38 66.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 0.6 OUTLIER -120.67 -162.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.749 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER 178.61 122.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.084 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 43' ' ' LYS . 50.7 t -49.93 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 110.166 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.87 -166.23 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.014 ' O ' HD13 ' A' ' 19' ' ' ILE . 2.7 tt0 -118.49 105.93 12.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 109.315 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -97.93 88.83 0.93 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.194 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 19' ' ' ILE . 0.1 OUTLIER 57.44 -98.99 0.09 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.606 -0.937 . . . . 0.0 109.799 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -100.09 118.41 36.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.902 -1.124 . . . . 0.0 110.055 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 143.46 3.2 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -87.68 168.33 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -1.016 . . . . 0.0 109.342 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 54' ' ' PHE . . . -168.88 158.69 9.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 108.845 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 61.7 m -63.86 94.48 0.1 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.879 -1.138 . . . . 0.0 109.194 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 47' ' ' GLY . 90.6 m-85 -94.24 178.92 5.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.15 130.3 25.27 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.29 157.84 29.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.329 2.02 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.397 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.854 HG22 ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.854 ' N ' HG22 ' A' ' 9' ' ' VAL . 13.7 m 66.65 -149.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.628 -1.295 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 12' ' ' LYS . 1.7 t -159.44 -49.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.53 ' N ' HG23 ' A' ' 11' ' ' THR . 3.9 ptmt -139.01 61.85 23.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 35.5 Cg_endo -77.78 -84.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.633 2.222 . . . . 0.0 110.473 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.38 -138.21 5.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 107.49 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.11 155.26 90.86 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.37 -167.96 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 110.596 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.561 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -121.88 141.08 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.089 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.731 HG21 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -132.57 166.97 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 109.263 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -44.86 -71.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' ARG . 90.6 mt -154.76 -109.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 22.1 mmm-85 -154.33 27.04 0.46 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.824 -1.172 . . . . 0.0 108.467 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 13.8 p 39.51 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.259 1.028 . . . . 0.0 110.415 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.76 55.94 3.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.605 -1.31 . . . . 0.0 108.936 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.6 mmm -98.53 -98.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.433 -0.792 . . . . 0.0 110.389 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 -105.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.595 -1.315 . . . . 0.0 110.43 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.78 92.31 49.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.782 -1.199 . . . . 0.0 109.865 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.33 164.87 33.12 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.374 2.05 . . . . 0.0 110.173 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 35.6 Cg_endo -77.87 177.43 8.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.702 2.268 . . . . 0.0 110.788 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HA2' ' A' ' 50' ' ' GLY . 60.8 m-80 -158.84 157.76 32.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.674 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -42.78 5.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.768 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -145.75 166.55 25.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.81 51.54 0.23 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 109.35 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.5 mmtt 79.87 51.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.343 1.068 . . . . 0.0 108.97 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.07 -97.62 0.06 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.576 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.8 t -156.31 138.39 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.383 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 173.77 -27.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.16 94.05 20.1 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 109.161 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 35.4 Cg_endo -77.6 -27.71 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.69 2.26 . . . . 0.0 110.756 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -61.68 -125.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 41' ' ' ILE . 5.1 tt -129.72 42.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.169 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 54' ' ' PHE . 23.2 mttt -119.82 -174.69 2.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 109.83 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 58.8 mmtt -149.2 167.33 26.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.51 92.08 5.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.43 -1.419 . . . . 0.0 111.041 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 96.6 m -92.29 -165.17 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' O ' HD11 ' A' ' 19' ' ' ILE . 7.9 mt-10 -101.52 140.52 35.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.699 -1.251 . . . . 0.0 109.688 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.731 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -122.3 33.35 4.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 8.0 t 75.9 -24.16 0.23 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.214 -0.58 . . . . 0.0 110.714 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 23.5 t -162.18 91.71 0.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.671 -1.268 . . . . 0.0 109.214 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA2' ' OD1' ' A' ' 30' ' ' ASN . . . 100.23 139.23 10.68 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -81.94 150.6 27.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -1.161 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.49 170.35 22.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 108.929 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 14.4 m -80.28 109.65 14.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.053 -1.029 . . . . 0.0 110.674 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m-85 -105.25 142.16 35.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -79.26 131.97 64.24 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.983 -1.073 . . . . 0.0 109.487 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 36.2 Cg_endo -78.62 -175.65 2.85 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.36 2.04 . . . . 0.0 110.667 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.18 71.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.465 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 4.4 t -152.64 160.59 43.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.094 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.544 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.75 61.31 15.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.984 -1.072 . . . . 0.0 110.267 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.7 Cg_endo -81.82 -40.65 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.509 2.139 . . . . 0.0 110.73 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' CA ' ' A' ' 57' ' ' GLN . . . -58.51 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.947 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 10.1 t -161.35 75.0 0.49 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.034 -1.274 . . . . 0.0 110.819 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 40.6 m -93.48 145.12 29.38 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 120.409 -1.432 . . . . 0.0 108.581 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.09 -163.38 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.56 2.174 . . . . 0.0 110.585 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.2 tp -85.35 131.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.014 HD12 ' HA2' ' A' ' 47' ' ' GLY . 27.3 mm -136.57 114.51 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 117.58 -1.648 . . . . 0.0 113.579 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -101.69 104.52 15.34 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.803 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -75.65 80.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.669 -1.269 . . . . 0.0 109.748 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.13 6.16 3.6 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.742 -0.599 . . . . 0.0 110.95 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' C ' ' O ' ' A' ' 22' ' ' ARG . 19.0 p -18.39 132.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.984 0.421 . . . . 0.0 111.624 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.89 60.13 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.6 mmt -143.56 124.76 14.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 2.9 tp -75.91 134.12 40.34 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 m120 77.03 90.52 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 34.0 Cg_endo -75.86 120.6 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.656 2.237 . . . . 0.0 111.363 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' ASN . 36.1 Cg_endo -78.75 -175.84 2.96 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.321 2.014 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 29' ' ' PRO . 56.8 m-80 -159.05 129.25 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -25.61 21.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 1.6 p -174.0 -169.55 0.49 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -161.2 -41.78 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 109.705 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 -65.87 1.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.937 . . . . 0.0 108.972 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -160.29 82.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.655 HG22 ' OD1' ' A' ' 37' ' ' ASP . 22.2 m -106.85 -77.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.655 ' OD1' HG22 ' A' ' 36' ' ' THR . 0.8 OUTLIER -118.66 -111.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.846 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER 39.99 86.82 0.12 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 0.0 109.401 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 35.3 Cg_endo -77.16 178.43 7.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.444 2.096 . . . . 0.0 110.534 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.07 -178.92 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 56' ' ' PRO . 8.7 pt -48.89 -24.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.118 -1.225 . . . . 0.0 109.075 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -52.87 138.11 30.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.166 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -153.51 -169.54 3.33 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.15 132.48 34.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.843 -1.161 . . . . 0.0 111.757 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 1.5 m -134.64 -166.38 1.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CB ' HG21 ' A' ' 19' ' ' ILE . 61.6 mt-10 -87.87 167.47 13.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.577 -1.327 . . . . 0.0 109.283 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 1.014 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -161.53 165.76 35.7 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -43.28 -43.45 4.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.205 -1.174 . . . . 0.0 109.033 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.508 ' N ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -116.9 129.52 56.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.789 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' CYS . . . 39.83 -115.54 0.58 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 10.9 mtt -149.35 176.98 10.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -1.117 . . . . 0.0 109.701 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -168.84 -173.61 1.89 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 60.8 m -86.48 96.96 10.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.785 -1.197 . . . . 0.0 111.936 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 47.9 m-85 -100.14 -124.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 108.183 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.831 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -86.59 -168.24 0.18 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.831 ' HD3' HG12 ' A' ' 55' ' ' VAL . 29.0 Cg_endo -72.22 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 120.725 0.95 . . . . 0.0 111.823 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.534 ' CA ' ' HA3' ' A' ' 14' ' ' GLY . 32.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.234 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.711 HG23 ' HG2' ' A' ' 34' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 -155.5 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.163 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 11' ' ' THR . 17.1 m -111.67 64.88 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -82.42 -55.29 0.57 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -79.77 177.36 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.327 2.018 . . . . 0.0 110.554 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.67 145.56 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.7 t -100.54 113.12 25.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -1.169 . . . . 0.0 109.51 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 11' ' ' THR . 74.2 m -72.21 137.64 81.55 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.599 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.2 Cg_endo -79.67 169.01 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.485 2.123 . . . . 0.0 110.148 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.3 mp -94.14 132.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.976 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.731 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -96.73 172.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 108.837 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -56.83 -55.85 29.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.052 -1.03 . . . . 0.0 110.388 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 22' ' ' ARG . 36.4 mm -160.35 -104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.867 -1.146 . . . . 0.0 109.138 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.669 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -143.53 102.74 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.377 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -35.93 124.06 0.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.318 0.58 . . . . 0.0 110.584 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.62 58.67 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.469 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 0.8 OUTLIER -127.93 124.15 36.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -77.97 3.6 14.27 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.576 -0.703 . . . . 0.0 109.425 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -129.83 77.73 76.33 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.324 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.2 Cg_endo -78.32 134.6 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.481 2.121 . . . . 0.0 110.484 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 36.3 Cg_endo -77.77 -171.36 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.33 2.02 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 82.4 m-20 -158.84 100.49 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 109.704 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -23.0 42.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 0.0 108.933 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.653 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.6 p -164.57 163.99 21.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -158.27 27.69 0.25 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.988 -1.07 . . . . 0.0 109.05 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.711 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -177.16 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -161.24 45.88 0.18 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.492 -0.755 . . . . 0.0 109.121 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -134.52 64.84 1.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 109.706 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 171.26 -171.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.024 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.67 76.83 0.5 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.072 -1.017 . . . . 0.0 108.856 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.7 -25.03 12.92 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.539 2.16 . . . . 0.0 110.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.76 -154.42 3.98 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 41' ' ' ILE . 10.5 tt -86.5 51.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.147 -1.208 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 54' ' ' PHE . 1.4 mptp? -131.2 177.83 7.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.022 -1.049 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -160.35 176.08 12.09 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -78.45 128.83 34.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.096 -1.628 . . . . 0.0 110.805 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -140.89 -165.99 2.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 3.1 tt0 -86.37 157.24 19.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.758 -1.213 . . . . 0.0 109.338 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.731 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -152.55 20.22 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.263 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 19' ' ' ILE . 1.1 p 82.45 -22.78 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.443 -1.033 . . . . 0.0 109.255 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 t -140.7 101.97 4.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 108.979 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 51' ' ' MET . . . 64.81 -126.36 32.01 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.476 ' CG ' ' C ' ' A' ' 50' ' ' GLY . 6.3 mtt -155.49 153.25 29.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -1.095 . . . . 0.0 108.57 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.34 -171.75 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 109.438 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 34.6 m -79.0 130.44 35.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 110.211 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 69.6 m-85 -129.23 172.37 11.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.481 -0.762 . . . . 0.0 109.188 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -96.06 108.97 44.45 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 37.2 Cg_endo -80.74 -156.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.364 2.042 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.363 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' HB3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 26.5 p 173.61 162.61 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.078 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.795 HG22 ' H ' ' A' ' 12' ' ' LYS . 1.5 m -128.99 -168.74 1.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.795 ' H ' HG22 ' A' ' 11' ' ' THR . 8.0 mmtp -89.03 -43.89 0.44 Allowed Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.169 -0.957 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.2 Cg_endo -78.96 -157.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.172 1.915 . . . . 0.0 110.874 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' CA ' ' HB2' ' A' ' 57' ' ' GLN . . . -40.86 101.87 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.87 -42.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.0 109.733 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.82 142.66 37.16 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.544 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 35.4 Cg_endo -78.93 -176.68 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.58 2.186 . . . . 0.0 110.929 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -80.18 137.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 109.126 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 18' ' ' ILE . 38.5 mm -136.76 101.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.0 110.124 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 48' ' ' SER . 0.1 OUTLIER -45.14 -93.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 22' ' ' ARG . 5.5 tp -121.84 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 21' ' ' ILE . 15.3 mtm-85 -143.21 56.46 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.316 -1.49 . . . . 0.0 109.509 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.569 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.2 p 34.34 55.42 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.839 -0.538 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 23' ' ' CYS . . . -20.04 -59.35 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.996 -0.44 . . . . 0.0 111.071 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 4.5 mmt 39.1 -98.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 110.02 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -150.42 -69.66 0.19 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.043 -1.035 . . . . 0.0 109.912 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -142.03 86.28 10.48 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.014 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.5 Cg_endo -77.97 142.01 19.39 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.605 2.204 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.1 Cg_endo -78.38 -168.2 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.658 2.238 . . . . 0.0 110.776 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -164.2 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.288 -0.883 . . . . 0.0 109.358 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -142.95 -33.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.545 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -169.07 174.45 6.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -147.98 -38.56 0.18 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.875 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.982 ' HB3' HG12 ' A' ' 9' ' ' VAL . 11.9 pttm -170.21 -40.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.727 -1.233 . . . . 0.0 110.455 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.05 21.81 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.202 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.545 ' HB ' ' CB ' ' A' ' 32' ' ' CYS . 3.6 m -111.79 164.68 12.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 109.364 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -108.39 139.92 42.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.677 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 29.8 m -115.86 84.81 13.56 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 36.0 Cg_endo -79.54 67.62 8.54 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.474 2.116 . . . . 0.0 110.083 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.89 -40.25 0.07 OUTLIER Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.409 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 41' ' ' ILE . 10.1 tt -148.85 90.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.777 -1.425 . . . . 0.0 110.912 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.619 ' CB ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER 45.86 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 112.291 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -160.68 -168.53 2.14 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.932 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.02 152.52 30.88 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.124 0.964 . . . . 0.0 111.129 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 1.5 m -160.62 -169.47 2.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 16.0 mt-10 -82.98 156.45 23.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.912 -1.118 . . . . 0.0 108.968 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -139.77 151.89 22.29 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.945 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 20' ' ' LEU . 14.1 m -64.55 -9.71 21.01 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -1.064 . . . . 0.0 109.568 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -161.55 86.79 0.67 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' MET . . . 88.75 112.86 1.22 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.699 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.8 ttt -47.94 173.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 108.799 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 165.41 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.729 ' O ' HG21 ' A' ' 41' ' ' ILE . 17.3 m -85.68 122.83 30.34 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.829 -1.17 . . . . 0.0 110.004 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 11.6 m-85 -116.15 179.55 3.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.0 p -113.55 86.14 9.95 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 42' ' ' LYS . 37.2 Cg_endo -78.9 -154.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.041 2.494 . . . . 0.0 110.775 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.55 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 73.1 mt-30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 34' ' ' LYS . 31.5 m . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.29 0.567 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.529 ' HB3' ' CE ' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -67.12 113.05 4.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.955 HG21 ' HA ' ' A' ' 45' ' ' CYS . 18.7 m -88.74 60.84 5.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 5.5 mttt -95.78 -49.19 0.25 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 111.686 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 37.1 Cg_endo -78.71 -104.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.002 1.801 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' PRO . . . 32.7 -142.21 0.05 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.433 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 39.6 t -143.11 68.47 1.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.008 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 84.4 m -64.41 155.12 81.79 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.054 -1.029 . . . . 0.0 108.874 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 36.4 Cg_endo -78.21 -176.53 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.458 2.105 . . . . 0.0 110.38 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -107.97 113.06 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.225 -0.922 . . . . 0.0 109.058 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.899 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 mm -90.45 -166.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.182 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 21' ' ' ILE . 3.5 pp -117.5 -53.79 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.55 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.956 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -162.99 178.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.626 ' N ' HG23 ' A' ' 21' ' ' ILE . 6.0 mtp180 -94.98 94.61 8.09 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.824 -1.172 . . . . 0.0 108.803 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.732 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -12.19 -53.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 79.02 -45.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.744 -1.223 . . . . 0.0 110.584 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.452 ' C ' ' O ' ' A' ' 24' ' ' ALA . 4.0 mmm -32.62 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.456 -0.777 . . . . 0.0 111.652 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -85.67 -178.32 6.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.057 -1.027 . . . . 0.0 110.662 -178.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -113.79 85.95 10.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.668 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' CG ' ' O ' ' A' ' 49' ' ' CYS . 35.8 Cg_endo -76.15 138.07 19.94 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.667 2.244 . . . . 0.0 110.291 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 37.1 Cg_endo -79.44 -102.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 110.355 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -161.61 154.82 21.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.773 -1.205 . . . . 0.0 109.563 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -104.16 -32.52 9.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 108.933 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 1.055 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -166.1 156.32 12.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.055 HD13 ' C ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -149.12 11.2 0.81 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.041 -177.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.8 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -177.82 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.943 -1.098 . . . . 0.0 109.686 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.8 82.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.434 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 93.9 m -159.24 123.79 4.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 57.89 -156.14 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.582 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 54.82 64.52 5.87 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 109.189 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 35.6 Cg_endo -78.63 128.21 8.5 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.771 2.314 . . . . 0.0 110.952 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.31 -155.13 20.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.47 -12.4 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.506 -0.996 . . . . 0.0 109.82 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.2 mtmp? -79.46 143.15 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.219 -0.926 . . . . 0.0 110.225 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 27.1 mttp -154.19 -179.36 7.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -80.81 130.45 35.07 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.685 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.955 ' HA ' HG21 ' A' ' 11' ' ' THR . 0.7 OUTLIER -134.45 -166.45 1.81 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 51' ' ' MET . 17.2 mt-10 -98.23 138.54 35.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.899 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -121.71 -139.45 5.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.753 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -113.95 -73.43 0.66 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.339 -1.095 . . . . 0.0 109.355 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' PRO . 7.2 t -78.56 -42.63 28.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.967 -1.083 . . . . 0.0 110.188 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 51' ' ' MET . . . -145.3 114.92 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 29.3 mtm -48.91 175.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 171.98 -163.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.6 -1.312 . . . . 0.0 110.581 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 56.3 m -78.17 90.12 4.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.947 -1.096 . . . . 0.0 112.635 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 86.4 m-85 -96.09 -123.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -82.75 -157.38 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.919 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.6 Cg_endo -65.52 -97.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.65 0 CA-C-N 121.119 1.435 . . . . 0.0 111.096 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.551 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.7 mt-30 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 120.302 -1.499 . . . . 0.0 110.037 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 34' ' ' LYS . 9.3 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.183 0.516 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.66 132.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 109.769 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 t -124.93 -37.33 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -81.48 -43.74 1.12 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.0 111.035 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 33.9 Cg_endo -77.08 -76.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.765 1.643 . . . . 0.0 110.933 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 42' ' ' LYS . . . -75.34 149.14 38.41 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -113.68 111.82 22.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -1.212 . . . . 0.0 109.943 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 58.8 m -75.44 143.96 76.99 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.192 -0.943 . . . . 0.0 109.076 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.54 -175.5 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.554 2.169 . . . . 0.0 110.988 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' C ' HD13 ' A' ' 19' ' ' ILE . 29.8 mm -118.54 154.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.603 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -117.88 166.08 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.023 . . . . 0.0 110.12 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -46.31 -74.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.791 ' N ' HD23 ' A' ' 20' ' ' LEU . 65.7 mt -159.3 -77.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 108.968 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.4 ttt85 -161.42 88.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.5 p -30.65 -42.16 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.678 -0.639 . . . . 0.0 111.257 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 72.38 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 24' ' ' ALA . 1.8 mmt 35.28 -92.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.821 -0.55 . . . . 0.0 110.779 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.542 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -132.61 -147.24 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.666 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.65 92.89 10.96 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.113 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.9 Cg_endo -72.82 146.77 43.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.487 2.125 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.9 Cg_endo -79.32 -159.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.65 2.233 . . . . 0.0 110.922 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.93 139.26 39.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 17.4 mmm180 -87.15 -38.94 15.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 110.026 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.828 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.2 p -155.76 172.01 19.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.022 -1.049 . . . . 0.0 109.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.828 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.5 36.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.42 -0.8 . . . . 0.0 109.123 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 95.08 -1.53 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.166 0.507 . . . . 0.0 109.79 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.36 -103.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.9 -1.125 . . . . 0.0 109.534 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.442 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -160.36 96.95 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.839 -1.163 . . . . 0.0 109.687 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 2.2 m-20 -172.87 -170.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -0.861 . . . . 0.0 108.86 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.615 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 1.3 m 62.64 173.03 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.991 -1.068 . . . . 0.0 109.121 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 31.1 Cg_endo -73.21 -171.07 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.137 1.892 . . . . 0.0 110.952 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . -87.13 -41.21 6.7 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.457 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.728 HD12 HG23 ' A' ' 55' ' ' VAL . 13.4 pt -41.72 121.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.09 -1.241 . . . . 0.0 109.684 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 47.17 -130.76 1.43 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.391 -0.818 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 3.2 mmtt -162.55 -95.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.47 -1.394 . . . . 0.0 109.46 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -133.67 135.39 44.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 110.543 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.564 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 91.5 m -138.19 -173.06 3.42 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -84.9 153.9 22.58 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.999 -1.063 . . . . 0.0 109.155 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -133.53 14.41 4.76 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.526 ' OG ' HG21 ' A' ' 19' ' ' ILE . 80.3 p 51.28 14.2 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.879 . . . . 0.0 110.287 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' PRO . 23.9 t -161.9 29.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.625 -1.297 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 51' ' ' MET . . . 120.29 108.43 2.19 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 50' ' ' GLY . 19.7 mtm -43.21 145.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -1.102 . . . . 0.0 109.699 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . -157.34 -165.35 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.066 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.72 123.3 34.21 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.584 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 30.6 m-85 -116.93 156.36 27.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -94.23 161.88 28.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 55' ' ' VAL . 34.0 Cg_endo -76.68 -165.31 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.633 2.222 . . . . 0.0 111.056 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.5 -179.608 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -87.27 -176.14 5.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.98 145.16 29.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' LYS . 35.7 Cg_endo -78.55 69.59 7.65 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.566 2.177 . . . . 0.0 110.545 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.793 HG12 ' HG2' ' A' ' 6' ' ' LYS . 85.8 t 51.88 -88.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.86 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.793 ' HG2' HG12 ' A' ' 5' ' ' VAL . 4.3 mmtm -106.73 170.07 8.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.517 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.49 -71.54 0.16 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.93 -153.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.63 2.22 . . . . 0.0 109.752 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 m -83.46 42.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.956 -1.09 . . . . 0.0 109.906 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.99 108.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.734 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -89.69 -21.03 22.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 108.949 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.05 72.44 76.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.768 . . . . 0.0 109.238 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.46 -93.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.56 2.174 . . . . 0.0 110.467 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 56' ' ' PRO . . . -136.52 -151.44 6.05 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -125.96 137.77 53.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -1.143 . . . . 0.0 109.708 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.23 152.72 95.6 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.903 . . . . 0.0 109.154 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.09 16.09 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.604 2.203 . . . . 0.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.62 123.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.913 -1.117 . . . . 0.0 108.526 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.965 HD13 ' O ' ' A' ' 46' ' ' GLU . 4.4 mp -143.65 126.45 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.339 -0.851 . . . . 0.0 109.644 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.047 ' HG ' HG22 ' A' ' 21' ' ' ILE . 47.8 tp 37.11 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.416 0.627 . . . . 0.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.047 HG22 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.15 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.879 . . . . 0.0 108.965 178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.725 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.87 35.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.921 -1.112 . . . . 0.0 109.682 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.572 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 5.13 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.557 0.694 . . . . 0.0 111.709 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.86 61.49 0.88 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.636 ' HB3' HD23 ' A' ' 26' ' ' LEU . 3.8 mmt -96.07 -100.12 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.497 -0.752 . . . . 0.0 110.319 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 25' ' ' MET . 1.0 OUTLIER -117.68 -134.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.762 -1.211 . . . . 0.0 110.006 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -111.79 90.51 13.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 109.761 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 34.6 Cg_endo -76.12 168.33 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.711 2.274 . . . . 0.0 110.271 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' C ' ' ND2' ' A' ' 30' ' ' ASN . 36.0 Cg_endo -77.87 174.93 11.82 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.559 2.172 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -155.27 134.97 12.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -85.86 -10.2 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.594 ' O ' HD23 ' A' ' 33' ' ' LEU . 30.3 p -161.02 163.78 31.4 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 32' ' ' CYS . 93.7 mt -158.04 -60.54 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.122 -0.986 . . . . 0.0 108.52 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' CE ' ' HB3' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -120.35 -39.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -84.46 58.43 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.584 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.524 ' CG2' ' SG ' ' A' ' 38' ' ' CYS . 27.1 m -42.64 125.3 3.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.54 44.88 1.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.33 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 36' ' ' THR . 1.8 m -102.24 116.16 63.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.99 102.68 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.169 1.913 . . . . 0.0 110.38 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.8 -130.34 4.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 41' ' ' ILE . 8.6 tp -117.95 58.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -1.168 . . . . 0.0 109.288 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -111.51 -178.02 3.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.432 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 1.2 tmtt? -164.08 125.88 2.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.359 -0.838 . . . . 0.0 108.759 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 21.9 t -56.22 112.79 1.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.088 -1.007 . . . . 0.0 110.236 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.612 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -124.78 -159.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 109.214 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.965 ' O ' HD13 ' A' ' 19' ' ' ILE . 5.1 mt-10 -116.37 113.51 23.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.81 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' HA2' HD13 ' A' ' 19' ' ' ILE . . . -94.47 62.35 1.72 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 49' ' ' CYS . 39.0 p 44.52 85.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.326 -1.102 . . . . 0.0 108.889 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER 87.4 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.675 -0.64 . . . . 0.0 109.648 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.53 153.15 11.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.549 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -111.27 162.23 15.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -1.047 . . . . 0.0 109.202 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -170.9 -170.4 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 52.1 m -77.06 115.68 17.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 110.86 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 60.7 m-85 -129.54 137.43 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.932 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.1 131.77 94.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.022 . . . . 0.0 108.625 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.3 Cg_endo -81.29 51.41 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.48 2.12 . . . . 0.0 110.672 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.593 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.25 71.34 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -137.31 65.55 49.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.631 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' VAL . 35.8 Cg_endo -78.32 4.9 5.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.539 2.16 . . . . 0.0 110.394 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 6' ' ' LYS . 13.9 p -43.89 168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' N ' HG22 ' A' ' 5' ' ' VAL . 6.4 ptpp? -106.51 -148.13 0.41 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.547 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' LYS . . . 136.54 91.99 0.32 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' C ' HG12 ' A' ' 9' ' ' VAL . 33.7 Cg_endo -76.16 159.29 37.26 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.455 2.103 . . . . 0.0 110.826 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.654 ' O ' HG22 ' A' ' 9' ' ' VAL . 7.7 p 40.55 59.35 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.322 0.582 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -153.24 -162.27 1.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -72.57 -28.22 62.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 7' ' ' GLY . 17.6 mttt -116.53 109.46 43.78 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 108.887 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.12 -175.63 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.402 2.068 . . . . 0.0 111.22 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.06 -125.64 0.16 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -109.14 73.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -1.17 . . . . 0.0 109.657 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 50.0 m -60.04 153.61 54.84 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.18 -0.95 . . . . 0.0 109.073 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -81.84 -157.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.132 2.554 . . . . 0.0 111.219 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.753 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -81.45 150.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 21' ' ' ILE . 20.0 mm -120.48 128.33 76.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 111.254 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.691 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.49 -24.85 14.29 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.811 ' H ' HG22 ' A' ' 19' ' ' ILE . 10.8 tp 117.95 92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.531 0.732 . . . . 0.0 110.414 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 27.32 39.3 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.66 -0.65 . . . . 0.0 112.32 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.669 ' O ' ' N ' ' A' ' 25' ' ' MET . 4.0 p 38.06 21.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.186 -0.946 . . . . 0.0 112.46 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' O ' ' C ' ' A' ' 25' ' ' MET . . . 45.78 -87.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.895 1.225 . . . . 0.0 108.453 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.669 ' N ' ' O ' ' A' ' 23' ' ' CYS . 11.4 mmm -5.22 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.299 0.571 . . . . 0.0 111.759 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 26' ' ' LEU . 2.6 pt? -51.29 166.39 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.764 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 58.74 80.47 0.28 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 109.673 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 36.3 Cg_endo -79.03 132.42 10.5 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.611 2.208 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 36.6 Cg_endo -81.03 -164.82 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.519 2.146 . . . . 0.0 110.324 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 29' ' ' PRO . 1.5 m120 -150.5 111.05 4.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.351 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.45 -10.83 20.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.988 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 16.1 p -158.21 155.83 29.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.04 -1.037 . . . . 0.0 108.435 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 51' ' ' MET . 87.3 mt -152.39 -41.35 0.1 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.033 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 174.44 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 36' ' ' THR . 13.6 t70 -41.32 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.278 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 172.45 -36.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.123 . . . . 0.0 110.057 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 17.2 t0 -42.33 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.86 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' THR . 1.3 m -170.63 65.77 0.47 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 109.691 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.7 Cg_endo -79.46 154.75 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.878 2.385 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -68.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.408 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -84.24 -118.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -1.228 . . . . 0.0 110.76 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 41' ' ' ILE . 11.3 ttmt -142.37 -34.58 0.45 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.625 -1.297 . . . . 0.0 110.247 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -163.9 1.31 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 12.2 t -106.92 143.98 34.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.658 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -138.01 -166.81 2.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.506 -0.746 . . . . 0.0 109.001 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG3' ' HB3' ' A' ' 51' ' ' MET . 1.7 mp0 -122.99 124.72 43.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 19' ' ' ILE . . . -149.56 -145.4 4.12 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.139 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.759 ' N ' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -65.89 117.0 7.65 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.913 -0.757 . . . . 0.0 109.826 -178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER 78.92 91.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.602 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -141.38 20.92 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.574 ' HG3' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.64 149.33 40.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -1.04 . . . . 0.0 109.14 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -145.1 162.39 37.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.682 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 m -66.6 113.34 4.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.222 -0.924 . . . . 0.0 110.47 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.658 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 19.2 m-30 -112.22 -172.21 2.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -109.57 81.97 2.05 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.424 -0.798 . . . . 0.0 108.948 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 33.7 Cg_endo -73.74 178.02 7.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.656 2.237 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.534 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.04 -68.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.253 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.11 99.73 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.66 -159.29 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.461 2.107 . . . . 0.0 110.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 75.5 t -68.43 -82.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER 170.19 179.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.633 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.2 -78.31 0.07 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 37.7 Cg_endo -80.93 58.26 6.93 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.983 2.455 . . . . 0.0 110.496 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 10' ' ' SER . 65.8 t 65.67 -94.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.618 -0.676 . . . . 0.0 109.434 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -168.62 75.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.585 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 12' ' ' LYS . 4.1 t -108.77 -39.81 5.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 2.1 mtmt -49.16 -51.76 53.85 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 109.685 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 36.1 Cg_endo -78.65 -47.07 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.385 2.056 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.86 -164.23 2.6 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -137.45 79.27 1.74 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.238 . . . . 0.0 109.821 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.2 m -47.8 166.25 0.21 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.197 -0.94 . . . . 0.0 108.752 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.639 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 34.4 Cg_endo -76.97 7.01 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.286 1.99 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.811 ' O ' HD13 ' A' ' 19' ' ' ILE . 14.5 mm 61.03 131.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.001 HG21 ' C ' ' A' ' 47' ' ' GLY . 2.3 mm -132.76 -138.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 2.4 pt? -161.7 -41.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 22' ' ' ARG . 39.7 mm -153.71 -105.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.447 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 21' ' ' ILE . 4.3 mtp180 169.65 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.685 -1.259 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 14.0 p 43.12 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 111.377 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' CG ' ' A' ' 25' ' ' MET . . . -73.45 83.63 1.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.402 -1.436 . . . . 0.0 107.633 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -168.23 96.26 0.41 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.4 -0.813 . . . . 0.0 109.141 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 5.3 tt -45.6 135.91 6.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.823 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 1.0 OUTLIER 163.95 -52.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.887 . . . . 0.0 110.315 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 27' ' ' ASN . 35.8 Cg_endo -80.33 111.26 2.6 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.654 2.236 . . . . 0.0 110.33 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 27' ' ' ASN . 36.6 Cg_endo -77.72 -100.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.197 1.931 . . . . 0.0 110.436 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' CG ' ' C ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -162.41 117.42 1.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.843 -1.161 . . . . 0.0 109.303 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.79 -26.23 34.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.756 ' O ' HD23 ' A' ' 33' ' ' LEU . 25.0 p -151.8 -176.21 5.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.32 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 173.86 -34.1 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.163 -0.961 . . . . 0.0 109.339 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 179.61 122.36 0.06 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 110.348 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 42.61 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.435 -0.791 . . . . 0.0 109.612 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.33 -142.48 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.346 -0.846 . . . . 0.0 109.184 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 47.41 60.54 15.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.032 -1.043 . . . . 0.0 109.416 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.6 Cg_endo -79.0 -179.86 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.591 2.194 . . . . 0.0 110.659 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . 44.9 -161.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.466 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 3.3 tt -41.81 -40.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.989 . . . . 0.0 109.824 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 5.4 mtmt -53.29 134.31 39.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.875 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 56' ' ' PRO . 3.2 mttt -149.25 148.84 30.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.421 -0.799 . . . . 0.0 109.002 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.62 124.15 20.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.033 -1.042 . . . . 0.0 109.789 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -133.64 -170.0 2.41 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -91.82 162.21 14.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 1.001 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -144.09 169.1 26.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.75 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -84.75 13.33 5.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.183 -1.186 . . . . 0.0 109.984 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.8 t 177.05 71.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.81 102.15 2.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 22' ' ' ARG . 1.6 mtt -49.3 168.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' CD1' ' A' ' 54' ' ' PHE . . . -179.53 168.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.993 -1.067 . . . . 0.0 110.053 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 m -68.65 99.75 1.04 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.639 ' CD2' ' HG3' ' A' ' 17' ' ' PRO . 96.2 m-85 -91.95 -169.16 2.19 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.279 -0.888 . . . . 0.0 109.046 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.5 104.92 36.59 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 34.9 Cg_endo -76.34 -159.75 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.186 1.924 . . . . 0.0 110.571 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 56' ' ' PRO . 2.3 pp0? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.255 0.55 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -26.8 64.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.699 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.19 103.03 10.66 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 -165.77 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.394 2.062 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 6' ' ' LYS . 8.5 p -101.95 -42.8 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 5' ' ' VAL . 16.9 mttt 56.52 81.74 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.207 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.84 100.95 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.58 37.68 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.647 2.231 . . . . 0.0 111.03 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.75 83.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.008 -1.058 . . . . 0.0 109.393 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.99 35.18 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.256 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -122.13 153.01 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 115.05 12.05 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -77.85 -156.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.243 1.962 . . . . 0.0 110.02 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . -41.74 -93.83 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.09 131.63 40.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.244 . . . . 0.0 109.703 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.0 m -96.14 151.81 38.45 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -78.81 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.122 2.548 . . . . 0.0 110.328 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.514 ' C ' HD13 ' A' ' 19' ' ' ILE . 33.9 mm -120.99 140.68 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.319 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -115.04 -165.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -70.15 -44.69 68.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.479 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 161.93 -64.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.744 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -175.37 77.77 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -32.75 113.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.915 0.864 . . . . 0.0 110.625 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.1 59.16 3.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.835 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -122.32 101.5 7.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 25' ' ' MET . 1.3 pt? 38.18 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.59 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 27' ' ' ASN . 7.7 p-10 -108.86 93.48 12.49 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.526 -0.734 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.0 Cg_endo -72.92 144.3 38.22 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.301 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.0 Cg_endo -77.98 -164.57 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.683 2.255 . . . . 0.0 110.705 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.96 112.79 6.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 22.8 ttt180 -55.46 -18.35 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.737 ' C ' HD23 ' A' ' 33' ' ' LEU . 20.9 p -151.12 177.96 9.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 109.001 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.867 HD12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -174.86 -40.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.008 -1.058 . . . . 0.0 110.073 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.867 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -141.61 -56.56 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 36' ' ' THR . 8.2 t70 -87.94 -97.32 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.0 109.227 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 38' ' ' CYS . 16.4 m 61.22 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 109.785 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 36' ' ' THR . 7.8 t70 91.93 -21.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.693 ' H ' HG22 ' A' ' 36' ' ' THR . 4.6 m 56.67 162.46 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.5 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 35.9 Cg_endo -78.98 -89.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.658 2.238 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -58.39 -158.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 41' ' ' ILE . 3.4 tp -75.86 82.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -1.107 . . . . 0.0 109.347 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -130.39 174.55 9.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.03 134.14 11.36 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 33.4 t -56.22 101.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.533 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.575 ' CB ' ' CD2' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -96.87 -167.36 1.54 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -116.36 93.99 4.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.782 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -72.67 -162.27 6.38 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.562 ' H ' HG21 ' A' ' 19' ' ' ILE . 5.5 p -94.37 -54.93 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.106 -1.232 . . . . 0.0 109.483 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 28' ' ' PRO . 10.1 t -67.02 -65.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.45 147.11 18.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.5 mtt -47.95 167.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 108.999 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.932 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -172.65 -176.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 36' ' ' THR . 3.5 m -91.58 98.63 11.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 109.315 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.932 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 13.5 m-30 -100.86 144.02 30.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 109.519 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.9 p -75.41 120.15 80.31 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 108.964 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.4 -172.81 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.302 2.001 . . . . 0.0 110.919 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' OXT' ' CG ' ' A' ' 57' ' ' GLN . 3.0 pt20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.621 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -157.0 172.04 19.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 108.988 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -174.27 75.1 0.35 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.13 -0.981 . . . . 0.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.71 ' O ' HG23 ' A' ' 5' ' ' VAL . 35.3 Cg_endo -77.87 -91.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.566 2.178 . . . . 0.0 110.199 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER 164.68 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 108.839 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.03 58.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.02 141.32 16.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.87 -84.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.591 2.194 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -117.6 58.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -98.88 -84.76 0.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.722 HG22 ' CD ' ' A' ' 12' ' ' LYS . 23.7 m -119.91 -94.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.081 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.722 ' CD ' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -131.94 57.08 27.38 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.959 -1.088 . . . . 0.0 109.505 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -77.94 -171.97 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.632 2.221 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . 55.19 169.02 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -129.23 135.11 48.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -1.056 . . . . 0.0 109.291 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 60.1 m -66.94 160.19 71.38 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HD2' HD11 ' A' ' 19' ' ' ILE . 36.4 Cg_endo -79.56 43.73 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 123.107 2.538 . . . . 0.0 111.589 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 17' ' ' PRO . 2.5 tp 40.47 100.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.89 . . . . 0.0 110.747 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -130.32 175.53 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 108.281 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -139.21 -65.29 0.49 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.534 -1.354 . . . . 0.0 111.78 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.046 ' N ' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -38.16 85.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.589 0.709 . . . . 0.0 111.187 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' LEU . 3.5 mtt180 -81.59 2.41 29.4 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 25' ' ' MET . 17.7 p 38.5 51.74 1.69 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.663 . . . . 0.0 110.661 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 89.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.067 -1.021 . . . . 0.0 109.028 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.715 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -127.23 -103.46 0.34 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.697 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.797 ' N ' HD23 ' A' ' 26' ' ' LEU . 2.0 pt? -164.57 26.08 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.508 -1.37 . . . . 0.0 110.84 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 2.9 m-20 164.76 80.07 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.859 -1.15 . . . . 0.0 110.145 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.03 170.37 17.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.517 2.145 . . . . 0.0 110.265 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.31 175.27 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.696 2.264 . . . . 0.0 110.353 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -144.56 93.91 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 109.389 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' MET . 10.7 tpt180 -89.61 -10.86 44.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.766 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 52' ' ' ALA . 17.5 p -153.56 169.01 24.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.972 -1.08 . . . . 0.0 109.814 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER 179.63 42.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.468 -0.77 . . . . 0.0 108.942 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' HG12 ' A' ' 9' ' ' VAL . 20.2 mtpt 65.34 -110.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 36' ' ' THR . 2.5 m-20 44.35 41.93 4.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.616 -1.303 . . . . 0.0 109.752 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 43.45 70.95 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.62 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -139.24 -169.57 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 42' ' ' LYS . 13.6 m 62.63 84.36 0.19 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.07 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.613 2.209 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.49 -130.63 45.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 1.6 tt -122.38 66.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 0.6 OUTLIER -120.67 -162.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.749 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER 178.61 122.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.084 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 43' ' ' LYS . 50.7 t -49.93 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 110.166 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.87 -166.23 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.014 ' O ' HD13 ' A' ' 19' ' ' ILE . 2.7 tt0 -118.49 105.93 12.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 109.315 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -97.93 88.83 0.93 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.194 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 19' ' ' ILE . 0.1 OUTLIER 57.44 -98.99 0.09 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.606 -0.937 . . . . 0.0 109.799 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -100.09 118.41 36.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.902 -1.124 . . . . 0.0 110.055 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 143.46 3.2 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -87.68 168.33 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -1.016 . . . . 0.0 109.342 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 54' ' ' PHE . . . -168.88 158.69 9.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 108.845 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 61.7 m -63.86 94.48 0.1 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.879 -1.138 . . . . 0.0 109.194 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 47' ' ' GLY . 90.6 m-85 -94.24 178.92 5.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.15 130.3 25.27 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.29 157.84 29.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.329 2.02 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.397 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 2.2 tt0 73.75 111.07 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -148.16 74.9 10.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.07 42.12 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.799 2.333 . . . . 0.0 111.055 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.06 97.77 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.035 . . . . 0.0 109.462 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -66.18 0.59 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.88 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.88 -77.84 0.26 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' O ' HG13 ' A' ' 9' ' ' VAL . 36.2 Cg_endo -78.05 -170.98 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.522 2.148 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.854 HG22 ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER 42.35 -88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.753 -0.592 . . . . 0.0 109.877 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.854 ' N ' HG22 ' A' ' 9' ' ' VAL . 13.7 m 66.65 -149.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.628 -1.295 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 12' ' ' LYS . 1.7 t -159.44 -49.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.53 ' N ' HG23 ' A' ' 11' ' ' THR . 3.9 ptmt -139.01 61.85 23.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 35.5 Cg_endo -77.78 -84.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.633 2.222 . . . . 0.0 110.473 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.38 -138.21 5.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 107.49 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.11 155.26 90.86 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.37 -167.96 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 110.596 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.561 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -121.88 141.08 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.089 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.731 HG21 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -132.57 166.97 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 109.263 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -44.86 -71.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' ARG . 90.6 mt -154.76 -109.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 22.1 mmm-85 -154.33 27.04 0.46 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.824 -1.172 . . . . 0.0 108.467 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 13.8 p 39.51 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.259 1.028 . . . . 0.0 110.415 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.76 55.94 3.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.605 -1.31 . . . . 0.0 108.936 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.6 mmm -98.53 -98.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.433 -0.792 . . . . 0.0 110.389 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 -105.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.595 -1.315 . . . . 0.0 110.43 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.78 92.31 49.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.782 -1.199 . . . . 0.0 109.865 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.33 164.87 33.12 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.374 2.05 . . . . 0.0 110.173 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 35.6 Cg_endo -77.87 177.43 8.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.702 2.268 . . . . 0.0 110.788 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HA2' ' A' ' 50' ' ' GLY . 60.8 m-80 -158.84 157.76 32.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.674 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -42.78 5.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.768 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -145.75 166.55 25.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.81 51.54 0.23 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 109.35 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.5 mmtt 79.87 51.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.343 1.068 . . . . 0.0 108.97 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.07 -97.62 0.06 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.576 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.8 t -156.31 138.39 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.383 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 173.77 -27.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.16 94.05 20.1 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 109.161 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 35.4 Cg_endo -77.6 -27.71 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.69 2.26 . . . . 0.0 110.756 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -61.68 -125.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 41' ' ' ILE . 5.1 tt -129.72 42.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.169 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 54' ' ' PHE . 23.2 mttt -119.82 -174.69 2.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 109.83 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 58.8 mmtt -149.2 167.33 26.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.51 92.08 5.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.43 -1.419 . . . . 0.0 111.041 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 96.6 m -92.29 -165.17 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' O ' HD11 ' A' ' 19' ' ' ILE . 7.9 mt-10 -101.52 140.52 35.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.699 -1.251 . . . . 0.0 109.688 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.731 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -122.3 33.35 4.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 8.0 t 75.9 -24.16 0.23 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.214 -0.58 . . . . 0.0 110.714 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 23.5 t -162.18 91.71 0.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.671 -1.268 . . . . 0.0 109.214 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA2' ' OD1' ' A' ' 30' ' ' ASN . . . 100.23 139.23 10.68 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -81.94 150.6 27.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -1.161 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.49 170.35 22.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 108.929 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 14.4 m -80.28 109.65 14.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.053 -1.029 . . . . 0.0 110.674 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m-85 -105.25 142.16 35.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -79.26 131.97 64.24 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.983 -1.073 . . . . 0.0 109.487 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 36.2 Cg_endo -78.62 -175.65 2.85 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.36 2.04 . . . . 0.0 110.667 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 12.4 pt20 -120.3 -0.03 10.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.541 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.97 98.58 35.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.12 -0.988 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 2' ' ' GLN . 34.8 Cg_endo -76.94 162.74 31.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.395 2.063 . . . . 0.0 110.466 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 6' ' ' LYS . 2.6 p -135.39 -174.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.106 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.723 ' H ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.47 150.42 24.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.005 . . . . 0.0 109.433 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . 161.71 -56.65 0.3 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' GLY . 36.2 Cg_endo -78.04 -167.06 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.628 2.219 . . . . 0.0 110.255 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 30.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.18 71.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.465 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 4.4 t -152.64 160.59 43.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.094 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.544 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.75 61.31 15.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.984 -1.072 . . . . 0.0 110.267 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.7 Cg_endo -81.82 -40.65 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.509 2.139 . . . . 0.0 110.73 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' CA ' ' A' ' 57' ' ' GLN . . . -58.51 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.947 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 10.1 t -161.35 75.0 0.49 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.034 -1.274 . . . . 0.0 110.819 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 40.6 m -93.48 145.12 29.38 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 120.409 -1.432 . . . . 0.0 108.581 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.09 -163.38 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.56 2.174 . . . . 0.0 110.585 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.2 tp -85.35 131.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.014 HD12 ' HA2' ' A' ' 47' ' ' GLY . 27.3 mm -136.57 114.51 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 117.58 -1.648 . . . . 0.0 113.579 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -101.69 104.52 15.34 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.803 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -75.65 80.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.669 -1.269 . . . . 0.0 109.748 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.13 6.16 3.6 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.742 -0.599 . . . . 0.0 110.95 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' C ' ' O ' ' A' ' 22' ' ' ARG . 19.0 p -18.39 132.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.984 0.421 . . . . 0.0 111.624 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.89 60.13 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.6 mmt -143.56 124.76 14.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 2.9 tp -75.91 134.12 40.34 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 m120 77.03 90.52 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 34.0 Cg_endo -75.86 120.6 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.656 2.237 . . . . 0.0 111.363 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' ASN . 36.1 Cg_endo -78.75 -175.84 2.96 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.321 2.014 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 29' ' ' PRO . 56.8 m-80 -159.05 129.25 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -25.61 21.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 1.6 p -174.0 -169.55 0.49 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -161.2 -41.78 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 109.705 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 -65.87 1.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.937 . . . . 0.0 108.972 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -160.29 82.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.655 HG22 ' OD1' ' A' ' 37' ' ' ASP . 22.2 m -106.85 -77.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.655 ' OD1' HG22 ' A' ' 36' ' ' THR . 0.8 OUTLIER -118.66 -111.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.846 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER 39.99 86.82 0.12 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 0.0 109.401 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 35.3 Cg_endo -77.16 178.43 7.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.444 2.096 . . . . 0.0 110.534 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.07 -178.92 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 56' ' ' PRO . 8.7 pt -48.89 -24.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.118 -1.225 . . . . 0.0 109.075 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -52.87 138.11 30.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.166 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -153.51 -169.54 3.33 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.15 132.48 34.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.843 -1.161 . . . . 0.0 111.757 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 1.5 m -134.64 -166.38 1.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CB ' HG21 ' A' ' 19' ' ' ILE . 61.6 mt-10 -87.87 167.47 13.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.577 -1.327 . . . . 0.0 109.283 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 1.014 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -161.53 165.76 35.7 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -43.28 -43.45 4.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.205 -1.174 . . . . 0.0 109.033 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.508 ' N ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -116.9 129.52 56.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.789 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' CYS . . . 39.83 -115.54 0.58 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 10.9 mtt -149.35 176.98 10.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -1.117 . . . . 0.0 109.701 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -168.84 -173.61 1.89 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 60.8 m -86.48 96.96 10.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.785 -1.197 . . . . 0.0 111.936 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 47.9 m-85 -100.14 -124.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 108.183 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.831 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -86.59 -168.24 0.18 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.831 ' HD3' HG12 ' A' ' 55' ' ' VAL . 29.0 Cg_endo -72.22 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 120.725 0.95 . . . . 0.0 111.823 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.534 ' CA ' ' HA3' ' A' ' 14' ' ' GLY . 32.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.234 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.29 144.87 9.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -152.87 84.14 4.61 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.374 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.35 0.86 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.748 2.299 . . . . 0.0 110.473 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.26 137.75 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -91.7 30.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.496 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -153.75 63.59 0.36 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 7' ' ' GLY . 36.2 Cg_endo -78.21 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.779 2.319 . . . . 0.0 110.553 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.711 HG23 ' HG2' ' A' ' 34' ' ' LYS . 2.5 p -172.82 -36.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 -155.5 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.163 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 11' ' ' THR . 17.1 m -111.67 64.88 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -82.42 -55.29 0.57 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -79.77 177.36 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.327 2.018 . . . . 0.0 110.554 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.67 145.56 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.7 t -100.54 113.12 25.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -1.169 . . . . 0.0 109.51 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 11' ' ' THR . 74.2 m -72.21 137.64 81.55 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.599 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.2 Cg_endo -79.67 169.01 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.485 2.123 . . . . 0.0 110.148 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.3 mp -94.14 132.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.976 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.731 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -96.73 172.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 108.837 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -56.83 -55.85 29.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.052 -1.03 . . . . 0.0 110.388 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 22' ' ' ARG . 36.4 mm -160.35 -104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.867 -1.146 . . . . 0.0 109.138 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.669 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -143.53 102.74 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.377 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -35.93 124.06 0.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.318 0.58 . . . . 0.0 110.584 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.62 58.67 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.469 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 0.8 OUTLIER -127.93 124.15 36.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -77.97 3.6 14.27 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.576 -0.703 . . . . 0.0 109.425 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -129.83 77.73 76.33 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.324 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.2 Cg_endo -78.32 134.6 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.481 2.121 . . . . 0.0 110.484 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 36.3 Cg_endo -77.77 -171.36 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.33 2.02 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 82.4 m-20 -158.84 100.49 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 109.704 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -23.0 42.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 0.0 108.933 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.653 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.6 p -164.57 163.99 21.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -158.27 27.69 0.25 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.988 -1.07 . . . . 0.0 109.05 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.711 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -177.16 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -161.24 45.88 0.18 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.492 -0.755 . . . . 0.0 109.121 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -134.52 64.84 1.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 109.706 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 171.26 -171.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.024 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.67 76.83 0.5 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.072 -1.017 . . . . 0.0 108.856 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.7 -25.03 12.92 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.539 2.16 . . . . 0.0 110.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.76 -154.42 3.98 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 41' ' ' ILE . 10.5 tt -86.5 51.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.147 -1.208 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 54' ' ' PHE . 1.4 mptp? -131.2 177.83 7.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.022 -1.049 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -160.35 176.08 12.09 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -78.45 128.83 34.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.096 -1.628 . . . . 0.0 110.805 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -140.89 -165.99 2.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 3.1 tt0 -86.37 157.24 19.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.758 -1.213 . . . . 0.0 109.338 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.731 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -152.55 20.22 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.263 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 19' ' ' ILE . 1.1 p 82.45 -22.78 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.443 -1.033 . . . . 0.0 109.255 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 t -140.7 101.97 4.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 108.979 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 51' ' ' MET . . . 64.81 -126.36 32.01 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.476 ' CG ' ' C ' ' A' ' 50' ' ' GLY . 6.3 mtt -155.49 153.25 29.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -1.095 . . . . 0.0 108.57 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.34 -171.75 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 109.438 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 34.6 m -79.0 130.44 35.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 110.211 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 69.6 m-85 -129.23 172.37 11.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.481 -0.762 . . . . 0.0 109.188 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -96.06 108.97 44.45 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 37.2 Cg_endo -80.74 -156.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.364 2.042 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.363 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.04 98.24 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.399 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.49 79.88 2.37 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.46 84.29 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.652 2.235 . . . . 0.0 110.428 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 5' ' ' VAL . 14.5 p -144.24 43.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.533 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' CD ' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -127.48 -18.59 4.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.116 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 154.94 18.29 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.97 33.96 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.765 2.31 . . . . 0.0 111.199 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' HB3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -111.19 -33.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.005 -1.059 . . . . 0.0 109.242 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 26.5 p 173.61 162.61 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.078 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.795 HG22 ' H ' ' A' ' 12' ' ' LYS . 1.5 m -128.99 -168.74 1.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.795 ' H ' HG22 ' A' ' 11' ' ' THR . 8.0 mmtp -89.03 -43.89 0.44 Allowed Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.169 -0.957 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.2 Cg_endo -78.96 -157.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.172 1.915 . . . . 0.0 110.874 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' CA ' ' HB2' ' A' ' 57' ' ' GLN . . . -40.86 101.87 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.87 -42.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.0 109.733 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.82 142.66 37.16 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.544 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 35.4 Cg_endo -78.93 -176.68 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.58 2.186 . . . . 0.0 110.929 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -80.18 137.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 109.126 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 18' ' ' ILE . 38.5 mm -136.76 101.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.0 110.124 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 48' ' ' SER . 0.1 OUTLIER -45.14 -93.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 22' ' ' ARG . 5.5 tp -121.84 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 21' ' ' ILE . 15.3 mtm-85 -143.21 56.46 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.316 -1.49 . . . . 0.0 109.509 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.569 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.2 p 34.34 55.42 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.839 -0.538 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 23' ' ' CYS . . . -20.04 -59.35 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.996 -0.44 . . . . 0.0 111.071 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 4.5 mmt 39.1 -98.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 110.02 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -150.42 -69.66 0.19 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.043 -1.035 . . . . 0.0 109.912 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -142.03 86.28 10.48 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.014 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.5 Cg_endo -77.97 142.01 19.39 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.605 2.204 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.1 Cg_endo -78.38 -168.2 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.658 2.238 . . . . 0.0 110.776 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -164.2 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.288 -0.883 . . . . 0.0 109.358 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -142.95 -33.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.545 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -169.07 174.45 6.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -147.98 -38.56 0.18 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.875 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.982 ' HB3' HG12 ' A' ' 9' ' ' VAL . 11.9 pttm -170.21 -40.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.727 -1.233 . . . . 0.0 110.455 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.05 21.81 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.202 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.545 ' HB ' ' CB ' ' A' ' 32' ' ' CYS . 3.6 m -111.79 164.68 12.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 109.364 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -108.39 139.92 42.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.677 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 29.8 m -115.86 84.81 13.56 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 36.0 Cg_endo -79.54 67.62 8.54 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.474 2.116 . . . . 0.0 110.083 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.89 -40.25 0.07 OUTLIER Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.409 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 41' ' ' ILE . 10.1 tt -148.85 90.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.777 -1.425 . . . . 0.0 110.912 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.619 ' CB ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER 45.86 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 112.291 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -160.68 -168.53 2.14 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.932 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.02 152.52 30.88 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.124 0.964 . . . . 0.0 111.129 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 1.5 m -160.62 -169.47 2.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 16.0 mt-10 -82.98 156.45 23.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.912 -1.118 . . . . 0.0 108.968 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -139.77 151.89 22.29 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.945 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 20' ' ' LEU . 14.1 m -64.55 -9.71 21.01 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -1.064 . . . . 0.0 109.568 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -161.55 86.79 0.67 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' MET . . . 88.75 112.86 1.22 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.699 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.8 ttt -47.94 173.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 108.799 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 165.41 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.729 ' O ' HG21 ' A' ' 41' ' ' ILE . 17.3 m -85.68 122.83 30.34 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.829 -1.17 . . . . 0.0 110.004 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 11.6 m-85 -116.15 179.55 3.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.0 p -113.55 86.14 9.95 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 42' ' ' LYS . 37.2 Cg_endo -78.9 -154.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.041 2.494 . . . . 0.0 110.775 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.55 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 73.1 mt-30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 2.7 mt-30 60.04 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.717 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.3 mp0 -50.21 143.57 12.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.54 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 5' ' ' VAL . 35.7 Cg_endo -78.17 -61.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.556 2.171 . . . . 0.0 110.045 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 5' ' ' VAL . 13.7 p 40.3 39.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -92.23 112.99 25.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.332 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.77 70.47 0.52 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.79 -158.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.588 2.192 . . . . 0.0 110.348 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 34' ' ' LYS . 31.5 m -49.0 -22.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.163 -0.961 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.529 ' HB3' ' CE ' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -67.12 113.05 4.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.955 HG21 ' HA ' ' A' ' 45' ' ' CYS . 18.7 m -88.74 60.84 5.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 5.5 mttt -95.78 -49.19 0.25 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 111.686 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 37.1 Cg_endo -78.71 -104.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.002 1.801 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' PRO . . . 32.7 -142.21 0.05 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.433 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 39.6 t -143.11 68.47 1.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.008 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 84.4 m -64.41 155.12 81.79 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.054 -1.029 . . . . 0.0 108.874 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 36.4 Cg_endo -78.21 -176.53 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.458 2.105 . . . . 0.0 110.38 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -107.97 113.06 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.225 -0.922 . . . . 0.0 109.058 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.899 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 mm -90.45 -166.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.182 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 21' ' ' ILE . 3.5 pp -117.5 -53.79 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.55 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.956 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -162.99 178.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.626 ' N ' HG23 ' A' ' 21' ' ' ILE . 6.0 mtp180 -94.98 94.61 8.09 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.824 -1.172 . . . . 0.0 108.803 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.732 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -12.19 -53.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 79.02 -45.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.744 -1.223 . . . . 0.0 110.584 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.452 ' C ' ' O ' ' A' ' 24' ' ' ALA . 4.0 mmm -32.62 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.456 -0.777 . . . . 0.0 111.652 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -85.67 -178.32 6.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.057 -1.027 . . . . 0.0 110.662 -178.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -113.79 85.95 10.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.668 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' CG ' ' O ' ' A' ' 49' ' ' CYS . 35.8 Cg_endo -76.15 138.07 19.94 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.667 2.244 . . . . 0.0 110.291 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 37.1 Cg_endo -79.44 -102.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 110.355 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -161.61 154.82 21.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.773 -1.205 . . . . 0.0 109.563 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -104.16 -32.52 9.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 108.933 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 1.055 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -166.1 156.32 12.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.055 HD13 ' C ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -149.12 11.2 0.81 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.041 -177.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.8 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -177.82 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.943 -1.098 . . . . 0.0 109.686 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.8 82.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.434 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 93.9 m -159.24 123.79 4.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 57.89 -156.14 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.582 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 54.82 64.52 5.87 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 109.189 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 35.6 Cg_endo -78.63 128.21 8.5 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.771 2.314 . . . . 0.0 110.952 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.31 -155.13 20.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.47 -12.4 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.506 -0.996 . . . . 0.0 109.82 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.2 mtmp? -79.46 143.15 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.219 -0.926 . . . . 0.0 110.225 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 27.1 mttp -154.19 -179.36 7.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -80.81 130.45 35.07 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.685 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.955 ' HA ' HG21 ' A' ' 11' ' ' THR . 0.7 OUTLIER -134.45 -166.45 1.81 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 51' ' ' MET . 17.2 mt-10 -98.23 138.54 35.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.899 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -121.71 -139.45 5.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.753 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -113.95 -73.43 0.66 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.339 -1.095 . . . . 0.0 109.355 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' PRO . 7.2 t -78.56 -42.63 28.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.967 -1.083 . . . . 0.0 110.188 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 51' ' ' MET . . . -145.3 114.92 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 29.3 mtm -48.91 175.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 171.98 -163.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.6 -1.312 . . . . 0.0 110.581 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 56.3 m -78.17 90.12 4.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.947 -1.096 . . . . 0.0 112.635 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 86.4 m-85 -96.09 -123.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -82.75 -157.38 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.919 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.6 Cg_endo -65.52 -97.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.65 0 CA-C-N 121.119 1.435 . . . . 0.0 111.096 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.551 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.7 mt-30 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 120.302 -1.499 . . . . 0.0 110.037 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 45.37 68.49 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.375 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.23 147.44 39.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.384 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 35.5 Cg_endo -78.59 126.87 7.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.627 2.218 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.712 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.9 p -89.87 57.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -77.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.1 -1.0 . . . . 0.0 109.252 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.91 -178.28 43.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 9' ' ' VAL . 35.0 Cg_endo -76.92 -154.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.79 2.327 . . . . 0.0 110.296 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 34' ' ' LYS . 9.3 m -40.58 -35.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.66 132.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 109.769 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 t -124.93 -37.33 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -81.48 -43.74 1.12 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.0 111.035 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 33.9 Cg_endo -77.08 -76.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.765 1.643 . . . . 0.0 110.933 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 42' ' ' LYS . . . -75.34 149.14 38.41 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -113.68 111.82 22.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -1.212 . . . . 0.0 109.943 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 58.8 m -75.44 143.96 76.99 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.192 -0.943 . . . . 0.0 109.076 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.54 -175.5 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.554 2.169 . . . . 0.0 110.988 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' C ' HD13 ' A' ' 19' ' ' ILE . 29.8 mm -118.54 154.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.603 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -117.88 166.08 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.023 . . . . 0.0 110.12 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -46.31 -74.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.791 ' N ' HD23 ' A' ' 20' ' ' LEU . 65.7 mt -159.3 -77.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 108.968 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.4 ttt85 -161.42 88.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.5 p -30.65 -42.16 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.678 -0.639 . . . . 0.0 111.257 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 72.38 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 24' ' ' ALA . 1.8 mmt 35.28 -92.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.821 -0.55 . . . . 0.0 110.779 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.542 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -132.61 -147.24 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.666 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.65 92.89 10.96 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.113 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.9 Cg_endo -72.82 146.77 43.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.487 2.125 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.9 Cg_endo -79.32 -159.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.65 2.233 . . . . 0.0 110.922 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.93 139.26 39.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 17.4 mmm180 -87.15 -38.94 15.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 110.026 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.828 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.2 p -155.76 172.01 19.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.022 -1.049 . . . . 0.0 109.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.828 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.5 36.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.42 -0.8 . . . . 0.0 109.123 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 95.08 -1.53 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.166 0.507 . . . . 0.0 109.79 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.36 -103.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.9 -1.125 . . . . 0.0 109.534 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.442 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -160.36 96.95 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.839 -1.163 . . . . 0.0 109.687 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 2.2 m-20 -172.87 -170.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -0.861 . . . . 0.0 108.86 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.615 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 1.3 m 62.64 173.03 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.991 -1.068 . . . . 0.0 109.121 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 31.1 Cg_endo -73.21 -171.07 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.137 1.892 . . . . 0.0 110.952 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . -87.13 -41.21 6.7 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.457 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.728 HD12 HG23 ' A' ' 55' ' ' VAL . 13.4 pt -41.72 121.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.09 -1.241 . . . . 0.0 109.684 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 47.17 -130.76 1.43 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.391 -0.818 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 3.2 mmtt -162.55 -95.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.47 -1.394 . . . . 0.0 109.46 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -133.67 135.39 44.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 110.543 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.564 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 91.5 m -138.19 -173.06 3.42 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -84.9 153.9 22.58 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.999 -1.063 . . . . 0.0 109.155 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -133.53 14.41 4.76 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.526 ' OG ' HG21 ' A' ' 19' ' ' ILE . 80.3 p 51.28 14.2 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.879 . . . . 0.0 110.287 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' PRO . 23.9 t -161.9 29.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.625 -1.297 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 51' ' ' MET . . . 120.29 108.43 2.19 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 50' ' ' GLY . 19.7 mtm -43.21 145.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -1.102 . . . . 0.0 109.699 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . -157.34 -165.35 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.066 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.72 123.3 34.21 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.584 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 30.6 m-85 -116.93 156.36 27.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -94.23 161.88 28.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 55' ' ' VAL . 34.0 Cg_endo -76.68 -165.31 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.633 2.222 . . . . 0.0 111.056 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.5 -179.608 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.123 0.487 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.99 108.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.734 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -89.69 -21.03 22.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 108.949 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.05 72.44 76.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.768 . . . . 0.0 109.238 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.46 -93.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.56 2.174 . . . . 0.0 110.467 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 56' ' ' PRO . . . -136.52 -151.44 6.05 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -125.96 137.77 53.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -1.143 . . . . 0.0 109.708 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.23 152.72 95.6 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.903 . . . . 0.0 109.154 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.09 16.09 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.604 2.203 . . . . 0.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.62 123.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.913 -1.117 . . . . 0.0 108.526 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.965 HD13 ' O ' ' A' ' 46' ' ' GLU . 4.4 mp -143.65 126.45 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.339 -0.851 . . . . 0.0 109.644 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.047 ' HG ' HG22 ' A' ' 21' ' ' ILE . 47.8 tp 37.11 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.416 0.627 . . . . 0.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.047 HG22 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.15 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.879 . . . . 0.0 108.965 178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.725 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.87 35.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.921 -1.112 . . . . 0.0 109.682 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.572 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 5.13 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.557 0.694 . . . . 0.0 111.709 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.86 61.49 0.88 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.636 ' HB3' HD23 ' A' ' 26' ' ' LEU . 3.8 mmt -96.07 -100.12 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.497 -0.752 . . . . 0.0 110.319 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 25' ' ' MET . 1.0 OUTLIER -117.68 -134.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.762 -1.211 . . . . 0.0 110.006 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -111.79 90.51 13.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 109.761 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 34.6 Cg_endo -76.12 168.33 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.711 2.274 . . . . 0.0 110.271 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' C ' ' ND2' ' A' ' 30' ' ' ASN . 36.0 Cg_endo -77.87 174.93 11.82 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.559 2.172 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.485 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -155.27 134.97 12.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -85.86 -10.2 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.594 ' O ' HD23 ' A' ' 33' ' ' LEU . 30.3 p -161.02 163.78 31.4 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 32' ' ' CYS . 93.7 mt -158.04 -60.54 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.122 -0.986 . . . . 0.0 108.52 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' CE ' ' HB3' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -120.35 -39.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -84.46 58.43 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.584 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.524 ' CG2' ' SG ' ' A' ' 38' ' ' CYS . 27.1 m -42.64 125.3 3.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.54 44.88 1.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.33 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 36' ' ' THR . 1.8 m -102.24 116.16 63.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.99 102.68 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.169 1.913 . . . . 0.0 110.38 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.8 -130.34 4.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 41' ' ' ILE . 8.6 tp -117.95 58.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -1.168 . . . . 0.0 109.288 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -111.51 -178.02 3.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.432 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.2 tmtt? -164.08 125.88 2.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.359 -0.838 . . . . 0.0 108.759 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 21.9 t -56.22 112.79 1.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.088 -1.007 . . . . 0.0 110.236 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.612 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -124.78 -159.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 109.214 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.965 ' O ' HD13 ' A' ' 19' ' ' ILE . 5.1 mt-10 -116.37 113.51 23.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.81 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' HA2' HD13 ' A' ' 19' ' ' ILE . . . -94.47 62.35 1.72 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 49' ' ' CYS . 39.0 p 44.52 85.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.326 -1.102 . . . . 0.0 108.889 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER 87.4 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.675 -0.64 . . . . 0.0 109.648 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.53 153.15 11.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.549 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -111.27 162.23 15.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -1.047 . . . . 0.0 109.202 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -170.9 -170.4 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 52.1 m -77.06 115.68 17.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 110.86 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 60.7 m-85 -129.54 137.43 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.932 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.1 131.77 94.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.022 . . . . 0.0 108.625 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.3 Cg_endo -81.29 51.41 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.48 2.12 . . . . 0.0 110.672 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.593 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.322 0.582 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 -162.27 1.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -72.57 -28.22 62.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -116.53 109.46 43.78 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 108.887 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.12 -175.63 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.402 2.068 . . . . 0.0 111.22 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.06 -125.64 0.16 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -109.14 73.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -1.17 . . . . 0.0 109.657 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 50.0 m -60.04 153.61 54.84 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.18 -0.95 . . . . 0.0 109.073 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -81.84 -157.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.132 2.554 . . . . 0.0 111.219 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.753 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -81.45 150.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 21' ' ' ILE . 20.0 mm -120.48 128.33 76.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 111.254 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.691 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.49 -24.85 14.29 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.811 ' H ' HG22 ' A' ' 19' ' ' ILE . 10.8 tp 117.95 92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.531 0.732 . . . . 0.0 110.414 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 27.32 39.3 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.66 -0.65 . . . . 0.0 112.32 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.669 ' O ' ' N ' ' A' ' 25' ' ' MET . 4.0 p 38.06 21.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.186 -0.946 . . . . 0.0 112.46 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' O ' ' C ' ' A' ' 25' ' ' MET . . . 45.78 -87.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.895 1.225 . . . . 0.0 108.453 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.669 ' N ' ' O ' ' A' ' 23' ' ' CYS . 11.4 mmm -5.22 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.299 0.571 . . . . 0.0 111.759 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 26' ' ' LEU . 2.6 pt? -51.29 166.39 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.764 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 58.74 80.47 0.28 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 109.673 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 36.3 Cg_endo -79.03 132.42 10.5 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.611 2.208 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 36.6 Cg_endo -81.03 -164.82 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.519 2.146 . . . . 0.0 110.324 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 29' ' ' PRO . 1.5 m120 -150.5 111.05 4.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.351 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.45 -10.83 20.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.988 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 16.1 p -158.21 155.83 29.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.04 -1.037 . . . . 0.0 108.435 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 51' ' ' MET . 87.3 mt -152.39 -41.35 0.1 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.033 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 174.44 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 36' ' ' THR . 13.6 t70 -41.32 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.278 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 172.45 -36.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.123 . . . . 0.0 110.057 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 17.2 t0 -42.33 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.86 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' THR . 1.3 m -170.63 65.77 0.47 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 109.691 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.7 Cg_endo -79.46 154.75 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.878 2.385 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -68.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.408 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -84.24 -118.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -1.228 . . . . 0.0 110.76 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 41' ' ' ILE . 11.3 ttmt -142.37 -34.58 0.45 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.625 -1.297 . . . . 0.0 110.247 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -163.9 1.31 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 12.2 t -106.92 143.98 34.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.658 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -138.01 -166.81 2.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.506 -0.746 . . . . 0.0 109.001 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG3' ' HB3' ' A' ' 51' ' ' MET . 1.7 mp0 -122.99 124.72 43.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 19' ' ' ILE . . . -149.56 -145.4 4.12 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.139 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.759 ' N ' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -65.89 117.0 7.65 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.913 -0.757 . . . . 0.0 109.826 -178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER 78.92 91.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.602 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -141.38 20.92 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.574 ' HG3' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.64 149.33 40.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -1.04 . . . . 0.0 109.14 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -145.1 162.39 37.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.682 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 m -66.6 113.34 4.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.222 -0.924 . . . . 0.0 110.47 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.658 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 19.2 m-30 -112.22 -172.21 2.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -109.57 81.97 2.05 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.424 -0.798 . . . . 0.0 108.948 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 33.7 Cg_endo -73.74 178.02 7.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.656 2.237 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.534 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 10' ' ' SER . 65.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -168.62 75.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.585 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 12' ' ' LYS . 4.1 t -108.77 -39.81 5.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 2.1 mtmt -49.16 -51.76 53.85 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 109.685 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 36.1 Cg_endo -78.65 -47.07 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.385 2.056 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.86 -164.23 2.6 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -137.45 79.27 1.74 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.238 . . . . 0.0 109.821 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.2 m -47.8 166.25 0.21 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.197 -0.94 . . . . 0.0 108.752 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.639 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 34.4 Cg_endo -76.97 7.01 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.286 1.99 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.811 ' O ' HD13 ' A' ' 19' ' ' ILE . 14.5 mm 61.03 131.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.001 HG21 ' C ' ' A' ' 47' ' ' GLY . 2.3 mm -132.76 -138.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 2.4 pt? -161.7 -41.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 22' ' ' ARG . 39.7 mm -153.71 -105.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.447 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 21' ' ' ILE . 4.3 mtp180 169.65 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.685 -1.259 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 14.0 p 43.12 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 111.377 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' CG ' ' A' ' 25' ' ' MET . . . -73.45 83.63 1.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.402 -1.436 . . . . 0.0 107.633 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -168.23 96.26 0.41 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.4 -0.813 . . . . 0.0 109.141 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 5.3 tt -45.6 135.91 6.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.823 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER 163.95 -52.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.887 . . . . 0.0 110.315 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 27' ' ' ASN . 35.8 Cg_endo -80.33 111.26 2.6 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.654 2.236 . . . . 0.0 110.33 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 27' ' ' ASN . 36.6 Cg_endo -77.72 -100.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.197 1.931 . . . . 0.0 110.436 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' CG ' ' C ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -162.41 117.42 1.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.843 -1.161 . . . . 0.0 109.303 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.79 -26.23 34.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.756 ' O ' HD23 ' A' ' 33' ' ' LEU . 25.0 p -151.8 -176.21 5.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.32 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 173.86 -34.1 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.163 -0.961 . . . . 0.0 109.339 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 179.61 122.36 0.06 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 110.348 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 42.61 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.435 -0.791 . . . . 0.0 109.612 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.33 -142.48 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.346 -0.846 . . . . 0.0 109.184 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 47.41 60.54 15.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.032 -1.043 . . . . 0.0 109.416 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.6 Cg_endo -79.0 -179.86 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.591 2.194 . . . . 0.0 110.659 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . 44.9 -161.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.466 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 3.3 tt -41.81 -40.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.989 . . . . 0.0 109.824 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 5.4 mtmt -53.29 134.31 39.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.875 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 56' ' ' PRO . 3.2 mttt -149.25 148.84 30.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.421 -0.799 . . . . 0.0 109.002 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.62 124.15 20.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.033 -1.042 . . . . 0.0 109.789 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -133.64 -170.0 2.41 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -91.82 162.21 14.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 1.001 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -144.09 169.1 26.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.75 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -84.75 13.33 5.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.183 -1.186 . . . . 0.0 109.984 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.8 t 177.05 71.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.81 102.15 2.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 22' ' ' ARG . 1.6 mtt -49.3 168.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' CD1' ' A' ' 54' ' ' PHE . . . -179.53 168.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.993 -1.067 . . . . 0.0 110.053 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 m -68.65 99.75 1.04 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.639 ' CD2' ' HG3' ' A' ' 17' ' ' PRO . 96.2 m-85 -91.95 -169.16 2.19 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.279 -0.888 . . . . 0.0 109.046 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.5 104.92 36.59 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 34.9 Cg_endo -76.34 -159.75 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.186 1.924 . . . . 0.0 110.571 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 56' ' ' PRO . 2.3 pp0? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.99 35.18 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.256 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -122.13 153.01 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 115.05 12.05 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -77.85 -156.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.243 1.962 . . . . 0.0 110.02 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . -41.74 -93.83 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.09 131.63 40.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.244 . . . . 0.0 109.703 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.0 m -96.14 151.81 38.45 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -78.81 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.122 2.548 . . . . 0.0 110.328 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.514 ' C ' HD13 ' A' ' 19' ' ' ILE . 33.9 mm -120.99 140.68 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.319 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -115.04 -165.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -70.15 -44.69 68.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.479 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 161.93 -64.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.744 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -175.37 77.77 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -32.75 113.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.915 0.864 . . . . 0.0 110.625 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.1 59.16 3.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.835 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -122.32 101.5 7.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 25' ' ' MET . 1.3 pt? 38.18 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.59 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -108.86 93.48 12.49 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.526 -0.734 . . . . 0.0 109.668 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.0 Cg_endo -72.92 144.3 38.22 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.301 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.0 Cg_endo -77.98 -164.57 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.683 2.255 . . . . 0.0 110.705 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -143.96 112.79 6.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 22.8 ttt180 -55.46 -18.35 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.737 ' C ' HD23 ' A' ' 33' ' ' LEU . 20.9 p -151.12 177.96 9.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 109.001 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.867 HD12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -174.86 -40.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.008 -1.058 . . . . 0.0 110.073 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.867 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -141.61 -56.56 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 36' ' ' THR . 8.2 t70 -87.94 -97.32 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.0 109.227 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 38' ' ' CYS . 16.4 m 61.22 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 109.785 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 36' ' ' THR . 7.8 t70 91.93 -21.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.693 ' H ' HG22 ' A' ' 36' ' ' THR . 4.6 m 56.67 162.46 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.5 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 35.9 Cg_endo -78.98 -89.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.658 2.238 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -58.39 -158.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 41' ' ' ILE . 3.4 tp -75.86 82.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -1.107 . . . . 0.0 109.347 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -130.39 174.55 9.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.03 134.14 11.36 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 33.4 t -56.22 101.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.533 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.575 ' CB ' ' CD2' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -96.87 -167.36 1.54 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -116.36 93.99 4.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.782 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -72.67 -162.27 6.38 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.562 ' H ' HG21 ' A' ' 19' ' ' ILE . 5.5 p -94.37 -54.93 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.106 -1.232 . . . . 0.0 109.483 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 28' ' ' PRO . 10.1 t -67.02 -65.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.45 147.11 18.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.5 mtt -47.95 167.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 108.999 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.932 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -172.65 -176.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 36' ' ' THR . 3.5 m -91.58 98.63 11.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 109.315 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.932 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 13.5 m-30 -100.86 144.02 30.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 109.519 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.9 p -75.41 120.15 80.31 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 108.964 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.4 -172.81 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.302 2.001 . . . . 0.0 110.919 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' OXT' ' CG ' ' A' ' 57' ' ' GLN . 3.0 pt20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.621 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -98.88 -84.76 0.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.722 HG22 ' CD ' ' A' ' 12' ' ' LYS . 23.7 m -119.91 -94.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.081 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.722 ' CD ' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -131.94 57.08 27.38 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.959 -1.088 . . . . 0.0 109.505 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -77.94 -171.97 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.632 2.221 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . 55.19 169.02 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -129.23 135.11 48.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -1.056 . . . . 0.0 109.291 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 60.1 m -66.94 160.19 71.38 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HD2' HD11 ' A' ' 19' ' ' ILE . 36.4 Cg_endo -79.56 43.73 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 123.107 2.538 . . . . 0.0 111.589 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 17' ' ' PRO . 2.5 tp 40.47 100.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.89 . . . . 0.0 110.747 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -130.32 175.53 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 108.281 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -139.21 -65.29 0.49 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.534 -1.354 . . . . 0.0 111.78 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.046 ' N ' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -38.16 85.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.589 0.709 . . . . 0.0 111.187 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' LEU . 3.5 mtt180 -81.59 2.41 29.4 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 25' ' ' MET . 17.7 p 38.5 51.74 1.69 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.663 . . . . 0.0 110.661 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 89.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.067 -1.021 . . . . 0.0 109.028 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.715 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -127.23 -103.46 0.34 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.697 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 26' ' ' LEU . 2.0 pt? -164.57 26.08 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.508 -1.37 . . . . 0.0 110.84 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 2.9 m-20 164.76 80.07 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.859 -1.15 . . . . 0.0 110.145 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.03 170.37 17.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.517 2.145 . . . . 0.0 110.265 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.31 175.27 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.696 2.264 . . . . 0.0 110.353 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -144.56 93.91 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 109.389 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' MET . 10.7 tpt180 -89.61 -10.86 44.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.766 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 52' ' ' ALA . 17.5 p -153.56 169.01 24.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.972 -1.08 . . . . 0.0 109.814 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER 179.63 42.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.468 -0.77 . . . . 0.0 108.942 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' HG12 ' A' ' 9' ' ' VAL . 20.2 mtpt 65.34 -110.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 36' ' ' THR . 2.5 m-20 44.35 41.93 4.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.616 -1.303 . . . . 0.0 109.752 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 43.45 70.95 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.62 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -139.24 -169.57 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 42' ' ' LYS . 13.6 m 62.63 84.36 0.19 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.07 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.613 2.209 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.49 -130.63 45.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 41' ' ' ILE . 1.6 tt -122.38 66.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 0.6 OUTLIER -120.67 -162.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.749 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER 178.61 122.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.084 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 43' ' ' LYS . 50.7 t -49.93 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 110.166 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.87 -166.23 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.014 ' O ' HD13 ' A' ' 19' ' ' ILE . 2.7 tt0 -118.49 105.93 12.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 109.315 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -97.93 88.83 0.93 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.194 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 19' ' ' ILE . 0.1 OUTLIER 57.44 -98.99 0.09 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.606 -0.937 . . . . 0.0 109.799 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -100.09 118.41 36.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.902 -1.124 . . . . 0.0 110.055 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 143.46 3.2 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -87.68 168.33 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -1.016 . . . . 0.0 109.342 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 54' ' ' PHE . . . -168.88 158.69 9.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 108.845 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 61.7 m -63.86 94.48 0.1 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.879 -1.138 . . . . 0.0 109.194 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 47' ' ' GLY . 90.6 m-85 -94.24 178.92 5.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.15 130.3 25.27 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.29 157.84 29.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.329 2.02 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.397 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.854 HG22 ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.854 ' N ' HG22 ' A' ' 9' ' ' VAL . 13.7 m 66.65 -149.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.628 -1.295 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 12' ' ' LYS . 1.7 t -159.44 -49.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.53 ' N ' HG23 ' A' ' 11' ' ' THR . 3.9 ptmt -139.01 61.85 23.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 35.5 Cg_endo -77.78 -84.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.633 2.222 . . . . 0.0 110.473 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.38 -138.21 5.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 107.49 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.11 155.26 90.86 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.37 -167.96 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 110.596 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.561 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -121.88 141.08 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.089 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.731 HG21 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -132.57 166.97 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 109.263 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -44.86 -71.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' ARG . 90.6 mt -154.76 -109.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 22.1 mmm-85 -154.33 27.04 0.46 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.824 -1.172 . . . . 0.0 108.467 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 13.8 p 39.51 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.259 1.028 . . . . 0.0 110.415 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.76 55.94 3.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.605 -1.31 . . . . 0.0 108.936 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.6 mmm -98.53 -98.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.433 -0.792 . . . . 0.0 110.389 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 -105.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.595 -1.315 . . . . 0.0 110.43 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.78 92.31 49.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.782 -1.199 . . . . 0.0 109.865 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.33 164.87 33.12 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.374 2.05 . . . . 0.0 110.173 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 35.6 Cg_endo -77.87 177.43 8.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.702 2.268 . . . . 0.0 110.788 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HA2' ' A' ' 50' ' ' GLY . 60.8 m-80 -158.84 157.76 32.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.674 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -42.78 5.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.768 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -145.75 166.55 25.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.81 51.54 0.23 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 109.35 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.5 mmtt 79.87 51.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.343 1.068 . . . . 0.0 108.97 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.07 -97.62 0.06 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.576 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.8 t -156.31 138.39 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.383 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 173.77 -27.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.16 94.05 20.1 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 109.161 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 35.4 Cg_endo -77.6 -27.71 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.69 2.26 . . . . 0.0 110.756 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -61.68 -125.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' ILE . 5.1 tt -129.72 42.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.169 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 54' ' ' PHE . 23.2 mttt -119.82 -174.69 2.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 109.83 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 58.8 mmtt -149.2 167.33 26.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.51 92.08 5.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.43 -1.419 . . . . 0.0 111.041 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 96.6 m -92.29 -165.17 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' O ' HD11 ' A' ' 19' ' ' ILE . 7.9 mt-10 -101.52 140.52 35.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.699 -1.251 . . . . 0.0 109.688 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.731 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -122.3 33.35 4.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 8.0 t 75.9 -24.16 0.23 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.214 -0.58 . . . . 0.0 110.714 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 23.5 t -162.18 91.71 0.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.671 -1.268 . . . . 0.0 109.214 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA2' ' OD1' ' A' ' 30' ' ' ASN . . . 100.23 139.23 10.68 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -81.94 150.6 27.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -1.161 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.49 170.35 22.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 108.929 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 14.4 m -80.28 109.65 14.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.053 -1.029 . . . . 0.0 110.674 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m-85 -105.25 142.16 35.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -79.26 131.97 64.24 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.983 -1.073 . . . . 0.0 109.487 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 36.2 Cg_endo -78.62 -175.65 2.85 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.36 2.04 . . . . 0.0 110.667 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.18 71.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.465 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 4.4 t -152.64 160.59 43.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.094 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.544 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.75 61.31 15.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.984 -1.072 . . . . 0.0 110.267 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.7 Cg_endo -81.82 -40.65 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.509 2.139 . . . . 0.0 110.73 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' CA ' ' A' ' 57' ' ' GLN . . . -58.51 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.947 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 10.1 t -161.35 75.0 0.49 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.034 -1.274 . . . . 0.0 110.819 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 40.6 m -93.48 145.12 29.38 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 120.409 -1.432 . . . . 0.0 108.581 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.09 -163.38 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.56 2.174 . . . . 0.0 110.585 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.2 tp -85.35 131.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.014 HD12 ' HA2' ' A' ' 47' ' ' GLY . 27.3 mm -136.57 114.51 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 117.58 -1.648 . . . . 0.0 113.579 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -101.69 104.52 15.34 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -75.65 80.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.669 -1.269 . . . . 0.0 109.748 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.13 6.16 3.6 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.742 -0.599 . . . . 0.0 110.95 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' C ' ' O ' ' A' ' 22' ' ' ARG . 19.0 p -18.39 132.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.984 0.421 . . . . 0.0 111.624 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.89 60.13 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.6 mmt -143.56 124.76 14.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 2.9 tp -75.91 134.12 40.34 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 m120 77.03 90.52 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 34.0 Cg_endo -75.86 120.6 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.656 2.237 . . . . 0.0 111.363 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' ASN . 36.1 Cg_endo -78.75 -175.84 2.96 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.321 2.014 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 29' ' ' PRO . 56.8 m-80 -159.05 129.25 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -25.61 21.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 1.6 p -174.0 -169.55 0.49 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -161.2 -41.78 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 109.705 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 -65.87 1.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.937 . . . . 0.0 108.972 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -160.29 82.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.655 HG22 ' OD1' ' A' ' 37' ' ' ASP . 22.2 m -106.85 -77.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.655 ' OD1' HG22 ' A' ' 36' ' ' THR . 0.8 OUTLIER -118.66 -111.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.846 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER 39.99 86.82 0.12 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 0.0 109.401 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 35.3 Cg_endo -77.16 178.43 7.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.444 2.096 . . . . 0.0 110.534 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.07 -178.92 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 56' ' ' PRO . 8.7 pt -48.89 -24.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.118 -1.225 . . . . 0.0 109.075 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -52.87 138.11 30.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.166 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -153.51 -169.54 3.33 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.15 132.48 34.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.843 -1.161 . . . . 0.0 111.757 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 1.5 m -134.64 -166.38 1.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CB ' HG21 ' A' ' 19' ' ' ILE . 61.6 mt-10 -87.87 167.47 13.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.577 -1.327 . . . . 0.0 109.283 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 1.014 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -161.53 165.76 35.7 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -43.28 -43.45 4.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.205 -1.174 . . . . 0.0 109.033 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.508 ' N ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -116.9 129.52 56.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.789 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' CYS . . . 39.83 -115.54 0.58 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 10.9 mtt -149.35 176.98 10.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -1.117 . . . . 0.0 109.701 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -168.84 -173.61 1.89 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 60.8 m -86.48 96.96 10.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.785 -1.197 . . . . 0.0 111.936 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 47.9 m-85 -100.14 -124.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 108.183 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.831 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -86.59 -168.24 0.18 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.831 ' HD3' HG12 ' A' ' 55' ' ' VAL . 29.0 Cg_endo -72.22 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 120.725 0.95 . . . . 0.0 111.823 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.534 ' CA ' ' HA3' ' A' ' 14' ' ' GLY . 32.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.234 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.711 HG23 ' HG2' ' A' ' 34' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 -155.5 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.163 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 11' ' ' THR . 17.1 m -111.67 64.88 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -82.42 -55.29 0.57 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -79.77 177.36 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.327 2.018 . . . . 0.0 110.554 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.67 145.56 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.7 t -100.54 113.12 25.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -1.169 . . . . 0.0 109.51 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 11' ' ' THR . 74.2 m -72.21 137.64 81.55 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.599 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.2 Cg_endo -79.67 169.01 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.485 2.123 . . . . 0.0 110.148 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.3 mp -94.14 132.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.976 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.731 HG21 ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -96.73 172.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 108.837 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -56.83 -55.85 29.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.052 -1.03 . . . . 0.0 110.388 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 22' ' ' ARG . 36.4 mm -160.35 -104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.867 -1.146 . . . . 0.0 109.138 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.669 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -143.53 102.74 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.377 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -35.93 124.06 0.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.318 0.58 . . . . 0.0 110.584 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.62 58.67 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.469 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 0.8 OUTLIER -127.93 124.15 36.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -77.97 3.6 14.27 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.576 -0.703 . . . . 0.0 109.425 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -129.83 77.73 76.33 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.324 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.2 Cg_endo -78.32 134.6 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.481 2.121 . . . . 0.0 110.484 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 36.3 Cg_endo -77.77 -171.36 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.33 2.02 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 82.4 m-20 -158.84 100.49 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 109.704 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -23.0 42.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 0.0 108.933 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.653 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.6 p -164.57 163.99 21.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -158.27 27.69 0.25 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.988 -1.07 . . . . 0.0 109.05 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.711 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -177.16 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -161.24 45.88 0.18 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.492 -0.755 . . . . 0.0 109.121 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -134.52 64.84 1.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 109.706 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 171.26 -171.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.024 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.67 76.83 0.5 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.072 -1.017 . . . . 0.0 108.856 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.7 -25.03 12.92 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.539 2.16 . . . . 0.0 110.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.76 -154.42 3.98 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 41' ' ' ILE . 10.5 tt -86.5 51.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.147 -1.208 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 54' ' ' PHE . 1.4 mptp? -131.2 177.83 7.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.022 -1.049 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -160.35 176.08 12.09 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -78.45 128.83 34.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.096 -1.628 . . . . 0.0 110.805 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -140.89 -165.99 2.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 3.1 tt0 -86.37 157.24 19.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.758 -1.213 . . . . 0.0 109.338 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.731 ' O ' HG21 ' A' ' 19' ' ' ILE . . . -152.55 20.22 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.263 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 19' ' ' ILE . 1.1 p 82.45 -22.78 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.443 -1.033 . . . . 0.0 109.255 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 t -140.7 101.97 4.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 108.979 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 51' ' ' MET . . . 64.81 -126.36 32.01 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.476 ' CG ' ' C ' ' A' ' 50' ' ' GLY . 6.3 mtt -155.49 153.25 29.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -1.095 . . . . 0.0 108.57 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.34 -171.75 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 109.438 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 34.6 m -79.0 130.44 35.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 110.211 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 69.6 m-85 -129.23 172.37 11.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.481 -0.762 . . . . 0.0 109.188 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -96.06 108.97 44.45 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 37.2 Cg_endo -80.74 -156.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.364 2.042 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.363 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' HB3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 26.5 p 173.61 162.61 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.078 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.795 HG22 ' H ' ' A' ' 12' ' ' LYS . 1.5 m -128.99 -168.74 1.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.795 ' H ' HG22 ' A' ' 11' ' ' THR . 8.0 mmtp -89.03 -43.89 0.44 Allowed Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.169 -0.957 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.2 Cg_endo -78.96 -157.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.172 1.915 . . . . 0.0 110.874 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' CA ' ' HB2' ' A' ' 57' ' ' GLN . . . -40.86 101.87 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.87 -42.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.0 109.733 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.82 142.66 37.16 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.544 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 35.4 Cg_endo -78.93 -176.68 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.58 2.186 . . . . 0.0 110.929 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -80.18 137.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 109.126 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 18' ' ' ILE . 38.5 mm -136.76 101.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.0 110.124 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 48' ' ' SER . 0.1 OUTLIER -45.14 -93.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 22' ' ' ARG . 5.5 tp -121.84 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 21' ' ' ILE . 15.3 mtm-85 -143.21 56.46 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.316 -1.49 . . . . 0.0 109.509 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.569 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.2 p 34.34 55.42 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.839 -0.538 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 23' ' ' CYS . . . -20.04 -59.35 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.996 -0.44 . . . . 0.0 111.071 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 4.5 mmt 39.1 -98.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 110.02 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -150.42 -69.66 0.19 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.043 -1.035 . . . . 0.0 109.912 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -142.03 86.28 10.48 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.014 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.5 Cg_endo -77.97 142.01 19.39 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.605 2.204 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.1 Cg_endo -78.38 -168.2 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.658 2.238 . . . . 0.0 110.776 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -164.2 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.288 -0.883 . . . . 0.0 109.358 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -142.95 -33.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.545 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -169.07 174.45 6.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -147.98 -38.56 0.18 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.875 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.982 ' HB3' HG12 ' A' ' 9' ' ' VAL . 11.9 pttm -170.21 -40.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.727 -1.233 . . . . 0.0 110.455 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.05 21.81 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.202 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.545 ' HB ' ' CB ' ' A' ' 32' ' ' CYS . 3.6 m -111.79 164.68 12.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 109.364 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -108.39 139.92 42.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.677 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 29.8 m -115.86 84.81 13.56 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 36.0 Cg_endo -79.54 67.62 8.54 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.474 2.116 . . . . 0.0 110.083 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.89 -40.25 0.07 OUTLIER Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.409 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 41' ' ' ILE . 10.1 tt -148.85 90.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.777 -1.425 . . . . 0.0 110.912 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.619 ' CB ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER 45.86 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 112.291 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -160.68 -168.53 2.14 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.932 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.02 152.52 30.88 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.124 0.964 . . . . 0.0 111.129 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 1.5 m -160.62 -169.47 2.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 16.0 mt-10 -82.98 156.45 23.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.912 -1.118 . . . . 0.0 108.968 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -139.77 151.89 22.29 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.945 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 20' ' ' LEU . 14.1 m -64.55 -9.71 21.01 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -1.064 . . . . 0.0 109.568 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -161.55 86.79 0.67 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' MET . . . 88.75 112.86 1.22 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.699 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.8 ttt -47.94 173.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 108.799 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 165.41 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.729 ' O ' HG21 ' A' ' 41' ' ' ILE . 17.3 m -85.68 122.83 30.34 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.829 -1.17 . . . . 0.0 110.004 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 11.6 m-85 -116.15 179.55 3.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.0 p -113.55 86.14 9.95 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 42' ' ' LYS . 37.2 Cg_endo -78.9 -154.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.041 2.494 . . . . 0.0 110.775 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.55 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 73.1 mt-30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 34' ' ' LYS . 31.5 m . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.29 0.567 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.529 ' HB3' ' CE ' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -67.12 113.05 4.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.955 HG21 ' HA ' ' A' ' 45' ' ' CYS . 18.7 m -88.74 60.84 5.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 5.5 mttt -95.78 -49.19 0.25 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 111.686 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 37.1 Cg_endo -78.71 -104.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.002 1.801 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' PRO . . . 32.7 -142.21 0.05 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.433 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 39.6 t -143.11 68.47 1.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.008 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 84.4 m -64.41 155.12 81.79 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.054 -1.029 . . . . 0.0 108.874 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 36.4 Cg_endo -78.21 -176.53 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.458 2.105 . . . . 0.0 110.38 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -107.97 113.06 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.225 -0.922 . . . . 0.0 109.058 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.899 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 mm -90.45 -166.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.182 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 21' ' ' ILE . 3.5 pp -117.5 -53.79 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.55 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.956 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -162.99 178.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.626 ' N ' HG23 ' A' ' 21' ' ' ILE . 6.0 mtp180 -94.98 94.61 8.09 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.824 -1.172 . . . . 0.0 108.803 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.732 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -12.19 -53.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 79.02 -45.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.744 -1.223 . . . . 0.0 110.584 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.452 ' C ' ' O ' ' A' ' 24' ' ' ALA . 4.0 mmm -32.62 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.456 -0.777 . . . . 0.0 111.652 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -85.67 -178.32 6.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.057 -1.027 . . . . 0.0 110.662 -178.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -113.79 85.95 10.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.668 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' CG ' ' O ' ' A' ' 49' ' ' CYS . 35.8 Cg_endo -76.15 138.07 19.94 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.667 2.244 . . . . 0.0 110.291 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 37.1 Cg_endo -79.44 -102.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 110.355 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -161.61 154.82 21.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.773 -1.205 . . . . 0.0 109.563 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -104.16 -32.52 9.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 108.933 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 1.055 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -166.1 156.32 12.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.055 HD13 ' C ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -149.12 11.2 0.81 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.041 -177.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.8 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -177.82 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.943 -1.098 . . . . 0.0 109.686 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.8 82.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.434 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 93.9 m -159.24 123.79 4.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 57.89 -156.14 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.582 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 54.82 64.52 5.87 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 109.189 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 35.6 Cg_endo -78.63 128.21 8.5 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.771 2.314 . . . . 0.0 110.952 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.31 -155.13 20.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.47 -12.4 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.506 -0.996 . . . . 0.0 109.82 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.2 mtmp? -79.46 143.15 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.219 -0.926 . . . . 0.0 110.225 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 27.1 mttp -154.19 -179.36 7.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -80.81 130.45 35.07 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.685 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.955 ' HA ' HG21 ' A' ' 11' ' ' THR . 0.7 OUTLIER -134.45 -166.45 1.81 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 51' ' ' MET . 17.2 mt-10 -98.23 138.54 35.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.899 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -121.71 -139.45 5.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.753 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -113.95 -73.43 0.66 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.339 -1.095 . . . . 0.0 109.355 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' PRO . 7.2 t -78.56 -42.63 28.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.967 -1.083 . . . . 0.0 110.188 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 51' ' ' MET . . . -145.3 114.92 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 29.3 mtm -48.91 175.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 171.98 -163.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.6 -1.312 . . . . 0.0 110.581 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 56.3 m -78.17 90.12 4.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.947 -1.096 . . . . 0.0 112.635 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 86.4 m-85 -96.09 -123.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -82.75 -157.38 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.919 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.6 Cg_endo -65.52 -97.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.65 0 CA-C-N 121.119 1.435 . . . . 0.0 111.096 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.551 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.7 mt-30 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 120.302 -1.499 . . . . 0.0 110.037 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 34' ' ' LYS . 9.3 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.183 0.516 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.66 132.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 109.769 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 t -124.93 -37.33 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -81.48 -43.74 1.12 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.0 111.035 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 33.9 Cg_endo -77.08 -76.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.765 1.643 . . . . 0.0 110.933 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 42' ' ' LYS . . . -75.34 149.14 38.41 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -113.68 111.82 22.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -1.212 . . . . 0.0 109.943 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 58.8 m -75.44 143.96 76.99 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.192 -0.943 . . . . 0.0 109.076 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.54 -175.5 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.554 2.169 . . . . 0.0 110.988 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' C ' HD13 ' A' ' 19' ' ' ILE . 29.8 mm -118.54 154.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.603 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -117.88 166.08 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.023 . . . . 0.0 110.12 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -46.31 -74.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.791 ' N ' HD23 ' A' ' 20' ' ' LEU . 65.7 mt -159.3 -77.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 108.968 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.4 ttt85 -161.42 88.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.5 p -30.65 -42.16 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.678 -0.639 . . . . 0.0 111.257 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 72.38 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 24' ' ' ALA . 1.8 mmt 35.28 -92.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.821 -0.55 . . . . 0.0 110.779 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.542 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -132.61 -147.24 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.666 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -108.65 92.89 10.96 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.113 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.9 Cg_endo -72.82 146.77 43.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.487 2.125 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.9 Cg_endo -79.32 -159.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.65 2.233 . . . . 0.0 110.922 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.93 139.26 39.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 17.4 mmm180 -87.15 -38.94 15.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 110.026 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.828 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.2 p -155.76 172.01 19.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.022 -1.049 . . . . 0.0 109.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.828 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.5 36.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.42 -0.8 . . . . 0.0 109.123 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 95.08 -1.53 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.166 0.507 . . . . 0.0 109.79 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.36 -103.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.9 -1.125 . . . . 0.0 109.534 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.442 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -160.36 96.95 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.839 -1.163 . . . . 0.0 109.687 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 2.2 m-20 -172.87 -170.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -0.861 . . . . 0.0 108.86 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.615 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 1.3 m 62.64 173.03 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.991 -1.068 . . . . 0.0 109.121 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 31.1 Cg_endo -73.21 -171.07 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.137 1.892 . . . . 0.0 110.952 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . -87.13 -41.21 6.7 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.457 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.728 HD12 HG23 ' A' ' 55' ' ' VAL . 13.4 pt -41.72 121.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.09 -1.241 . . . . 0.0 109.684 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 47.17 -130.76 1.43 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.391 -0.818 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 3.2 mmtt -162.55 -95.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.47 -1.394 . . . . 0.0 109.46 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -133.67 135.39 44.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 110.543 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.564 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 91.5 m -138.19 -173.06 3.42 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -84.9 153.9 22.58 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.999 -1.063 . . . . 0.0 109.155 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -133.53 14.41 4.76 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.526 ' OG ' HG21 ' A' ' 19' ' ' ILE . 80.3 p 51.28 14.2 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.879 . . . . 0.0 110.287 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' PRO . 23.9 t -161.9 29.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.625 -1.297 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 51' ' ' MET . . . 120.29 108.43 2.19 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 50' ' ' GLY . 19.7 mtm -43.21 145.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -1.102 . . . . 0.0 109.699 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . -157.34 -165.35 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.066 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.72 123.3 34.21 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.584 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 30.6 m-85 -116.93 156.36 27.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -94.23 161.88 28.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 55' ' ' VAL . 34.0 Cg_endo -76.68 -165.31 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.633 2.222 . . . . 0.0 111.056 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.5 -179.608 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -87.27 -176.14 5.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.98 145.16 29.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' LYS . 35.7 Cg_endo -78.55 69.59 7.65 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.566 2.177 . . . . 0.0 110.545 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.793 HG12 ' HG2' ' A' ' 6' ' ' LYS . 85.8 t 51.88 -88.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.86 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.793 ' HG2' HG12 ' A' ' 5' ' ' VAL . 4.3 mmtm -106.73 170.07 8.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.517 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.49 -71.54 0.16 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.93 -153.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.63 2.22 . . . . 0.0 109.752 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 m -83.46 42.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.956 -1.09 . . . . 0.0 109.906 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.99 108.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.734 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -89.69 -21.03 22.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 108.949 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.05 72.44 76.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.768 . . . . 0.0 109.238 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.46 -93.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.56 2.174 . . . . 0.0 110.467 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 56' ' ' PRO . . . -136.52 -151.44 6.05 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -125.96 137.77 53.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -1.143 . . . . 0.0 109.708 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.23 152.72 95.6 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.903 . . . . 0.0 109.154 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.09 16.09 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.604 2.203 . . . . 0.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.62 123.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.913 -1.117 . . . . 0.0 108.526 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.965 HD13 ' O ' ' A' ' 46' ' ' GLU . 4.4 mp -143.65 126.45 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.339 -0.851 . . . . 0.0 109.644 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.047 ' HG ' HG22 ' A' ' 21' ' ' ILE . 47.8 tp 37.11 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.416 0.627 . . . . 0.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.047 HG22 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.15 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.879 . . . . 0.0 108.965 178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.725 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.87 35.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.921 -1.112 . . . . 0.0 109.682 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.572 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 5.13 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.557 0.694 . . . . 0.0 111.709 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.86 61.49 0.88 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.636 ' HB3' HD23 ' A' ' 26' ' ' LEU . 3.8 mmt -96.07 -100.12 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.497 -0.752 . . . . 0.0 110.319 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 25' ' ' MET . 1.0 OUTLIER -117.68 -134.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.762 -1.211 . . . . 0.0 110.006 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -111.79 90.51 13.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 109.761 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 34.6 Cg_endo -76.12 168.33 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.711 2.274 . . . . 0.0 110.271 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' C ' ' ND2' ' A' ' 30' ' ' ASN . 36.0 Cg_endo -77.87 174.93 11.82 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.559 2.172 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -155.27 134.97 12.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -85.86 -10.2 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.594 ' O ' HD23 ' A' ' 33' ' ' LEU . 30.3 p -161.02 163.78 31.4 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 32' ' ' CYS . 93.7 mt -158.04 -60.54 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.122 -0.986 . . . . 0.0 108.52 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' CE ' ' HB3' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -120.35 -39.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -84.46 58.43 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.584 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.524 ' CG2' ' SG ' ' A' ' 38' ' ' CYS . 27.1 m -42.64 125.3 3.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.54 44.88 1.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.33 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 36' ' ' THR . 1.8 m -102.24 116.16 63.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.99 102.68 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.169 1.913 . . . . 0.0 110.38 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.8 -130.34 4.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 41' ' ' ILE . 8.6 tp -117.95 58.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -1.168 . . . . 0.0 109.288 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -111.51 -178.02 3.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.432 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.2 tmtt? -164.08 125.88 2.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.359 -0.838 . . . . 0.0 108.759 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 21.9 t -56.22 112.79 1.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.088 -1.007 . . . . 0.0 110.236 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.612 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -124.78 -159.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 109.214 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.965 ' O ' HD13 ' A' ' 19' ' ' ILE . 5.1 mt-10 -116.37 113.51 23.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.81 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' HA2' HD13 ' A' ' 19' ' ' ILE . . . -94.47 62.35 1.72 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 49' ' ' CYS . 39.0 p 44.52 85.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.326 -1.102 . . . . 0.0 108.889 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER 87.4 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.675 -0.64 . . . . 0.0 109.648 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.53 153.15 11.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.549 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -111.27 162.23 15.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -1.047 . . . . 0.0 109.202 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -170.9 -170.4 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 52.1 m -77.06 115.68 17.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 110.86 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 60.7 m-85 -129.54 137.43 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.932 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.1 131.77 94.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.022 . . . . 0.0 108.625 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.3 Cg_endo -81.29 51.41 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.48 2.12 . . . . 0.0 110.672 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.593 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.25 71.34 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -137.31 65.55 49.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.631 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' VAL . 35.8 Cg_endo -78.32 4.9 5.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.539 2.16 . . . . 0.0 110.394 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 6' ' ' LYS . 13.9 p -43.89 168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' N ' HG22 ' A' ' 5' ' ' VAL . 6.4 ptpp? -106.51 -148.13 0.41 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.547 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' LYS . . . 136.54 91.99 0.32 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' C ' HG12 ' A' ' 9' ' ' VAL . 33.7 Cg_endo -76.16 159.29 37.26 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.455 2.103 . . . . 0.0 110.826 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.7 p 40.55 59.35 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.322 0.582 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -153.24 -162.27 1.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -72.57 -28.22 62.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 7' ' ' GLY . 17.6 mttt -116.53 109.46 43.78 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 108.887 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.12 -175.63 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.402 2.068 . . . . 0.0 111.22 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.06 -125.64 0.16 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -109.14 73.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -1.17 . . . . 0.0 109.657 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 50.0 m -60.04 153.61 54.84 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.18 -0.95 . . . . 0.0 109.073 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -81.84 -157.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.132 2.554 . . . . 0.0 111.219 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.753 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -81.45 150.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 21' ' ' ILE . 20.0 mm -120.48 128.33 76.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 111.254 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.691 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.49 -24.85 14.29 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.811 ' H ' HG22 ' A' ' 19' ' ' ILE . 10.8 tp 117.95 92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.531 0.732 . . . . 0.0 110.414 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 27.32 39.3 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.66 -0.65 . . . . 0.0 112.32 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.669 ' O ' ' N ' ' A' ' 25' ' ' MET . 4.0 p 38.06 21.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.186 -0.946 . . . . 0.0 112.46 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' O ' ' C ' ' A' ' 25' ' ' MET . . . 45.78 -87.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.895 1.225 . . . . 0.0 108.453 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.669 ' N ' ' O ' ' A' ' 23' ' ' CYS . 11.4 mmm -5.22 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.299 0.571 . . . . 0.0 111.759 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 26' ' ' LEU . 2.6 pt? -51.29 166.39 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.764 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 58.74 80.47 0.28 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 109.673 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 36.3 Cg_endo -79.03 132.42 10.5 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.611 2.208 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 36.6 Cg_endo -81.03 -164.82 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.519 2.146 . . . . 0.0 110.324 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 29' ' ' PRO . 1.5 m120 -150.5 111.05 4.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.351 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.45 -10.83 20.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.988 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 16.1 p -158.21 155.83 29.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.04 -1.037 . . . . 0.0 108.435 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 51' ' ' MET . 87.3 mt -152.39 -41.35 0.1 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.033 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 174.44 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 36' ' ' THR . 13.6 t70 -41.32 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.278 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 172.45 -36.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.123 . . . . 0.0 110.057 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 17.2 t0 -42.33 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.86 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' THR . 1.3 m -170.63 65.77 0.47 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 109.691 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.7 Cg_endo -79.46 154.75 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.878 2.385 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -68.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.408 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -84.24 -118.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -1.228 . . . . 0.0 110.76 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 41' ' ' ILE . 11.3 ttmt -142.37 -34.58 0.45 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.625 -1.297 . . . . 0.0 110.247 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -163.9 1.31 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 12.2 t -106.92 143.98 34.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.658 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -138.01 -166.81 2.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.506 -0.746 . . . . 0.0 109.001 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG3' ' HB3' ' A' ' 51' ' ' MET . 1.7 mp0 -122.99 124.72 43.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 19' ' ' ILE . . . -149.56 -145.4 4.12 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.139 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.759 ' N ' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -65.89 117.0 7.65 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.913 -0.757 . . . . 0.0 109.826 -178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER 78.92 91.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.602 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -141.38 20.92 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.574 ' HG3' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.64 149.33 40.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -1.04 . . . . 0.0 109.14 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -145.1 162.39 37.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.682 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 m -66.6 113.34 4.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.222 -0.924 . . . . 0.0 110.47 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.658 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 19.2 m-30 -112.22 -172.21 2.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -109.57 81.97 2.05 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.424 -0.798 . . . . 0.0 108.948 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 33.7 Cg_endo -73.74 178.02 7.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.656 2.237 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.534 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.04 -68.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.253 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.11 99.73 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.66 -159.29 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.461 2.107 . . . . 0.0 110.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 75.5 t -68.43 -82.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER 170.19 179.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.633 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.2 -78.31 0.07 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 37.7 Cg_endo -80.93 58.26 6.93 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.983 2.455 . . . . 0.0 110.496 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 10' ' ' SER . 65.8 t 65.67 -94.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.618 -0.676 . . . . 0.0 109.434 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -168.62 75.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.585 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 12' ' ' LYS . 4.1 t -108.77 -39.81 5.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 2.1 mtmt -49.16 -51.76 53.85 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 109.685 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 36.1 Cg_endo -78.65 -47.07 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.385 2.056 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.86 -164.23 2.6 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -137.45 79.27 1.74 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.238 . . . . 0.0 109.821 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.2 m -47.8 166.25 0.21 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.197 -0.94 . . . . 0.0 108.752 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.639 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 34.4 Cg_endo -76.97 7.01 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.286 1.99 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.811 ' O ' HD13 ' A' ' 19' ' ' ILE . 14.5 mm 61.03 131.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.001 HG21 ' C ' ' A' ' 47' ' ' GLY . 2.3 mm -132.76 -138.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 21' ' ' ILE . 2.4 pt? -161.7 -41.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 22' ' ' ARG . 39.7 mm -153.71 -105.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.447 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 21' ' ' ILE . 4.3 mtp180 169.65 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.685 -1.259 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 14.0 p 43.12 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 111.377 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' CG ' ' A' ' 25' ' ' MET . . . -73.45 83.63 1.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.402 -1.436 . . . . 0.0 107.633 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -168.23 96.26 0.41 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.4 -0.813 . . . . 0.0 109.141 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 5.3 tt -45.6 135.91 6.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.823 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER 163.95 -52.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.887 . . . . 0.0 110.315 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 27' ' ' ASN . 35.8 Cg_endo -80.33 111.26 2.6 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.654 2.236 . . . . 0.0 110.33 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 27' ' ' ASN . 36.6 Cg_endo -77.72 -100.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.197 1.931 . . . . 0.0 110.436 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' CG ' ' C ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -162.41 117.42 1.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.843 -1.161 . . . . 0.0 109.303 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.79 -26.23 34.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.756 ' O ' HD23 ' A' ' 33' ' ' LEU . 25.0 p -151.8 -176.21 5.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.32 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 173.86 -34.1 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.163 -0.961 . . . . 0.0 109.339 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 179.61 122.36 0.06 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 110.348 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 42.61 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.435 -0.791 . . . . 0.0 109.612 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.33 -142.48 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.346 -0.846 . . . . 0.0 109.184 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 47.41 60.54 15.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.032 -1.043 . . . . 0.0 109.416 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 36.6 Cg_endo -79.0 -179.86 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.591 2.194 . . . . 0.0 110.659 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . 44.9 -161.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.466 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 3.3 tt -41.81 -40.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.989 . . . . 0.0 109.824 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 5.4 mtmt -53.29 134.31 39.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.875 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 56' ' ' PRO . 3.2 mttt -149.25 148.84 30.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.421 -0.799 . . . . 0.0 109.002 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.62 124.15 20.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.033 -1.042 . . . . 0.0 109.789 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -133.64 -170.0 2.41 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -91.82 162.21 14.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 1.001 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -144.09 169.1 26.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.75 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -84.75 13.33 5.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.183 -1.186 . . . . 0.0 109.984 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.8 t 177.05 71.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.81 102.15 2.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 22' ' ' ARG . 1.6 mtt -49.3 168.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' CD1' ' A' ' 54' ' ' PHE . . . -179.53 168.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.993 -1.067 . . . . 0.0 110.053 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 m -68.65 99.75 1.04 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.639 ' CD2' ' HG3' ' A' ' 17' ' ' PRO . 96.2 m-85 -91.95 -169.16 2.19 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.279 -0.888 . . . . 0.0 109.046 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.5 104.92 36.59 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 34.9 Cg_endo -76.34 -159.75 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.186 1.924 . . . . 0.0 110.571 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 56' ' ' PRO . 2.3 pp0? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.255 0.55 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -26.8 64.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.699 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.19 103.03 10.66 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 -165.77 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.394 2.062 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 6' ' ' LYS . 8.5 p -101.95 -42.8 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 5' ' ' VAL . 16.9 mttt 56.52 81.74 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.207 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.84 100.95 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.58 37.68 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.647 2.231 . . . . 0.0 111.03 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.75 83.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.008 -1.058 . . . . 0.0 109.393 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.99 35.18 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.256 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -122.13 153.01 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 115.05 12.05 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -77.85 -156.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.243 1.962 . . . . 0.0 110.02 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . -41.74 -93.83 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.09 131.63 40.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.244 . . . . 0.0 109.703 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.0 m -96.14 151.81 38.45 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HD2' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -78.81 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.122 2.548 . . . . 0.0 110.328 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.514 ' C ' HD13 ' A' ' 19' ' ' ILE . 33.9 mm -120.99 140.68 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.319 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -115.04 -165.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -70.15 -44.69 68.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.479 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 161.93 -64.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.744 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -175.37 77.77 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -32.75 113.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.915 0.864 . . . . 0.0 110.625 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.1 59.16 3.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.835 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -122.32 101.5 7.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 25' ' ' MET . 1.3 pt? 38.18 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.59 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -108.86 93.48 12.49 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.526 -0.734 . . . . 0.0 109.668 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.0 Cg_endo -72.92 144.3 38.22 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.301 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.0 Cg_endo -77.98 -164.57 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.683 2.255 . . . . 0.0 110.705 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -143.96 112.79 6.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 22.8 ttt180 -55.46 -18.35 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.737 ' C ' HD23 ' A' ' 33' ' ' LEU . 20.9 p -151.12 177.96 9.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 109.001 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.867 HD12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -174.86 -40.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.008 -1.058 . . . . 0.0 110.073 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.867 ' HG2' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -141.61 -56.56 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 36' ' ' THR . 8.2 t70 -87.94 -97.32 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.0 109.227 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 38' ' ' CYS . 16.4 m 61.22 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 109.785 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 36' ' ' THR . 7.8 t70 91.93 -21.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.693 ' H ' HG22 ' A' ' 36' ' ' THR . 4.6 m 56.67 162.46 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.5 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 35.9 Cg_endo -78.98 -89.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.658 2.238 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -58.39 -158.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 41' ' ' ILE . 3.4 tp -75.86 82.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -1.107 . . . . 0.0 109.347 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -130.39 174.55 9.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.03 134.14 11.36 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 33.4 t -56.22 101.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.533 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.575 ' CB ' ' CD2' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -96.87 -167.36 1.54 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -116.36 93.99 4.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.782 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 19' ' ' ILE . . . -72.67 -162.27 6.38 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.562 ' H ' HG21 ' A' ' 19' ' ' ILE . 5.5 p -94.37 -54.93 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.106 -1.232 . . . . 0.0 109.483 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 28' ' ' PRO . 10.1 t -67.02 -65.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.45 147.11 18.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.5 mtt -47.95 167.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 108.999 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.932 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -172.65 -176.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 36' ' ' THR . 3.5 m -91.58 98.63 11.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 109.315 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.932 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 13.5 m-30 -100.86 144.02 30.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 109.519 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.9 p -75.41 120.15 80.31 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 108.964 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.4 -172.81 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.302 2.001 . . . . 0.0 110.919 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' OXT' ' CG ' ' A' ' 57' ' ' GLN . 3.0 pt20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.621 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -157.0 172.04 19.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 108.988 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -174.27 75.1 0.35 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.13 -0.981 . . . . 0.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.71 ' O ' HG23 ' A' ' 5' ' ' VAL . 35.3 Cg_endo -77.87 -91.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.566 2.178 . . . . 0.0 110.199 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER 164.68 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 108.839 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.03 58.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.02 141.32 16.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.87 -84.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.591 2.194 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -117.6 58.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -98.88 -84.76 0.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.722 HG22 ' CD ' ' A' ' 12' ' ' LYS . 23.7 m -119.91 -94.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.081 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.722 ' CD ' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -131.94 57.08 27.38 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.959 -1.088 . . . . 0.0 109.505 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -77.94 -171.97 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.632 2.221 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 13' ' ' PRO . . . 55.19 169.02 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -129.23 135.11 48.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -1.056 . . . . 0.0 109.291 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 60.1 m -66.94 160.19 71.38 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HD2' HD11 ' A' ' 19' ' ' ILE . 36.4 Cg_endo -79.56 43.73 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 123.107 2.538 . . . . 0.0 111.589 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 17' ' ' PRO . 2.5 tp 40.47 100.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.89 . . . . 0.0 110.747 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -130.32 175.53 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 108.281 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -139.21 -65.29 0.49 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.534 -1.354 . . . . 0.0 111.78 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.046 ' N ' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -38.16 85.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.589 0.709 . . . . 0.0 111.187 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' LEU . 3.5 mtt180 -81.59 2.41 29.4 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 25' ' ' MET . 17.7 p 38.5 51.74 1.69 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.663 . . . . 0.0 110.661 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 89.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.067 -1.021 . . . . 0.0 109.028 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.715 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -127.23 -103.46 0.34 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.697 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 26' ' ' LEU . 2.0 pt? -164.57 26.08 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.508 -1.37 . . . . 0.0 110.84 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 2.9 m-20 164.76 80.07 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.859 -1.15 . . . . 0.0 110.145 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.03 170.37 17.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.517 2.145 . . . . 0.0 110.265 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.31 175.27 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.696 2.264 . . . . 0.0 110.353 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -144.56 93.91 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 109.389 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' MET . 10.7 tpt180 -89.61 -10.86 44.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.766 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 52' ' ' ALA . 17.5 p -153.56 169.01 24.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.972 -1.08 . . . . 0.0 109.814 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER 179.63 42.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.468 -0.77 . . . . 0.0 108.942 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' HG12 ' A' ' 9' ' ' VAL . 20.2 mtpt 65.34 -110.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 36' ' ' THR . 2.5 m-20 44.35 41.93 4.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.616 -1.303 . . . . 0.0 109.752 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER 43.45 70.95 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.62 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -139.24 -169.57 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 42' ' ' LYS . 13.6 m 62.63 84.36 0.19 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.07 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.613 2.209 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.49 -130.63 45.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 41' ' ' ILE . 1.6 tt -122.38 66.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 0.6 OUTLIER -120.67 -162.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.749 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER 178.61 122.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.084 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 43' ' ' LYS . 50.7 t -49.93 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 110.166 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.87 -166.23 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.014 ' O ' HD13 ' A' ' 19' ' ' ILE . 2.7 tt0 -118.49 105.93 12.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 109.315 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -97.93 88.83 0.93 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.194 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 19' ' ' ILE . 0.1 OUTLIER 57.44 -98.99 0.09 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.606 -0.937 . . . . 0.0 109.799 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -100.09 118.41 36.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.902 -1.124 . . . . 0.0 110.055 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 143.46 3.2 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -87.68 168.33 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -1.016 . . . . 0.0 109.342 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 54' ' ' PHE . . . -168.88 158.69 9.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 108.845 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 61.7 m -63.86 94.48 0.1 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.879 -1.138 . . . . 0.0 109.194 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 47' ' ' GLY . 90.6 m-85 -94.24 178.92 5.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.15 130.3 25.27 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.29 157.84 29.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.329 2.02 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.397 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 2.2 tt0 73.75 111.07 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -148.16 74.9 10.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.07 42.12 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.799 2.333 . . . . 0.0 111.055 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.06 97.77 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.035 . . . . 0.0 109.462 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -66.18 0.59 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.88 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.88 -77.84 0.26 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' O ' HG13 ' A' ' 9' ' ' VAL . 36.2 Cg_endo -78.05 -170.98 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.522 2.148 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.854 HG22 ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER 42.35 -88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.753 -0.592 . . . . 0.0 109.877 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.854 ' N ' HG22 ' A' ' 9' ' ' VAL . 13.7 m 66.65 -149.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.628 -1.295 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 12' ' ' LYS . 1.7 t -159.44 -49.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.53 ' N ' HG23 ' A' ' 11' ' ' THR . 3.9 ptmt -139.01 61.85 23.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 35.5 Cg_endo -77.78 -84.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.633 2.222 . . . . 0.0 110.473 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.38 -138.21 5.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 107.49 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.11 155.26 90.86 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.37 -167.96 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 110.596 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.561 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -121.88 141.08 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.089 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.731 HG21 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -132.57 166.97 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 109.263 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' C ' HG13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -44.86 -71.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' ARG . 90.6 mt -154.76 -109.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 22.1 mmm-85 -154.33 27.04 0.46 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.824 -1.172 . . . . 0.0 108.467 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 13.8 p 39.51 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.259 1.028 . . . . 0.0 110.415 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.76 55.94 3.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.605 -1.31 . . . . 0.0 108.936 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.6 mmm -98.53 -98.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.433 -0.792 . . . . 0.0 110.389 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 -105.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.595 -1.315 . . . . 0.0 110.43 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.78 92.31 49.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.782 -1.199 . . . . 0.0 109.865 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.33 164.87 33.12 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.374 2.05 . . . . 0.0 110.173 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 35.6 Cg_endo -77.87 177.43 8.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.702 2.268 . . . . 0.0 110.788 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' OD1' ' HA2' ' A' ' 50' ' ' GLY . 60.8 m-80 -158.84 157.76 32.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.674 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -42.78 5.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.768 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -145.75 166.55 25.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.81 51.54 0.23 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 109.35 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.5 mmtt 79.87 51.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.343 1.068 . . . . 0.0 108.97 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.07 -97.62 0.06 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.576 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.8 t -156.31 138.39 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.383 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 32' ' ' CYS . 0.3 OUTLIER 173.77 -27.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.16 94.05 20.1 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 109.161 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 35.4 Cg_endo -77.6 -27.71 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.69 2.26 . . . . 0.0 110.756 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' PRO . . . -61.68 -125.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' ILE . 5.1 tt -129.72 42.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.169 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 54' ' ' PHE . 23.2 mttt -119.82 -174.69 2.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 109.83 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 58.8 mmtt -149.2 167.33 26.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.51 92.08 5.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.43 -1.419 . . . . 0.0 111.041 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 96.6 m -92.29 -165.17 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' O ' HD11 ' A' ' 19' ' ' ILE . 7.9 mt-10 -101.52 140.52 35.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.699 -1.251 . . . . 0.0 109.688 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.731 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -122.3 33.35 4.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 8.0 t 75.9 -24.16 0.23 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.214 -0.58 . . . . 0.0 110.714 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 23.5 t -162.18 91.71 0.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.671 -1.268 . . . . 0.0 109.214 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA2' ' OD1' ' A' ' 30' ' ' ASN . . . 100.23 139.23 10.68 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -81.94 150.6 27.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -1.161 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.49 170.35 22.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 108.929 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 14.4 m -80.28 109.65 14.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.053 -1.029 . . . . 0.0 110.674 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m-85 -105.25 142.16 35.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -79.26 131.97 64.24 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.983 -1.073 . . . . 0.0 109.487 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 36.2 Cg_endo -78.62 -175.65 2.85 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.36 2.04 . . . . 0.0 110.667 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 12.4 pt20 -120.3 -0.03 10.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.541 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.97 98.58 35.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.12 -0.988 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 2' ' ' GLN . 34.8 Cg_endo -76.94 162.74 31.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.395 2.063 . . . . 0.0 110.466 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 6' ' ' LYS . 2.6 p -135.39 -174.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.106 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.723 ' H ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.47 150.42 24.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.005 . . . . 0.0 109.433 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . 161.71 -56.65 0.3 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' GLY . 36.2 Cg_endo -78.04 -167.06 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.628 2.219 . . . . 0.0 110.255 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 30.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.18 71.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.465 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 4.4 t -152.64 160.59 43.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.094 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.544 ' N ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.75 61.31 15.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.984 -1.072 . . . . 0.0 110.267 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 36.7 Cg_endo -81.82 -40.65 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.509 2.139 . . . . 0.0 110.73 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' CA ' ' A' ' 57' ' ' GLN . . . -58.51 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.947 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 10.1 t -161.35 75.0 0.49 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.034 -1.274 . . . . 0.0 110.819 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 40.6 m -93.48 145.12 29.38 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 120.409 -1.432 . . . . 0.0 108.581 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.09 -163.38 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.56 2.174 . . . . 0.0 110.585 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.2 tp -85.35 131.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.014 HD12 ' HA2' ' A' ' 47' ' ' GLY . 27.3 mm -136.57 114.51 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 117.58 -1.648 . . . . 0.0 113.579 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -101.69 104.52 15.34 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -75.65 80.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.669 -1.269 . . . . 0.0 109.748 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.13 6.16 3.6 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.742 -0.599 . . . . 0.0 110.95 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' C ' ' O ' ' A' ' 22' ' ' ARG . 19.0 p -18.39 132.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.984 0.421 . . . . 0.0 111.624 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.89 60.13 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.6 mmt -143.56 124.76 14.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 2.9 tp -75.91 134.12 40.34 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 m120 77.03 90.52 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 34.0 Cg_endo -75.86 120.6 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.656 2.237 . . . . 0.0 111.363 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' ASN . 36.1 Cg_endo -78.75 -175.84 2.96 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.321 2.014 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 29' ' ' PRO . 56.8 m-80 -159.05 129.25 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -25.61 21.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 1.6 p -174.0 -169.55 0.49 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -161.2 -41.78 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 109.705 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 -65.87 1.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.937 . . . . 0.0 108.972 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -160.29 82.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.655 HG22 ' OD1' ' A' ' 37' ' ' ASP . 22.2 m -106.85 -77.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.655 ' OD1' HG22 ' A' ' 36' ' ' THR . 0.8 OUTLIER -118.66 -111.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.846 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER 39.99 86.82 0.12 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 0.0 109.401 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 35.3 Cg_endo -77.16 178.43 7.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.444 2.096 . . . . 0.0 110.534 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.07 -178.92 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 56' ' ' PRO . 8.7 pt -48.89 -24.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.118 -1.225 . . . . 0.0 109.075 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -52.87 138.11 30.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.166 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -153.51 -169.54 3.33 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.15 132.48 34.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.843 -1.161 . . . . 0.0 111.757 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 1.5 m -134.64 -166.38 1.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CB ' HG21 ' A' ' 19' ' ' ILE . 61.6 mt-10 -87.87 167.47 13.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.577 -1.327 . . . . 0.0 109.283 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 1.014 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -161.53 165.76 35.7 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -43.28 -43.45 4.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.205 -1.174 . . . . 0.0 109.033 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.508 ' N ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -116.9 129.52 56.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.789 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' CYS . . . 39.83 -115.54 0.58 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 10.9 mtt -149.35 176.98 10.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -1.117 . . . . 0.0 109.701 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -168.84 -173.61 1.89 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 60.8 m -86.48 96.96 10.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.785 -1.197 . . . . 0.0 111.936 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 47.9 m-85 -100.14 -124.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 108.183 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.831 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -86.59 -168.24 0.18 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.831 ' HD3' HG12 ' A' ' 55' ' ' VAL . 29.0 Cg_endo -72.22 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 120.725 0.95 . . . . 0.0 111.823 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.534 ' CA ' ' HA3' ' A' ' 14' ' ' GLY . 32.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.234 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.29 144.87 9.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -152.87 84.14 4.61 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.374 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.35 0.86 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.748 2.299 . . . . 0.0 110.473 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.26 137.75 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -91.7 30.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.496 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -153.75 63.59 0.36 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 7' ' ' GLY . 36.2 Cg_endo -78.21 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.779 2.319 . . . . 0.0 110.553 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.711 HG23 ' HG2' ' A' ' 34' ' ' LYS . 2.5 p -172.82 -36.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 -155.5 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.163 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 11' ' ' THR . 17.1 m -111.67 64.88 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -82.42 -55.29 0.57 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 12' ' ' LYS . 36.3 Cg_endo -79.77 177.36 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.327 2.018 . . . . 0.0 110.554 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.67 145.56 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.7 t -100.54 113.12 25.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -1.169 . . . . 0.0 109.51 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 11' ' ' THR . 74.2 m -72.21 137.64 81.55 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.599 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.2 Cg_endo -79.67 169.01 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.485 2.123 . . . . 0.0 110.148 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.3 mp -94.14 132.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.976 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.731 HG21 ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -96.73 172.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 108.837 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -56.83 -55.85 29.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.052 -1.03 . . . . 0.0 110.388 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 22' ' ' ARG . 36.4 mm -160.35 -104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.867 -1.146 . . . . 0.0 109.138 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.669 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -143.53 102.74 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.377 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -35.93 124.06 0.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.318 0.58 . . . . 0.0 110.584 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.62 58.67 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.469 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 0.8 OUTLIER -127.93 124.15 36.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -77.97 3.6 14.27 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.576 -0.703 . . . . 0.0 109.425 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -129.83 77.73 76.33 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.324 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.2 Cg_endo -78.32 134.6 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.481 2.121 . . . . 0.0 110.484 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 36.3 Cg_endo -77.77 -171.36 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.33 2.02 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 82.4 m-20 -158.84 100.49 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 109.704 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -23.0 42.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 0.0 108.933 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.653 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.6 p -164.57 163.99 21.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -158.27 27.69 0.25 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.988 -1.07 . . . . 0.0 109.05 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.711 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -177.16 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -161.24 45.88 0.18 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.492 -0.755 . . . . 0.0 109.121 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -134.52 64.84 1.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 109.706 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 0.2 OUTLIER 171.26 -171.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.024 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.67 76.83 0.5 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.072 -1.017 . . . . 0.0 108.856 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.7 -25.03 12.92 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.539 2.16 . . . . 0.0 110.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.76 -154.42 3.98 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 41' ' ' ILE . 10.5 tt -86.5 51.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.147 -1.208 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 54' ' ' PHE . 1.4 mptp? -131.2 177.83 7.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.022 -1.049 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -160.35 176.08 12.09 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -78.45 128.83 34.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.096 -1.628 . . . . 0.0 110.805 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -140.89 -165.99 2.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 3.1 tt0 -86.37 157.24 19.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.758 -1.213 . . . . 0.0 109.338 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.731 ' O ' HG21 ' A' ' 19' ' ' ILE . . . -152.55 20.22 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.263 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 19' ' ' ILE . 1.1 p 82.45 -22.78 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.443 -1.033 . . . . 0.0 109.255 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 t -140.7 101.97 4.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 108.979 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 51' ' ' MET . . . 64.81 -126.36 32.01 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.476 ' CG ' ' C ' ' A' ' 50' ' ' GLY . 6.3 mtt -155.49 153.25 29.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -1.095 . . . . 0.0 108.57 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 44' ' ' CYS . . . -155.34 -171.75 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 109.438 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 34.6 m -79.0 130.44 35.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 110.211 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 69.6 m-85 -129.23 172.37 11.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.481 -0.762 . . . . 0.0 109.188 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.4 p -96.06 108.97 44.45 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 37.2 Cg_endo -80.74 -156.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.364 2.042 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.363 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.04 98.24 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.399 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.49 79.88 2.37 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.46 84.29 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.652 2.235 . . . . 0.0 110.428 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 5' ' ' VAL . 14.5 p -144.24 43.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.533 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -127.48 -18.59 4.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.116 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 154.94 18.29 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.97 33.96 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.765 2.31 . . . . 0.0 111.199 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' HB3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -111.19 -33.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.005 -1.059 . . . . 0.0 109.242 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 26.5 p 173.61 162.61 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.078 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.795 HG22 ' H ' ' A' ' 12' ' ' LYS . 1.5 m -128.99 -168.74 1.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.795 ' H ' HG22 ' A' ' 11' ' ' THR . 8.0 mmtp -89.03 -43.89 0.44 Allowed Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.169 -0.957 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 36.2 Cg_endo -78.96 -157.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.172 1.915 . . . . 0.0 110.874 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' CA ' ' HB2' ' A' ' 57' ' ' GLN . . . -40.86 101.87 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.87 -42.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.0 109.733 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.82 142.66 37.16 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.544 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 35.4 Cg_endo -78.93 -176.68 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.58 2.186 . . . . 0.0 110.929 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -80.18 137.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 109.126 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 18' ' ' ILE . 38.5 mm -136.76 101.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.0 110.124 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 48' ' ' SER . 0.1 OUTLIER -45.14 -93.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 22' ' ' ARG . 5.5 tp -121.84 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 21' ' ' ILE . 15.3 mtm-85 -143.21 56.46 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.316 -1.49 . . . . 0.0 109.509 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.569 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.2 p 34.34 55.42 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.839 -0.538 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 23' ' ' CYS . . . -20.04 -59.35 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.996 -0.44 . . . . 0.0 111.071 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 4.5 mmt 39.1 -98.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 110.02 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -150.42 -69.66 0.19 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.043 -1.035 . . . . 0.0 109.912 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -142.03 86.28 10.48 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.014 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 35.5 Cg_endo -77.97 142.01 19.39 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.605 2.204 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.1 Cg_endo -78.38 -168.2 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.658 2.238 . . . . 0.0 110.776 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -164.2 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.288 -0.883 . . . . 0.0 109.358 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -142.95 -33.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.545 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -169.07 174.45 6.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -147.98 -38.56 0.18 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.875 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.982 ' HB3' HG12 ' A' ' 9' ' ' VAL . 11.9 pttm -170.21 -40.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.727 -1.233 . . . . 0.0 110.455 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.05 21.81 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.202 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.545 ' HB ' ' CB ' ' A' ' 32' ' ' CYS . 3.6 m -111.79 164.68 12.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 109.364 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -108.39 139.92 42.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.677 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 29.8 m -115.86 84.81 13.56 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 36.0 Cg_endo -79.54 67.62 8.54 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.474 2.116 . . . . 0.0 110.083 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.89 -40.25 0.07 OUTLIER Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.409 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 41' ' ' ILE . 10.1 tt -148.85 90.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.777 -1.425 . . . . 0.0 110.912 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.619 ' CB ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER 45.86 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 112.291 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -160.68 -168.53 2.14 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.932 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -79.02 152.52 30.88 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.124 0.964 . . . . 0.0 111.129 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 1.5 m -160.62 -169.47 2.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 16.0 mt-10 -82.98 156.45 23.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.912 -1.118 . . . . 0.0 108.968 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -139.77 151.89 22.29 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.945 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 20' ' ' LEU . 14.1 m -64.55 -9.71 21.01 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -1.064 . . . . 0.0 109.568 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -161.55 86.79 0.67 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' MET . . . 88.75 112.86 1.22 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.699 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.8 ttt -47.94 173.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 108.799 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 165.41 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.729 ' O ' HG21 ' A' ' 41' ' ' ILE . 17.3 m -85.68 122.83 30.34 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.829 -1.17 . . . . 0.0 110.004 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 11.6 m-85 -116.15 179.55 3.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.0 p -113.55 86.14 9.95 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 42' ' ' LYS . 37.2 Cg_endo -78.9 -154.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.041 2.494 . . . . 0.0 110.775 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.55 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 73.1 mt-30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 2.7 mt-30 60.04 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.717 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.3 mp0 -50.21 143.57 12.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.54 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 5' ' ' VAL . 35.7 Cg_endo -78.17 -61.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.556 2.171 . . . . 0.0 110.045 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 5' ' ' VAL . 13.7 p 40.3 39.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -92.23 112.99 25.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.332 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.77 70.47 0.52 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.79 -158.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.588 2.192 . . . . 0.0 110.348 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 34' ' ' LYS . 31.5 m -49.0 -22.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.163 -0.961 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.529 ' HB3' ' CE ' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -67.12 113.05 4.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.955 HG21 ' HA ' ' A' ' 45' ' ' CYS . 18.7 m -88.74 60.84 5.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 5.5 mttt -95.78 -49.19 0.25 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 111.686 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 37.1 Cg_endo -78.71 -104.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.002 1.801 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' PRO . . . 32.7 -142.21 0.05 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.433 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 39.6 t -143.11 68.47 1.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.008 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' N ' ' OXT' ' A' ' 57' ' ' GLN . 84.4 m -64.41 155.12 81.79 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.054 -1.029 . . . . 0.0 108.874 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HG3' ' HB3' ' A' ' 54' ' ' PHE . 36.4 Cg_endo -78.21 -176.53 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.458 2.105 . . . . 0.0 110.38 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -107.97 113.06 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.225 -0.922 . . . . 0.0 109.058 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.899 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 mm -90.45 -166.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.182 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 21' ' ' ILE . 3.5 pp -117.5 -53.79 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.55 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.956 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -162.99 178.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.626 ' N ' HG23 ' A' ' 21' ' ' ILE . 6.0 mtp180 -94.98 94.61 8.09 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.824 -1.172 . . . . 0.0 108.803 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.732 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -12.19 -53.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 79.02 -45.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.744 -1.223 . . . . 0.0 110.584 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.452 ' C ' ' O ' ' A' ' 24' ' ' ALA . 4.0 mmm -32.62 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.456 -0.777 . . . . 0.0 111.652 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -85.67 -178.32 6.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.057 -1.027 . . . . 0.0 110.662 -178.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -113.79 85.95 10.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.668 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' CG ' ' O ' ' A' ' 49' ' ' CYS . 35.8 Cg_endo -76.15 138.07 19.94 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.667 2.244 . . . . 0.0 110.291 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 37.1 Cg_endo -79.44 -102.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 110.355 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -161.61 154.82 21.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.773 -1.205 . . . . 0.0 109.563 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -104.16 -32.52 9.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 108.933 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 1.055 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -166.1 156.32 12.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.055 HD13 ' C ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -149.12 11.2 0.81 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.041 -177.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.8 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -177.82 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.943 -1.098 . . . . 0.0 109.686 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.8 82.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.434 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 93.9 m -159.24 123.79 4.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 57.89 -156.14 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.582 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 54.82 64.52 5.87 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 109.189 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 38' ' ' CYS . 35.6 Cg_endo -78.63 128.21 8.5 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.771 2.314 . . . . 0.0 110.952 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.31 -155.13 20.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.47 -12.4 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.506 -0.996 . . . . 0.0 109.82 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.2 mtmp? -79.46 143.15 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.219 -0.926 . . . . 0.0 110.225 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 27.1 mttp -154.19 -179.36 7.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -80.81 130.45 35.07 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.685 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.955 ' HA ' HG21 ' A' ' 11' ' ' THR . 0.7 OUTLIER -134.45 -166.45 1.81 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 51' ' ' MET . 17.2 mt-10 -98.23 138.54 35.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.899 ' C ' HG21 ' A' ' 19' ' ' ILE . . . -121.71 -139.45 5.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.753 ' N ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -113.95 -73.43 0.66 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.339 -1.095 . . . . 0.0 109.355 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' PRO . 7.2 t -78.56 -42.63 28.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.967 -1.083 . . . . 0.0 110.188 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 51' ' ' MET . . . -145.3 114.92 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 29.3 mtm -48.91 175.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 51' ' ' MET . . . 171.98 -163.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.6 -1.312 . . . . 0.0 110.581 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 56.3 m -78.17 90.12 4.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.947 -1.096 . . . . 0.0 112.635 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 86.4 m-85 -96.09 -123.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG12 ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -82.75 -157.38 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.919 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.6 Cg_endo -65.52 -97.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.65 0 CA-C-N 121.119 1.435 . . . . 0.0 111.096 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.551 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.7 mt-30 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 120.302 -1.499 . . . . 0.0 110.037 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 45.37 68.49 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.375 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.23 147.44 39.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.384 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 35.5 Cg_endo -78.59 126.87 7.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.627 2.218 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.712 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.9 p -89.87 57.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -77.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.1 -1.0 . . . . 0.0 109.252 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.91 -178.28 43.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 9' ' ' VAL . 35.0 Cg_endo -76.92 -154.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.79 2.327 . . . . 0.0 110.296 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 34' ' ' LYS . 9.3 m -40.58 -35.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.66 132.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 109.769 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 t -124.93 -37.33 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -81.48 -43.74 1.12 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.0 111.035 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' LYS . 33.9 Cg_endo -77.08 -76.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.765 1.643 . . . . 0.0 110.933 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 42' ' ' LYS . . . -75.34 149.14 38.41 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -113.68 111.82 22.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -1.212 . . . . 0.0 109.943 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 58.8 m -75.44 143.96 76.99 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.192 -0.943 . . . . 0.0 109.076 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 54' ' ' PHE . 36.6 Cg_endo -79.54 -175.5 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.554 2.169 . . . . 0.0 110.988 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' C ' HD13 ' A' ' 19' ' ' ILE . 29.8 mm -118.54 154.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.603 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -117.88 166.08 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.023 . . . . 0.0 110.12 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -46.31 -74.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.791 ' N ' HD23 ' A' ' 20' ' ' LEU . 65.7 mt -159.3 -77.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 108.968 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.4 ttt85 -161.42 88.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.5 p -30.65 -42.16 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.678 -0.639 . . . . 0.0 111.257 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 23' ' ' CYS . . . 72.38 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 24' ' ' ALA . 1.8 mmt 35.28 -92.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.821 -0.55 . . . . 0.0 110.779 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.542 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -132.61 -147.24 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.666 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -108.65 92.89 10.96 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.113 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 26' ' ' LEU . 32.9 Cg_endo -72.82 146.77 43.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.487 2.125 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 28' ' ' PRO . 36.9 Cg_endo -79.32 -159.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.65 2.233 . . . . 0.0 110.922 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.93 139.26 39.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 17.4 mmm180 -87.15 -38.94 15.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 110.026 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.828 ' C ' HD23 ' A' ' 33' ' ' LEU . 1.2 p -155.76 172.01 19.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.022 -1.049 . . . . 0.0 109.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.828 HD23 ' C ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -161.5 36.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.42 -0.8 . . . . 0.0 109.123 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 95.08 -1.53 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.166 0.507 . . . . 0.0 109.79 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.36 -103.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.9 -1.125 . . . . 0.0 109.534 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.442 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -160.36 96.95 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.839 -1.163 . . . . 0.0 109.687 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 2.2 m-20 -172.87 -170.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -0.861 . . . . 0.0 108.86 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.615 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 1.3 m 62.64 173.03 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.991 -1.068 . . . . 0.0 109.121 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 31.1 Cg_endo -73.21 -171.07 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.137 1.892 . . . . 0.0 110.952 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ILE . . . -87.13 -41.21 6.7 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.457 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.728 HD12 HG23 ' A' ' 55' ' ' VAL . 13.4 pt -41.72 121.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.09 -1.241 . . . . 0.0 109.684 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 47.17 -130.76 1.43 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.391 -0.818 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 3.2 mmtt -162.55 -95.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.47 -1.394 . . . . 0.0 109.46 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -133.67 135.39 44.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 110.543 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.564 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 91.5 m -138.19 -173.06 3.42 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -84.9 153.9 22.58 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.999 -1.063 . . . . 0.0 109.155 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -133.53 14.41 4.76 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.526 ' OG ' HG21 ' A' ' 19' ' ' ILE . 80.3 p 51.28 14.2 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.879 . . . . 0.0 110.287 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' PRO . 23.9 t -161.9 29.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.625 -1.297 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 51' ' ' MET . . . 120.29 108.43 2.19 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 50' ' ' GLY . 19.7 mtm -43.21 145.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -1.102 . . . . 0.0 109.699 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . -157.34 -165.35 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.066 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.72 123.3 34.21 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.584 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 17' ' ' PRO . 30.6 m-85 -116.93 156.36 27.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -94.23 161.88 28.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 55' ' ' VAL . 34.0 Cg_endo -76.68 -165.31 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.633 2.222 . . . . 0.0 111.056 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.5 -179.608 . . . . . . . . 0 0 . 1 stop_ save_